
<html lang="en"     class="pb-page"  data-request-id="a491eb05-6b4c-4c0c-ad58-2015634c3491"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b01649;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-23"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors" /></meta><meta name="dc.Creator" content="Fubao  Huang" /></meta><meta name="dc.Creator" content="Mengmeng  Ning" /></meta><meta name="dc.Creator" content="Kai  Wang" /></meta><meta name="dc.Creator" content="Jia  Liu" /></meta><meta name="dc.Creator" content="Wenbo  Guan" /></meta><meta name="dc.Creator" content="Ying  Leng" /></meta><meta name="dc.Creator" content="Jianhua  Shen" /></meta><meta name="dc.Description" content="Although intensively expressed within intestine, the precise roles of intestinal dipeptidyl peptidase IV (DPPIV) in numerous pathologies remain incompletely understood. Here, we first reported a no..." /></meta><meta name="Description" content="Although intensively expressed within intestine, the precise roles of intestinal dipeptidyl peptidase IV (DPPIV) in numerous pathologies remain incompletely understood. Here, we first reported a no..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2019" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01649" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01649" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01649" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01649" /></link>
        
    
    

<title>Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01649" /></meta><meta property="og:title" content="Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0006.jpeg" /></meta><meta property="og:description" content="Although intensively expressed within intestine, the precise roles of intestinal dipeptidyl peptidase IV (DPPIV) in numerous pathologies remain incompletely understood. Here, we first reported a nonsystemic intestine-targeted (NSIT) DPPIV inhibitor with β-homophenylalanine scaffold, compound 7, which selectively inhibited the intestinal rather than plasmatic DPPIV at an oral dosage as high as 30 mg/kg. We expect that compound 7 could serve as a qualified tissue-selective tool to determine undetected physiological or pathological roles of intestinal DPPIV." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01649"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01649">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01649&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01649&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01649&amp;href=/doi/10.1021/acs.jmedchem.9b01649" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10919-10925</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01606" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.9b01878" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Fubao Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fubao Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research,  Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fubao++Huang">Fubao Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mengmeng Ning</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mengmeng Ning</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research,  Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mengmeng++Ning">Mengmeng Ning</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kai Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kai Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research,  Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kai++Wang">Kai Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jia Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Liu">Jia Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenbo Guan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenbo Guan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research,  Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenbo++Guan">Wenbo Guan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying Leng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Leng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research,  Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>For Y.L.: phone, +86-21-50806059; E-mail, <a href="/cdn-cgi/l/email-protection#83faefe6ede4c3f0eaeeeeade2e0ade0ed"><span class="__cf_email__" data-cfemail="bec7d2dbd0d9fecdd7d3d390dfdd90ddd0">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Leng">Ying Leng</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jianhua Shen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianhua Shen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research,  Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</div></div><span class="conrtib-corresp"><strong>*</strong>For J.S.: phone, +86-21-20231969; E-mail, <a href="/cdn-cgi/l/email-protection#711b190219141f3102181c1c5f10125f121f"><span class="__cf_email__" data-cfemail="33595b405b565d73405a5e5e1d52501d505d">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianhua++Shen">Jianhua Shen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9273-3409" title="Orcid link">http://orcid.org/0000-0002-9273-3409</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01649&amp;href=/doi/10.1021%2Facs.jmedchem.9b01649" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10919–10925</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 October 2019</li><li><span class="item_label"><b>Published</b> online</span>20 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01649" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01649</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10919%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFubao%2BHuang%252C%2BMengmeng%2BNing%252C%2BKai%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D23%26contentID%3Dacs.jmedchem.9b01649%26title%3DDiscovery%2Bof%2BHighly%2BPolar%2B%25CE%25B2-Homophenylalanine%2BDerivatives%2Bas%2BNonsystemic%2BIntestine-Targeted%2BDipeptidyl%2BPeptidase%2BIV%2BInhibitors%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10925%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01649"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">636</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01649" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fubao&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Mengmeng&quot;,&quot;last_name&quot;:&quot;Ning&quot;},{&quot;first_name&quot;:&quot;Kai&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wenbo&quot;,&quot;last_name&quot;:&quot;Guan&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Leng&quot;},{&quot;first_name&quot;:&quot;Jianhua&quot;,&quot;last_name&quot;:&quot;Shen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10919-10925&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01649&quot;},&quot;abstract&quot;:&quot;Although intensively expressed within intestine, the precise roles of intestinal dipeptidyl peptidase IV (DPPIV) in numerous pathologies remain incompletely understood. Here, we first reported a nonsystemic intestine-targeted (NSIT) DPPIV inhibitor with β-homophenylalanine scaffold, compound 7, which selectively inhibited the intestinal rather than plasmatic DPPIV at an oral dosage as high as 30 mg/kg. We expect that compound 7 could serve as a qualified tissue-selective tool to determine undetected physiological or pathological roles of intestinal DPPIV.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01649&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01649" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01649&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01649" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01649&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01649" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01649&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01649&amp;href=/doi/10.1021/acs.jmedchem.9b01649" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01649" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01649" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (980 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01649%26sid%3Dliteratum%253Aachs%26pmid%3D31747282%26genre%3Darticle%26aulast%3DHuang%26date%3D2019%26atitle%3DDiscovery%2Bof%2BHighly%2BPolar%2B%25CE%25B2-Homophenylalanine%2BDerivatives%2Bas%2BNonsystemic%2BIntestine-Targeted%2BDipeptidyl%2BPeptidase%2BIV%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D23%26spage%3D10919%26epage%3D10925%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/jmcmar.2019.62.issue-23/20191212/jmcmar.2019.62.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Although intensively expressed within intestine, the precise roles of intestinal dipeptidyl peptidase IV (DPPIV) in numerous pathologies remain incompletely understood. Here, we first reported a nonsystemic intestine-targeted (NSIT) DPPIV inhibitor with β-homophenylalanine scaffold, compound <b>7</b>, which selectively inhibited the intestinal rather than plasmatic DPPIV at an oral dosage as high as 30 mg/kg. We expect that compound <b>7</b> could serve as a qualified tissue-selective tool to determine undetected physiological or pathological roles of intestinal DPPIV.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dipeptidyl peptidase IV (DPPIV), also referred as T-cell antigen CD26, is a 110 kDa glycoprotein that exists in two major isoforms, a membrane-anchored form and a soluble form.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> DPPIV is viewed as a complex protein and plays important roles in many physiological processes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> For example, as a serine peptidase, DPPIV can regulate the catabolism of over 40 bioactive peptides, which are related to metabolism, nociception, psychoneuroendocrine regulation, cardiovascular adaptation, and so on.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition, it is also involved in cell adhesion and the immune response through its nonenzymatic functions via interactions with contiguous membrane or extracellular matrix proteins.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Furthermore, the extensive distribution of the DPPIV protein further amplifies its complexity. Soluble DPPIV principally circulates in body fluids, such as plasma, cerebrospinal fluid, and seminal fluid, while the membrane-bound form can be found in numerous tissues including the lung, intestine, brain, pancreas, kidney, blood vessels, liver, lymph nodes, and spleen and is predominately situated on the surface of epithelial, endothelial, and immune cells.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Therefore, because of the variety of its enzymatic and nonenzymatic functions, the panoply of its bioactive substrates and binding partners and the universality of its distribution, changes in DPPIV expression and/or activity are closely associated with a great number of pathological conditions, for example, metabolic disorders,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> tumors,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> autoimmune,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and inflammatory diseases.<a onclick="showRef(event, 'ref2 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref6">(2,6)</a> Among them, the relationship between DPPIV and glucose homeostasis is extensively studied and more than 12 DPPIV inhibitors are currently approved to treat type 2 diabetes.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Research on DPPIV inhibitors’ glucoregulatory mechanisms found that changes to the incretin hormones pathway, such as preventing the inactivation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), and several incretin-independent pathways collectively contribute to the antidiabetic actions of DPPIV.<a onclick="showRef(event, 'ref1 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref1 ref9 ref10">(1,9,10)</a></div><div class="NLM_p last">Usually, the biological roles of DPPIV will change with its location and the molecular targets it interacts with.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, the specific roles of DPPIV derived from different tissues or cells in many physiological and pathological processes remain inadequately understood. Even for the deeply studied hypoglycemic effect, the precise roles of DPPIV-containing cells and tissues were only identified by Mulvihill and co-workers in 2017, 11 years after the first DPPIV inhibitor was marketed. They found that DPPIV from endothelial and hematopoietic cells contributed to glucose-lowering actions, while enterocyte DPPIV, although representing substantial intestinal DPPIV activity, did not produce significant effects on the plasma DPPIV activity and incretin hormone levels.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Furthermore, the precise role of enterocyte DPPIV in other physiological processes is also unknown and previous studies on DPPIV usually employed systemic inhibitors or conventional gene knockout and therefore could not accurately reflect the consequences of DPPIV inhibition in specific tissues. In view of the intensive distribution of the DPPIV enzyme in the intestine and the high involvement of the intestine in a large number of physiological processes,<a onclick="showRef(event, 'ref3 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref3 ref12 ref13">(3,12,13)</a> we expect to identify a series of nonsystemic intestine-targeted (NSIT) DPPIV inhibitors that could be used as chemical tools to determine the biological functions of intestinal DPPIV.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Molecular Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently, NSIT drugs have been designed for various diseases including inflammatory bowel disease, diabetes mellitus, and obesity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A number of approaches have been successively developed to obtain NSIT drug candidates, resulting in three categories of NSIT drugs: nonabsorbable prodrugs, rapidly metabolized soft drugs, and compounds with physicochemical properties outside “Lipinski’s Rule of Five”.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For instance, compound <b>2</b>, an apical sodium-dependent bile acid transporter (ASBT) inhibitor, is an example of the last class (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> By introducing a highly polar and zwitterionic aminodiacid moiety to the pharmacophores (<b>1</b>), the structural units accounting for nearly all of the pharmacological activity, the resulting compound <b>2</b> generated moderately increased potency (4-fold) but substantially decreased the cLogP value, cellular permeability, and portal vein and systemic drug levels after oral administration (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Consequently, the introduction of highly polar moieties, also known as kinetophores that minimally influence the intrinsic pharmacological activity of pharmacophores but significantly alter specific physicochemical characteristics, facilitate the nonsystemic targeting of the intestine.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) The design of NSIT compounds with high polar moieties. (B) The design of the NSIT DPPIV inhibitors. The site where the highly polar moieties were introduced was labeled with a blue box. (C) The binding mode of β-homophenylalanine derivatives with DPPIV.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Inspired by the design of compound <b>2</b>, we attempted to obtain NSIT DPPIV inhibitors by introducing highly polar kinetophores to a known systemic DPPIV inhibitor, namely, pharmacophore. According to the binding modes of DPPIV with known inhibitors, the S2 binding pocket, formed by Phe357, Ser209, and Arg358, is large enough to tolerate multifarious changes in its substituents without inducing significantly adverse effect on the pharmacological activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Therefore, we selected a β-homophenylalanine derivative, <b>3</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> as the starting point for the NSIT DPPIV inhibitors discovery program (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), and focused exploration on the benzothiazole moiety that is in the S2 pocket (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> There are three reasons for this choice: first, β-homophenylalanine is a reliable and widely studied scaffold among DPPIV inhibitors, as sitagliptin, the first marketed DPPIV inhibitor, is a β-homophenylalanine derivative;<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> second, these derivatives are convenient to prepare and the β-homophenylalanine moiety is commercially available; finally, position 6 of the benzothiazole moiety seems to be a preferable choice to introduce the kinetophores (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), and a previous study revealed that this position could tolerate relatively large substituents such as a 2-morpholinoethyoxyl group.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Collectively, we adjusted the pharmacokinetic behavior of <b>3</b> to meet the need of high intestinal retention by introducing highly polar kinetophores to position 6 of the benzothiazole moiety (labeled by a blue box in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The designed compounds <b>4</b>–<b>12</b> were synthesized by using the route outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, the attack of 6-(ethoxymethoxy) benzo[<i>d</i>]thiazole (<b>3a</b>) to the sulfinamide intermediate (<b>3b</b>) generated the intermediate <b>3c</b>. After the deprotection of <b>3c</b> and condensation with β-homophenylalanine, the pharmacophore (<b>3f</b>) was obtained from the oxidization of the above condensation product, <b>3e</b>. Subsequently, the intermediates <b>3g</b>–<b>3i</b> were obtained by a nucleophilic substitution reaction between <b>3f</b> and benzyl aliphatic esters containing bromide substitution. The carboxyl group was exposed under reductive conditions and then condensed with different highly polar moieties to obtain <b>4</b>–<b>12</b>. Detailed synthetic procedures and structural characterization are provided in the Supporting Information.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>4</b>–<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, dry THF, rt; (b) dry THF, rt; (c) nBu-Li, dry THF, −78 °C; (d) acetyl chloride, EtOH, rt; (e) HATU, DIPEA, DMF, rt; (f) mCPBA, DCM; (g) K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (h) Pd/C, H<sub>2</sub>, MeOH, rt; (i) DCM/TFA (v/v = 5:1), rt.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> In Vitro DPPIV Inhibitory Potency, Aqueous Solubility, and Caco-2 Permeability Assays</h3><div class="NLM_p">To cover multiple structural types, we characterized the kinetophores with sulfonic acid, quaternary ammonium salt, and saccharide fragments, which will present anion, cation, and neutral forms, respectively, under the physiological conditions. In addition, to minimize the potential adverse effect on the pre-existing inhibitory activity, these three hydrophilic fragments were extended far from the benzothiazole moiety by an aliphatic chain containing 2, 6, or 12 carbon atoms. Consequently, we synthesized nine compounds in these three categories and tested their ability to inhibit the DPPIV activity of mouse plasma in vitro.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds with the sulfonic acid substituent (<b>7</b>–<b>9</b>) showed the best inhibitory potency of mouse plasma DPPIV compared with the compounds containing the other two high polar substituents (<b>4</b>–<b>6</b> and <b>10</b>–<b>12</b>) when linked by an aliphatic chain of the same length. The two-carbon atom-length aliphatic chain (<b>4</b>, <b>7</b>, and <b>10</b>) might be the optimal linker, as the inhibitory activity decreased as the length of the chain increased. In addition, the compounds with short linkers exhibited negative ClogP values (<b>4</b>, <b>5</b>, <b>7</b>, and <b>8</b>), suggesting a high hydrophilcity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We then determined the aqueous solubility of the six compounds with good inhibitory activity under three different conditions (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The results show that <b>4</b>, <b>7</b>, and <b>10</b>, whose highly polar moiety was linked by two-carbon atoms, exhibited decent aqueous solubility under all three conditions, while a longer aliphatic chain would interfere with the solubility to some extent (<b>8</b> and <b>11</b>). Collectively, the compounds linked a polar moiety by two-carbon atoms possessed preferable DPPIV inhibitory potency and aqueous solubility.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Results of the Inhibitory Potency of Compounds on Mouse Plasma DPPIV in Vitro</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0004.gif" alt="" id="GRAPHIC-d7e521-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0005.gif" alt="" id="gr4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Calculated by ChemDraw Professional 16.0.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Result of Caco-2 Permeability</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">solubility</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">mean <i>P</i><sub>app</sub> (nm/s)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">pH 6.8 (μM)</th><th class="colsep0 rowsep0" align="center">pH 7.4 (μM)</th><th class="colsep0 rowsep0" align="center">pH 7.0 (μM)</th><th class="colsep0 rowsep0" align="center" char=".">apical to basal</th><th class="colsep0 rowsep0" align="center" char=".">basal to apical</th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">20–50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">295</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">20–50</td><td class="colsep0 rowsep0" align="center">20–50</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sitagliptin</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">122.4</td><td class="colsep0 rowsep0" align="char" char=".">48.7</td></tr></tbody></table></div></div><div class="NLM_p last">A further Caco-2 permeability evaluation found that the above six compounds had a much low apparent permeability coefficient (<i>P</i><sub>app</sub> A to B less than 0.4 nm/s) compared to sitagliptin with moderate permeability, suggesting a poor ability to penetrate the membrane of Caco-2 cells (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). A longer linker might facilitate the corresponding compound become a substrate of efflux transporters, resulting in a high efflux ratio (<b>5</b>, <b>8</b>, and <b>11</b>). On the contrary, compound <b>10</b> showed the lowest efflux ratio among tested compounds, indicating that it might be a suitable substrate of uptake transporters, which might be easy to be absorbed into the blood. Taken together, these results showed that <b>4</b> and <b>7</b> owned excellent potency, decent aqueous solubility, and poor membrane permeability, preferably meeting the designing goals. Then they were selected for further study.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Stability Evaluation in Human and Mouse Intestinal S9 Fraction</h3><div class="NLM_p last">To explore whether there are the metabolites that generated within the intestine and could enter systemic circulation and inhibit systemic DPPIV, we evaluated the intestinal stability of <b>4</b> and <b>7</b> by commercially human and mouse intestinal S9 fractions. Compared to the positive controls, testosterone and 7-hydroxycoumarin (7-HC), we were delighted to find that <b>4</b> and <b>7</b> showed decent metabolic stability against both phase I and phase II enzymes in human and mouse intestinal S9 fractions (Table S1), indicating the low possibility of generating systemic metabolites.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Pharmacokinetic Study and Plasmic and Intestinal DPPIV Activity Determination</h3><div class="NLM_p">We subsequently determined the plasma exposure of <b>4</b> and <b>7</b> after oral administration at 30 mg/kg. Surprisingly, although compounds <b>4</b> and <b>7</b> had similar Caco-2 cell permeability, they showed great difference in plasma concentrations after oral administration. As shown in Figure S1, <b>4</b> possessed 45-fold and 38-fold higher plasma concentration than that of <b>7</b> at the 2 and 4 h time points, respectively.</div><div class="NLM_p">Furthermore, we characterized the alteration of plasmic and intestinal DPPIV activity after oral administration of <b>4</b> and <b>7</b>, taking sitagliptin as a positive comparison. Although the dosage was as high as 30 mg/kg, the plasmic DPPIV activity of the <b>7</b>-treated group showed a trend similar to that of the control group, indicating a negligible impact on the plasma DPPIV enzyme (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). However, <b>4</b> and sitagliptin could significantly inhibit the plasma DPPIV activity even at the 8 h time point after oral administration (Figure S3A). On the basis of the results of oral plasma exposure, we supposed that the significant plasma DPPIV inhibition of  <b>4</b> might result from its high concentration in the plasma. In the intestine, both the compounds <b>4</b>-treated, <b>7</b>-treated, and sitagliptin-treated groups showed intensive DPPIV inhibition in all three selected parts of the intestine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B and Figure S3B). Notably, the significant intestinal DPPIV inhibition of compound <b>7</b> could also be reflected by its high concentration within the intestine (Figure S2).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Relative DPPIV activity in plasma (A) and the intestine (B) after oral administration 30 mg/kg of sitagliptin and compound <b>7</b> to mice. The intestinal DPPIV activity was tested at 8 h after oral administration (<i>n</i> = 6). The data are expressed as the mean ± SEM **<i>P</i> < 0.01, compared with control groups. Student’s <i>t</i>-test statistical analysis was used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Selectivity and Preliminary Toxicity Investigations</h3><div class="NLM_p">As a qualified chemical tool, isozyme selectivity is essential. After determining the inhibitory effects of <b>7</b> on DPP8 and DPP9, we were delighted to find that <b>7</b> showed a greater than 2000-fold selectivity toward these two isozymes (Table S2).</div><div class="NLM_p last">To evaluate the cytotoxic effect of <b>7</b>, human hepatocellular carcinoma cell line (HepG2), human embryonic kidney 293 cell line (HEK293), and mouse primary hepatocytes were treated with <b>7</b> for 24 h, and cell viability was measured using the MTT assay. As shown in Figure S4, <b>7</b> exhibited no obvious cytotoxicity after 24 h of treatment up to a concentration of 200 μM. For the acute toxicity study, ICR mice were treated with single doses of <b>7</b> (1000 mg/kg). All of the animals survived the 4 days of the experimental period (Figure S5A). General conditions, such as body weight and clinical and behavioral symptoms, were recorded during this period, and no obvious change or death attributable to the toxicity of <b>7</b> was observed (Figure S5B). <b>7</b> was found to be safe at the dosage of 1000 mg/kg employed in the present study.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">DPPIV possesses multiple physiological functions and is widely distributed in body tissues.<a onclick="showRef(event, 'ref9 ref11 ref18'); return false;" href="javascript:void(0);" class="ref ref9 ref11 ref18">(9,11,18)</a> The discriminatory contribution of DPPIV with different cellular sites on glucose homeostasis indicates that the biological roles of DPPIV are cell or tissues specific.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, studies regarding DPPIV were rarely performed depending on its cellular sites or originating tissues, probably due to the lack of tissue-selective DPPIV inhibitors. Here, by introducing high polar moieties to a systemic DPPIV inhibitor, we discovered a NSIT DPPIV inhibitor, <b>7</b>, which was distributed throughout the intestine and could selectively inhibit intestinal DPPIV activity while having no significant effect on the plasmatic DPPIV activity after oral administration at a dose as high as 30 mg/kg. In addition, compared with systemic compounds, NSIT molecules might harbor low toxicity risks as a result of their extremely poor systemic exposure. Therefore, coupled with the good performance of <b>7</b> in isozyme selectivity and preliminary toxicity investigations, we believed that it could serve as a qualified NSIT DPPIV inhibitor to determine the precise roles of intestinal DPPIV in various physiological and pathological processes.</div><div class="NLM_p">For example, the relationship between DPPIV and inflammatory bowel disease (IBD) has been determined in a vast number of publications.<a onclick="showRef(event, 'ref2 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref2 ref19 ref20 ref21 ref22">(2,19−22)</a> However, the defined role of DPPIV in the process of IBD remains unclear, and several mechanisms have been proposed, including the changing of the immune response at systemic and local levels<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20,23)</a> and the degradation of glucagon-like peptide-2 (GLP-2),<a onclick="showRef(event, 'ref19 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref24">(19,24)</a> a potent and specific gastrointestinal growth factor. Although there are still some inconsistencies, most studies observed that DPPIV inhibition could lead to the alleviation of IBD,<a onclick="showRef(event, 'ref6 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref6 ref24 ref25 ref26">(6,24−26)</a> suggesting a potential and novel approach to treat IBD. However, DPPIV inhibition in all of these studies was accomplished by a systemic DPPIV inhibitor or nonspecific <i>DPPIV</i> gene knockout, and, as far as we know, no selective intestinal DPPIV inhibitor was applied. Because the nidus of IBD is located within the intestine, illuminating the role of intestinal DPPIV in the progress of IBD is beneficial for understanding the pathological process or even for developing a new treatment for IBD.</div><div class="NLM_p">A NSIT DPPIV inhibitor could also be used to comprehensively understand the impact of the DPPIV inhibitor on the gut microbiota. Recently, Olivares et al. found that vildagliptin, a systemic DPPIV inhibitor, could prevent the disruption of intestinal homeostasis in association with modulation of the gut microbiota.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Very recently, Liao et al. revealed an important alteration of gut microbiota induced by sitagliptin treatment, indicating a new hypoglycemic mechanism and an additional benefit of DPPIV inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Considering that sitagliptin and vildagliptin decreased both systemic and intestinal DPPIV activity,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> we could not exclude that this beneficial effects or the alteration in the composition of the gut microbiota resulted from the changes of the systemic environment induced by vildagliptin. In this context, comparing the effects of systemic and intestinal DPPIV inhibitors on the gut microbiota is conducive for determing the precise regulatory mechanisms for gut dysfunctions. Furthermore, with increasing knowledge of the relationships between intestinal microbiota and numerous human pathologies, managing the microbial composition will gradually become an attractive therapeutic approach to different diseases.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32">(29−32)</a> Therefore, clarifying the effects of the NSIT DPPIV inhibitor on the gut microbiota might provide a new method to regulate the gut microbiota, which may open new therapeutic approaches to different dysfunctions.</div><div class="NLM_p">Finally, whether the marketed DPPIV inhibitors could reduce the cardiovascular (CV) events and mortality in type 2 diabetic patients is a pending question.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> Except for linagliptin, most marketed DPPIV inhibitors could not produce significantly beneficial effects on the risk of CV events, and even worse, saxagliptin was found to be responsible for an increased risk of heart failure.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Because CV complications are the main cause of death in type 2 diabetic patients, it is worthwhile to study the potential risks of DPPIV inhibitors thoroughly.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Currently, several mechanisms have been suggested but all are focused on the consequences of systemic DPPIV inhibition such as the increased level of stromal cell-derived factor-1 (SDF-1) in circulatory system,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> the sympathetic activation,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and the inhibition of luminal sodium–hydrogen exchanger 3, (NHE3).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> However, as shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the systemic DPPIV inhibitor simultaneously inhibited plasmic and intestinal DPPIV activity even at the 8 h time point after oral administration, indicating that it is hard to distinguish the effects of plasmic and intestinal DPPIV on the risk of CV. Therefore, <b>7</b>, a NSIT DPPIV inhibitor, might contribute to the determination of the specific roles of plasmic and intestinal DPPIV in the pathology of CV or other disorders.</div><div class="NLM_p last">Collectively, by adjusting the physicochemical properties of a systemic DPPIV inhibitor out of the Lipinski’s rule of five, we first reported a NSIT DPPIV inhibitor, <b>7</b>, and the studies regarding the application of this compound are undergoing.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Chemistry</h3><div class="NLM_p last">All reagents were purchased from commercial suppliers and used without further drying or purification unless otherwise stated. Yields were not optimized. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker AC400 or AC500 NMR spectrometer using tetramethylsilane (CDCl<sub>3</sub>) or deuterium reagent itself (DMSO-<i>d</i><sub>6</sub>) as an internal reference. Low-resolution mass spectra were determined on an Agilent liquid chromatography mass spectrometer system that consisted of an Agilent 1260 infinity LC coupled to Agilent 6120 quadrupole mass spectrometer (ESI). High-resolution mass spectra were conducted on a triple TOF 5600+ MS/MS system (AB Sciex, Concord, Ontario, Canada) in the negative or positive ESI mode. The purity of test compounds were determined by HPLC (Agilent ChemStation, Purospher STAR RP-18 end-capped (2 μm), 2.1 mm × 50 mm, 30 °C, UV 240 nM), and the mobile phase was method A in Table S3. All the assayed compounds are purified by preparative liquid chromatograph (Instrument: Unimicro Easysep-1010 series LC, UV 254 nm, 25 °C; Column: Agilent Prep-C18 10 μm, 21.2 mm × 250 mm, the mobile phase was methods B–D in Table S3) and possess a more than 95% purity. Column chromatography was performed on silica gel (200–300 mesh) or with prepacked silica cartridges (4–40 g) from Bonna-Agela Technologies Inc. (Tianjin, China) and eluted with a <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="de9db1b3bcb798b2bfadb69e">[email protected]</a> Rf 200 from Teledyne Isco, and preparative TLC was performed on HSGF 254 (0.4–0.5 mm thickness; Yantai Jiangyou Company, Yantai, Shangdong, China).</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (<i>R</i>)-4-((1,1-Dioxido-4-(6-(2-oxo-2-((2-(trimethylammonio)ethyl)amino)ethoxy)benzo[<i>d</i>]thiazol-2-yl)tetrahydro-2<i>H</i>-thiopyran-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-aminium Trifluoroacetate (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>3j</b> (1 g, 1.5 mmol) in DMF was successively added HATU (1.1 g, 3.0 mmol), DIPEA (784 μL, 4.5 mmol), and the trifluoroacetate of 2-amino-<i>N</i>,<i>N</i>,<i>N</i>-trimethylethan-1-aminium trifluoroacetate (759 mg, 2.3 mmol). The mixture was stirred for 2 h at room temperature. The solvent was directly evaporated in vacuo, and the residue was redissolved by the mixed solution of DCM and TFA (v/v = 5:1). After stirring overnight, the mixture was directly evaporated in vacuo, and the residue was purified by preparative liquid chromatograph to give <b>4</b> (white solid, 464 mg, yield 35%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.01 (s, 1H), 8.52 (t, <i>J</i> = 5.9 Hz, 1H), 8.06–7.95 (m, 3H), 7.88 (d, <i>J</i> = 8.9 Hz, 1H), 7.61 (d, <i>J</i> = 2.6 Hz, 1H), 7.58 (td, <i>J</i> = 10.3, 7.0 Hz, 1H), 7.53–7.46 (m, 1H), 7.18 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 4.60 (s, 2H), 3.69 (dq, <i>J</i> = 12.7, 6.9 Hz, 1H), 3.58 (q, <i>J</i> = 6.1 Hz, 2H), 3.52–3.41 (m, 4H), 3.24–3.16 (m, 2H), 3.09 (s, 9H), 2.99–2.74 (m, 4H), 2.70–2.52 (m, 4H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 174.60, 170.45, 168.18, 157.99 (q, <i>J</i> = 31.5 Hz), 156.14 (dd, <i>J</i> = 243.1, 9.3 Hz), 155.50, 148.33 (dt, <i>J</i> = 248.2, 14.5 Hz), 147.31, 145.98 (ddd, <i>J</i> = 242.7, 13.6, 3.9 Hz), 135.75, 123.37, 119.91 (d, <i>J</i> = 5.9 Hz), 119.64 (dd, <i>J</i> = 19.4, 5.1 Hz), 117.09 (q, <i>J</i> = 299.3 Hz), 115.89, 106.18 (dd, <i>J</i> = 29.0, 20.2 Hz), 106.16, 67.52, 63.68, 56.73, 52.61, 52.58, 52.56, 47.28, 46.50, 46.46, 36.72, 35.12, 33.60, 33.31, 32.99. HRMS (ESI): <i>m</i>/<i>z</i> [M-CF<sub>3</sub>COOH-CF<sub>3</sub>COO<sup>–</sup>]<sup>+</sup> calcd for C<sub>29</sub>H<sub>37</sub>F<sub>3</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub><sup>+</sup> 656.2183; found 656.2192. HPLC purity 96%; <i>t</i><sub>R</sub> 4.86 min.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>R</i>)-4-((1,1-Dioxido-4-(6-(2-oxo-2-((2-sulfethyl)amino)ethoxy)benzo[<i>d</i>]thiazol-2-yl)tetrahydro-2<i>H</i>-thiopyran-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-aminium Trifluoroacetate (<b>7</b>)</h3><div class="NLM_p">Starting with <b>3j</b> (1 g, 1.5 mmol) and 2-aminoethane-1-sulfonic acid (288 mg, 2.3 mmol), <b>7</b> was obtained by using the process of the preparation of <b>4</b> (white solid, 41%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.01 (s, 1H), 8.41–8.30 (m, 1H), 7.85 (d, <i>J</i> = 8.9 Hz, 1H), 7.69–7.25 (m, 6H), 7.14 (d, <i>J</i> = 8.7 Hz, 1H), 4.53 (s, 2H), 3.69–3.63 (m, 1H), 3.46–3.34 (m, 6H), 3.18 (d, <i>J</i> = 11.7 Hz, 2H), 3.01–2.78 (m, 4H), 2.67–2.57 (m, 4H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 174.71, 170.83, 167.08, 158.47 (q, <i>J</i> = 31.1 Hz), 156.17 (dd, <i>J</i> = 243.3, 9.9 Hz), 155.59, 148.50 (dt, <i>J</i> = 248.2, 13.9 Hz), 147.34, 146.04 (dd, <i>J</i> = 242.0, 11.8 Hz), 135.79, 123.36, 120.11 (d, <i>J</i> = 18.4 Hz), 119.71 (dd, <i>J</i> = 19.3, 5.2 Hz), 117.21 (d, <i>J</i> = 299.8 Hz), 116.06, 106.24, 106.01 (dd, <i>J</i> = 29.0, 21.4 Hz), 67.66, 56.79, 50.11, 47.55, 46.60, 46.56, 37.11, 35.23, 33.59, 33.42, 31.36. HRMS (ESI): <i>m</i>/<i>z</i> [M-CF<sub>3</sub>COO<sup>–</sup>]<sup>+</sup> calcd for C<sub>26</sub>H<sub>30</sub>F<sub>3</sub>N<sub>4</sub>O<sub>8</sub>S<sub>3</sub><sup>+</sup> 679.1172; found 679.1179. HPLC purity, 98%; <i>t</i><sub>R</sub>, 5.37 min.</div><div class="NLM_p last">The detailed experimental experiment procedures and other designed compounds were synthesized by following a similar procedure (Supporting Information).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01649" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01649?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01649</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">DPPIV inhibitory effects of compounds in vitro, the solubility test, Caco-2 permeability assay, the stability test in human and mouse intestinal S9 fraction, in vivo pharmacokinetic study, determina-tion of plasma and intestinal DPPIV activity in vivo, DPP8 and DPP9 inhibitory effect of compounds in vitro, in vitro cytotoxicity test by MTT assay, acute toxicity study of compound <b>7</b> in mice, synthetic chemistry and abbreviations (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_001.pdf">jm9b01649_si_001.pdf (1.04 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_002.csv">jm9b01649_si_002.csv (1.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01649" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Leng</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, 
    Shanghai Institute of Materia Medica, 
    , , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#136a7f767d7453607a7e7e3d72703d707d"><span class="__cf_email__" data-cfemail="c2bbaea7aca582b1abafafeca3a1eca1ac">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianhua Shen</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, 
    Shanghai Institute of Materia Medica, 
    , , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9273-3409" title="Orcid link">http://orcid.org/0000-0002-9273-3409</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#03696b706b666d43706a6e6e2d62602d606d"><span class="__cf_email__" data-cfemail="bed4d6cdd6dbd0fecdd7d3d390dfdd90ddd0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fubao Huang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, 
    Shanghai Institute of Materia Medica, 
    , , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mengmeng Ning</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, 
    Shanghai Institute of Materia Medica, 
    , , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kai Wang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, 
    Shanghai Institute of Materia Medica, 
    , , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Liu</span> - <span class="hlFld-Affiliation affiliation">Shanghai Institute of Materia Medica, , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenbo Guan</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, 
    Shanghai Institute of Materia Medica, 
    , , Chinese Academy of Sciences (CAS), 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing, 100049, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>F.H. and M.N. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM1903ZZ-02).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethyl formamide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electron spray ionization</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">under voltage</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">formic acid</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">nBu-Li</td><td class="NLM_def"><p class="first last"><i>n</i>-butyllithium</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">mCPBA</td><td class="NLM_def"><p class="first last">3-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">K<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">potassium carbonate</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">NH<sub>4</sub>Cl</td><td class="NLM_def"><p class="first last">ammonium chloride</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylaminopyridine</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulvihill, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">1019</span>, <span class="refDoi"> DOI: 10.1210/er.2014-1035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1210%2Fer.2014-1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=25216328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslaitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=992-1019&author=E.+E.+Mulvihillauthor=D.+J.+Drucker&title=Pharmacology%2C+physiology%2C+and+mechanisms+of+action+of+dipeptidyl+peptidase-4+inhibitors&doi=10.1210%2Fer.2014-1035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors</span></div><div class="casAuthors">Mulvihill, Erin E.; Drucker, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">992-1019</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase-4 (DPP4) is a widely expressed enzyme transducing actions through an anchored transmembrane mol. and a sol. circulating protein.  Both membrane-assocd. and sol. DPP4 exert catalytic activity, cleaving proteins contg. a position 2 alanine or proline.  DPP4-mediated enzymic cleavage alternatively inactivates peptides or generates new bioactive moieties that may exert competing or novel activities.  The widespread use of selective DPP4 inhibitors for the treatment of type 2 diabetes has heightened interest in the mol. mechanisms through which DPP4 inhibitors exert their pleiotropic actions.  Here we review the biol. of DPP4 with a focus on: (1) identification of pharmacol. vs physiol. DPP4 substrates; and (2) elucidation of mechanisms of actions of DPP4 in studies employing genetic elimination or chem. redn. of DPP4 activity.  We review data identifying the roles of key DPP4 substrates in transducing the glucoregulatory, anti-inflammatory, and cardiometabolic actions of DPP4 inhibitors in both preclin. and clin. studies.  Finally, we highlight exptl. pitfalls and tech. challenges encountered in studies designed to understand the mechanisms of action and downstream targets activated by inhibition of DPP4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj5PTsXnHpF7Vg90H21EOLACvtfcHk0lhTR4K39UHLmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslaitA%253D%253D&md5=af460e2173f81d832bbbeb0170b1ceef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2014-1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2014-1035%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DE.%2BE.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DPharmacology%252C%2520physiology%252C%2520and%2520mechanisms%2520of%2520action%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors%26jtitle%3DEndocr.%2520Rev.%26date%3D2014%26volume%3D35%26spage%3D992%26epage%3D1019%26doi%3D10.1210%2Fer.2014-1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span> <span> </span><span class="NLM_article-title">Cut to the chase: a review of CD26/dipeptidyl peptidase-4’s (DPP4) entanglement in the immune system</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1111/cei.12781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1111%2Fcei.12781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=26919392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFelu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2016&pages=1-21&author=C.+Klemannauthor=L.+Wagnerauthor=M.+Stephanauthor=S.+von+Horsten&title=Cut+to+the+chase%3A+a+review+of+CD26%2Fdipeptidyl+peptidase-4%E2%80%99s+%28DPP4%29+entanglement+in+the+immune+system&doi=10.1111%2Fcei.12781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system</span></div><div class="casAuthors">Klemann, C.; Wagner, L.; Stephan, M.; von Hoersten, S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : CD26/DPP4 (dipeptidyl peptidase 4/DP4/DPPIV) is a surface T cell activation antigen and has been shown to have DPP4 enzymic activity, cleaving-off amino-terminal dipeptides with either L-proline or L-alanine at the penultimate position.  It plays a major role in glucose metab. by N-terminal truncation and inactivation of the incretins glucagon-like peptide-1 (GLP) and gastric inhibitory protein (GIP).  In 2006, DPP4 inhibitors have been introduced to clinics and have been demonstrated to efficiently enhance the endogenous insulin secretion via prolongation of the half-life of GLP-1 and GIP in patients.  However, a large no. of studies demonstrate clearly that CD26/DPP4 also plays an integral role in the immune system, particularly in T cell activation.  Therefore, inhibition of DPP4 might represent a double-edged sword.  Apart from the metabolic benefit, the assocd. immunol. effects of long term DPP4 inhibition on regulatory processes such as T cell homeostasis, maturation and activation are not understood fully at this stage.  The current data point to an important role for CD26/DPP4 in maintaining lymphocyte compn. and function, T cell activation and co-stimulation, memory T cell generation and thymic emigration patterns during immune-senescence.  In rodents, crit. immune changes occur at baseline levels as well as after in-vitro and in-vivo challenge.  In patients receiving DPP4 inhibitors, evidence of immunol. side effects also became apparent.  The scope of this review is to recapitulate the role of CD26/DPP4 in the immune system regarding its pharmacol. inhibition and T cell-dependent immune regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0CXJvQ8yuG7Vg90H21EOLACvtfcHk0ljOa4dNF5JTAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFelu7o%253D&md5=db8f51db1d071a4c1b69d66f526e4b92</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fcei.12781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcei.12781%26sid%3Dliteratum%253Aachs%26aulast%3DKlemann%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DStephan%26aufirst%3DM.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26atitle%3DCut%2520to%2520the%2520chase%253A%2520a%2520review%2520of%2520CD26%252Fdipeptidyl%2520peptidase-4%25E2%2580%2599s%2520%2528DPP4%2529%2520entanglement%2520in%2520the%2520immune%2520system%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2016%26volume%3D185%26spage%3D1%26epage%3D21%26doi%3D10.1111%2Fcei.12781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambeir, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durinx, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV</span>. <i>Crit. Rev. Clin. Lab. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1080/713609354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1080%2F713609354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=12892317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVWhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=209-294&author=A.+M.+Lambeirauthor=C.+Durinxauthor=S.+Scharpeauthor=I.+De+Meester&title=Dipeptidyl-peptidase+IV+from+bench+to+bedside%3A+an+update+on+structural+properties%2C+functions%2C+and+clinical+aspects+of+the+enzyme+DPP+IV&doi=10.1080%2F713609354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV</span></div><div class="casAuthors">Lambeir, Anne-Marie; Durinx, Christine; Scharpe, Simon; De Meester, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-294</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">CRC Press LLC</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl-peptidase IV/CD26 (DPP IV) is a cell-surface protease belonging to the prolyloligopeptidase family.  It selectively removes the N-terminal dipeptide from peptides with proline or alanine in the second position.  Apart from its catalytic activity, it interacts with several proteins, for instance, adenosine deaminase, the HIV gp120 protein, fibronectin, collagen, the chemokine receptor CXCR4, and the tyrosine phosphatase CD45.  DPP IV is expressed on a specific set of T lymphocytes, where it is up-regulated after activation.  It is also expressed in a variety of tissues, primarily on endothelial and epithelial cells.  A sol. form is present in plasma and other body fluids.  DPP IV has been proposed as a diagnostic or prognostic marker for various tumors, hematol. malignancies, immunol., inflammatory, psychoneuroendocrine disorders, and viral infections.  DPP IV truncates many bioactive peptides of medical importance.  It plays a role in glucose homeostasis through proteolytic inactivation of the incretins.  DPP IV inhibitors improve glucose tolerance and pancreatic islet cell function in animal models of type 2 diabetes and in diabetic patients.  The role of DPP IV/CD26 within the immune system is a combination of its exopeptidase activity and its interactions with different mols.  This enables DPP IV/CD26 to serve as a co-stimulatory mol. to influence T cell activity and to modulate chemotaxis.  DPP IV is also implicated in HIV-1 entry, malignant transformation, and tumor invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHXuhbNS1H4rVg90H21EOLACvtfcHk0ljOa4dNF5JTAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVWhs70%253D&md5=623830d8e73b25e69a250fab0a79224f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F713609354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F713609354%26sid%3Dliteratum%253Aachs%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDurinx%26aufirst%3DC.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DDipeptidyl-peptidase%2520IV%2520from%2520bench%2520to%2520bedside%253A%2520an%2520update%2520on%2520structural%2520properties%252C%2520functions%252C%2520and%2520clinical%2520aspects%2520of%2520the%2520enzyme%2520DPP%2520IV%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2003%26volume%3D40%26spage%3D209%26epage%3D294%26doi%3D10.1080%2F713609354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vliegen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungraithmayr, W.</span></span> <span> </span><span class="NLM_article-title">CD26/DPP4 - a potential biomarker and target for cancer therapy</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.pharmthera.2019.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30822465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFKmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2019&pages=135-159&author=N.+Enzauthor=G.+Vliegenauthor=I.+De+Meesterauthor=W.+Jungraithmayr&title=CD26%2FDPP4+-+a+potential+biomarker+and+target+for+cancer+therapy&doi=10.1016%2Fj.pharmthera.2019.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">CD26/DPP4 - a potential biomarker and target for cancer therapy</span></div><div class="casAuthors">Enz, Njanja; Vliegen, Gwendolyn; De Meester, Ingrid; Jungraithmayr, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-159</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  CD26/dipeptidyl peptidase (DPP)4 is a membrane-bound protein found in many cell types of the body, and a sol. form is present in body fluids.  There is longstanding evidence that various primary tumors and also metastases express CD26/DPP4 to a variable extent.  By cleaving dipeptides from peptides with a proline or alanine in the penultimate position at the N-terminus, it regulates the activity of incretin hormones, chemokines and many other peptides.  Due to these effects and interactions with other mols., a tumor promoting or suppressing role can be attributed to CD26/DPP4.  In this review, we discuss the existing evidence on the expression of sol. or membrane-bound CD26/DPP4 in malignant diseases, along with the most recent findings on CD26/DPP4 as a therapeutic target in specific malignancies.  The expression and possible involvement of the related DPP8 and DPP9 in cancer are also reviewed.  A higher expression of CD26/DPP4 is found in a wide variety of tumor entities, however more research on CD26/DPP4 in the tumor microenvironment is needed to fully explore its use as a tumor biomarker.  Circulating sol. CD26/DPP4 has also been studied as a cancer biomarker, however, the obsd. decrease in most cancer patients does not seem to be cancer specific.  Encouraging results from exptl. work and a recently reported first phase clin. trial targeting CD26/DPP4 in mesothelioma, renal and urol. tumors pave the way for follow-up clin. studies, also in other tumor entities, possibly leading to the development of more effective complementary therapies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzB5zypDCnWrVg90H21EOLACvtfcHk0ljOa4dNF5JTAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFKmurY%253D&md5=dda5996f4532dc2f90257c1ea5e8dad4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DEnz%26aufirst%3DN.%26aulast%3DVliegen%26aufirst%3DG.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DJungraithmayr%26aufirst%3DW.%26atitle%3DCD26%252FDPP4%2520-%2520a%2520potential%2520biomarker%2520and%2520target%2520for%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D198%26spage%3D135%26epage%3D159%26doi%3D10.1016%2Fj.pharmthera.2019.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, N. H.</span></span> <span> </span><span class="NLM_article-title">CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.2174/138955707780059853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2174%2F138955707780059853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=17346218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=253-273&author=M.+A.+Thompsonauthor=K.+Ohnumaauthor=M.+Abeauthor=C.+Morimotoauthor=N.+H.+Dang&title=CD26%2Fdipeptidyl+peptidase+IV+as+a+novel+therapeutic+target+for+cancer+and+immune+disorders&doi=10.2174%2F138955707780059853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders</span></div><div class="casAuthors">Thompson, Michael A.; Ohnuma, Kei; Abe, Masako; Morimoto, Chikao; Dang, Nam H.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-273</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  CD26 is a 110 kDa surface glycoprotein with intrinsic dipeptidyl peptidase IV (DPPIV) activity that is expressed on numerous cell types and has a multitude of biol. functions.  An important aspect of CD26 biol. is its peptidase activity and its functional and phys. assocn. with mols. with key roles in various cellular pathways and biol. programs.  CD26 role in immune regulation was extensively characterized, with recent findings elucidating its linkage with signaling pathways and structures involved in T-lymphocyte activation as well as antigen presenting cell-T-cell interaction.  Recent work also suggests that CD26 has a significant role in tumor biol., being both a marker of disease behavior clin. as well as playing an important role in tumor pathogenesis and development.  In this paper, we will review emerging data that suggest CD26 may be an appropriate therapeutic target for the treatment of selected neoplasms and immune disorders.  Through the use of various exptl. approaches and agents to influence CD26/DPPIV expression and activity, such as anti-CD26 antibodies, CD26/DPPIV chem. inhibitors, siRNAs to inhibit CD26 expression, overexpressing CD26 transfectants and sol. CD26 mols., our group has shown that CD26 interacts with structures with essential cellular functions.  Its assocn. with such key mols. as topoisomerase IIα, p38 MAPK, and integrin β1, has important clin. implications, including its potential ability to regulate tumor sensitivity to selected chemotherapies and to influence tumor migration/metastases and tumorigenesis.  Importantly, our recent in vitro and in vivo data support the hypothesis that CD26 may indeed be an appropriate target for therapy for selected cancers and immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc8lHdX5wDwbVg90H21EOLACvtfcHk0ljOa4dNF5JTAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOitL4%253D&md5=661d69378a2cec8076f69ea3a013d9f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138955707780059853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955707780059853%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DM.%2BA.%26aulast%3DOhnuma%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DMorimoto%26aufirst%3DC.%26aulast%3DDang%26aufirst%3DN.%2BH.%26atitle%3DCD26%252Fdipeptidyl%2520peptidase%2520IV%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520cancer%2520and%2520immune%2520disorders%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D253%26epage%3D273%26doi%3D10.2174%2F138955707780059853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yazbeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, C. A.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2009.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.tips.2009.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=19837468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCku7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=600-607&author=R.+Yazbeckauthor=G.+S.+Howarthauthor=C.+A.+Abbott&title=Dipeptidyl+peptidase+inhibitors%2C+an+emerging+drug+class+for+inflammatory+disease%3F&doi=10.1016%2Fj.tips.2009.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?</span></div><div class="casAuthors">Yazbeck, Roger; Howarth, Gordon S.; Abbott, Catherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">600-607</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase (DPP)-4 is a member of the S9b serine protease family, which also includes DPP8 and DPP9.  DPP4 cleaves a no. of regulatory factors, including chemokines and growth factors.  DPP4 inhibitors have recently emerged as an effective treatment option for type 2 diabetes.  Early in vitro studies demonstrated that DPP4 inhibitors inhibit T-cell proliferation and cytokine prodn., leading to their investigation in numerous pre-clin. models of inflammatory diseases, including arthritis, multiple sclerosis and inflammatory bowel disease.  Recent data suggest that the early DPP4-specific inhibitors might also bind DPP8 and DPP9, thus exerting their effects through non-specific binding.  This review highlights recent insights into the applicability of DPP inhibitors as novel pharmacol. agents for inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2WLV8JySyLbVg90H21EOLACvtfcHk0lgRIGIdBHRjZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCku7zJ&md5=e41944d63ac774802cc75abfe559cfde</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DYazbeck%26aufirst%3DR.%26aulast%3DHowarth%26aufirst%3DG.%2BS.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26atitle%3DDipeptidyl%2520peptidase%2520inhibitors%252C%2520an%2520emerging%2520drug%2520class%2520for%2520inflammatory%2520disease%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D600%26epage%3D607%26doi%3D10.1016%2Fj.tips.2009.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. Y.</span></span> <span> </span><span class="NLM_article-title">Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.ejmech.2018.03.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29609120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=145-157&author=N.+Liauthor=L.+J.+Wangauthor=B.+Jiangauthor=X.+Q.+Liauthor=C.+L.+Guoauthor=S.+J.+Guoauthor=D.+Y.+Shi&title=Recent+progress+of+the+development+of+dipeptidyl+peptidase-4+inhibitors+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1016%2Fj.ejmech.2018.03.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Li, Ning; Wang, Li-Jun; Jiang, Bo; Li, Xiang-qian; Guo, Chuan-long; Guo, Shu-ju; Shi, Da-Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-157</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Diabetes is a fast growing chronic metabolic disorder around the world.  Dipeptidyl peptidase-4 (DPP-4) is a new promising target during type 2 diabetes glycemic control.  Thus, a no. of potent DPP-4 inhibitors were developed and play a rapidly evolving role in the management of type 2 diabetes in recent years.  This article reviews the development of synthetic and natural DPP-4 inhibitors from 2012 to 2017 and provides their physico-chem. properties, biol. activities against DPP-4 and selectivity over dipeptidyl peptidase-8/9.  Moreover, the glucose-lowering mechanisms and the active site of DPP-4 are also discussed.  The authors also discuss strategies and structure-activity relationships for identifying potent DPP-4 inhibitors, which will provide useful information for developing potent DPP-4 drugs as type 2 diabetes treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_uDljP-EfLVg90H21EOLACvtfcHk0lgRIGIdBHRjZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVemsbw%253D&md5=a1ab96e621c8712c3c9a03302384b5c1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.041%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%2BQ.%26aulast%3DGuo%26aufirst%3DC.%2BL.%26aulast%3DGuo%26aufirst%3DS.%2BJ.%26aulast%3DShi%26aufirst%3DD.%2BY.%26atitle%3DRecent%2520progress%2520of%2520the%2520development%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D151%26spage%3D145%26epage%3D157%26doi%3D10.1016%2Fj.ejmech.2018.03.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havale, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, M.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.bmc.2009.01.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=19217790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1Cjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1783-1802&author=S.+H.+Havaleauthor=M.+Pal&title=Medicinal+chemistry+approaches+to+the+inhibition+of+dipeptidyl+peptidase-4+for+the+treatment+of+type+2+diabetes&doi=10.1016%2Fj.bmc.2009.01.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes</span></div><div class="casAuthors">Havale, Shrikanth H.; Pal, Manojit</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1783-1802</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Emerging as an epidemic of the 21st century type 2 diabetes has become a major health problem throughout the globe.  The no. of deaths attributable to diabetes reflects the insufficient glycemic control achieved with the treatments used in recent past.  DPP-4 inhibitors have been investigated as a new therapy with novel mechanisms of action and improved tolerability.  DPP-4, a protease that specifically cleaves dipeptides from proteins and oligopeptides after a penultimate N-terminal proline or alanine, is involved in the degrdn. of a no. of neuropeptides, peptide hormones and cytokines, including the incretins GLP-1 and GIP.  As soon as released from the gut in response to food intake, GLP-1 and GIP exert a potent glucose-dependent insulinotropic action, thereby playing a key role in the maintenance of post-meal glycemic control.  Consequently, inhibiting DPP-4 prolongs the action of GLP-1 and GIP, which in turn improves glucose homeostasis with a low risk of hypoglycemia and potential for disease modification.  Indeed, clin. trials involving diabetic patients have shown improved glucose control by administering DPP-4 inhibitors, thus demonstrating the benefit of this promising new class of antidiabetics.  Intense research activities in this area have resulted in the launch of sitagliptin and vildagliptin (in Europe only) and the advancement of a few others into preregistration/phase 3, for example, saxagliptin, alogliptin and ABT-279.  Achieving desired selectivity for DPP-4 over other related peptidases such as DPP-8 and DPP-9 (inhibition of which was linked to toxicity in animal studies) and long-acting potential for maximal efficacy (particularly in more severe diabetic patients) were the major challenges.  Whether these goals are achieved with the present series of inhibitors in the advanced stages of clin. development is yet to be confirmed.  Nevertheless, treatment of this metabolic disorder esp. in the early stages of the disease via DPP-4 inhibition has been recognized as a validated principle and a large no. of inhibitors are presently in various stage of pre-clin./clin. development.  Sitagliptin is a new weapon in the arsenal of oral antihyperglycemic agents.  This review will focus on the journey of drug discovery of DPP-4 inhibitors for oral delivery covering a brief scientific background and medicinal chem. approaches along with the status of advanced clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokOQ7xVWB37LVg90H21EOLACvtfcHk0lgRIGIdBHRjZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1Cjsb4%253D&md5=4d3aa42f3e5e3151c283b9287bb74154</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DHavale%26aufirst%3DS.%2BH.%26aulast%3DPal%26aufirst%3DM.%26atitle%3DMedicinal%2520chemistry%2520approaches%2520to%2520the%2520inhibition%2520of%2520dipeptidyl%2520peptidase-4%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1783%26epage%3D1802%26doi%3D10.1016%2Fj.bmc.2009.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J. J.</span></span> <span> </span><span class="NLM_article-title">Do we know the true mechanism of action of the DPP-4 inhibitors?</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1111/dom.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1111%2Fdom.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=28544214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=34-41&author=E.+S.+Andersenauthor=C.+F.+Deaconauthor=J.+J.+Holst&title=Do+we+know+the+true+mechanism+of+action+of+the+DPP-4+inhibitors%3F&doi=10.1111%2Fdom.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Do we know the true mechanism of action of the DPP-4 inhibitors?</span></div><div class="casAuthors">Andersen, Emilie S.; Deacon, Carolyn F.; Holst, Jens J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The prevalence of type 2 diabetes is increasing, which is alarming because of its serious complications.  Anti-diabetic treatment aims to control glucose homeostasis as tightly as possible in order to reduce these complications.  Dipeptidyl peptidase-4 (DPP-4) inhibitors are a recent addn. to the anti-diabetic treatment modalities, and have become widely accepted because of their good efficacy, their benign side-effect profile and their low hypoglycemia risk.  The actions of DPP-4 inhibitors are not direct, but rather are mediated indirectly through preservation of the substrates they protect from degrdn.  The two incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, are known substrates, but other incretin-independent mechanisms may also be involved.  It seems likely therefore that the mechanisms of action of DPP-4 inhibitors are more complex than originally thought, and may involve several substrates and encompass local paracrine, systemic endocrine and neural pathways, which are discussed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriEo3tDF-sUbVg90H21EOLACvtfcHk0liXlzIMhh_Eyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL&md5=2d2783806da287d3bb50b932056fb5d2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fdom.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13018%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DE.%2BS.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26atitle%3DDo%2520we%2520know%2520the%2520true%2520mechanism%2520of%2520action%2520of%2520the%2520DPP-4%2520inhibitors%253F%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2018%26volume%3D20%26spage%3D34%26epage%3D41%26doi%3D10.1111%2Fdom.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions</span>. <i>Indian J. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.4103/2230-8210.141319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.4103%2F2230-8210.141319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=25364668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=753-759&author=A.+K.+Singh&title=Dipeptidyl+peptidase-4+inhibitors%3A+Novel+mechanism+of+actions&doi=10.4103%2F2230-8210.141319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 inhibitors: novel mechanism of actions</span></div><div class="casAuthors">Singh, Awadhesh Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">753-759</span>CODEN:
                <span class="NLM_cas:coden">IJEMGB</span>;
        ISSN:<span class="NLM_cas:issn">2230-9500</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications and Media Pvt. Ltd.</span>)
        </div><div class="casAbstract">A review.  The pharmacol. actions of the glucagon-like peptide-1 receptor agonists (GLP-1RA) are largely predictable as they interact directly with GLP-1 receptors on beta cells to mediate their glucose lowering effects by increasing GLP-1 in pharmacol. range and not at all dependent upon endogenous GLP-1 secretion.  The mechanism of action of dipeptidyl peptidase-4 inhibitors (DPP-4I) are relatively less clear although classical mechanism is to inhibit the endogenous GLP-1 metab. and thereby increasing GLP-1 level in the physiol. range.  DPP-4I also increase the half-life of GLP-1 to some extent by inhibiting their quick degrdn. by DPP enzyme ubiquitously present in the body.  Interestingly, even with the effective blockade with currently existing DPP-4I, the half-life of GLP-1 only increases from 1 min to 5 min and therefore its residual time in plasma still remains pretty short.  Intriguingly, this GLP-1 rise is so modest and so short-lived that it may be difficult to believe that this would sufficiently engage and activate the GLP-1 receptor in beta cell to produce significant insulinotropic effect.  However, in clin. trials as well as in real life scenario, the anti-glycemic efficacies seen with DPP-4I are quite satisfactory and sometime very much competitive to GLP-1RA as evident from their head-to-head trials including meta-anal.  This efficacy outcome challenges the "only" GLP-1 dependent mechanism of glucose lowering and provokes an insight that other neuro-endocrine pathway may be playing a second fiddle.  This review will collate those emerging concept and put a perspective as to how DPP-4I might be working though other pathway besides direct GLP-1 mediated receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEPwMXTYmqrVg90H21EOLACvtfcHk0liXlzIMhh_Eyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVensrc%253D&md5=0a38e63a35aa25cdf57910fdc88e697f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4103%2F2230-8210.141319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2230-8210.141319%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%2BK.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%253A%2520Novel%2520mechanism%2520of%2520actions%26jtitle%3DIndian%2520J.%2520Endocrinol.%2520Metab.%26date%3D2014%26volume%3D18%26spage%3D753%26epage%3D759%26doi%3D10.4103%2F2230-8210.141319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulvihill, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladanac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ussher, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggio, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burmeister, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, K. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span> <span> </span><span class="NLM_article-title">Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2016.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.cmet.2016.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=27839908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=152-165&author=E.+E.+Mulvihillauthor=E.+M.+Varinauthor=B.+Gladanacauthor=J.+E.+Campbellauthor=J.+R.+Ussherauthor=L.+L.+Baggioauthor=B.+Yustaauthor=J.+Ayalaauthor=M.+A.+Burmeisterauthor=D.+Matthewsauthor=K.+W.+A.+Bangauthor=J.+E.+Ayalaauthor=D.+J.+Drucker&title=Cellular+sites+and+mechanisms+linking+reduction+of+dipeptidyl+peptidase-4+activity+to+control+of+incretin+hormone+action+and+glucose+homeostasis&doi=10.1016%2Fj.cmet.2016.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis</span></div><div class="casAuthors">Mulvihill, Erin E.; Varin, Elodie M.; Gladanac, Bojana; Campbell, Jonathan E.; Ussher, John R.; Baggio, Laurie L.; Yusta, Bernardo; Ayala, Jennifer; Burmeister, Melissa A.; Matthews, Dianne; Bang, K. W. Annie; Ayala, Julio E.; Drucker, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-165</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pharmacol. inhibition of the dipeptidyl peptidase-4 (DPP4) enzyme potentiates incretin action and is widely used to treat type 2 diabetes.  Nevertheless, the precise cells and tissues crit. for incretin degrdn. and glucose homeostasis remain unknown.  Here, we use mouse genetics and pharmacol. DPP4 inhibition to identify DPP4+ cell types essential for incretin action.  Although enterocyte DPP4 accounted for substantial intestinal DPP4 activity, ablation of enterocyte DPP4 in Dpp4Gut-/- mice did not produce alterations in plasma DPP4 activity, incretin hormone levels, and glucose tolerance.  In contrast, endothelial cell (EC)-derived DPP4 contributed substantially to levels of sol. plasma DPP4 activity, incretin degrdn., and glucose control.  Surprisingly, DPP4+ cells of bone marrow origin mediated the selective degrdn. of fasting GIP, but not GLP-1.  Collectively, these findings identify distinct roles for DPP4 in the EC vs. the bone marrow compartment for selective incretin degrdn. and DPP4i-mediated glucoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEb9Z3NduUzrVg90H21EOLACvtfcHk0liXlzIMhh_Eyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL3E&md5=6863e0483ae2e8629f2b2d4c5c39d29d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2016.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DE.%2BE.%26aulast%3DVarin%26aufirst%3DE.%2BM.%26aulast%3DGladanac%26aufirst%3DB.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DUssher%26aufirst%3DJ.%2BR.%26aulast%3DBaggio%26aufirst%3DL.%2BL.%26aulast%3DYusta%26aufirst%3DB.%26aulast%3DAyala%26aufirst%3DJ.%26aulast%3DBurmeister%26aufirst%3DM.%2BA.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DBang%26aufirst%3DK.%2BW.%2BA.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DCellular%2520sites%2520and%2520mechanisms%2520linking%2520reduction%2520of%2520dipeptidyl%2520peptidase-4%2520activity%2520to%2520control%2520of%2520incretin%2520hormone%2520action%2520and%2520glucose%2520homeostasis%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D25%26spage%3D152%26epage%3D165%26doi%3D10.1016%2Fj.cmet.2016.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, H.</span></span> <span> </span><span class="NLM_article-title">Role of gut microbiota-gut hormone axis in the pathophysiology of functional gastrointestinal disorders</span>. <i>J. Neurogastroenterol. Motil.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.5056/jnm18071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.5056%2Fjnm18071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29969855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FksFWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=367-386&author=H.+Fukuiauthor=X.+Xuauthor=H.+Miwa&title=Role+of+gut+microbiota-gut+hormone+axis+in+the+pathophysiology+of+functional+gastrointestinal+disorders&doi=10.5056%2Fjnm18071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders</span></div><div class="casAuthors">Fukui Hirokazu; Xu Xin; Miwa Hiroto; Xu Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurogastroenterology and motility</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-386</span>
        ISSN:<span class="NLM_cas:issn">2093-0879</span>.
    </div><div class="casAbstract">Gut microbiota exert a pivotal influence on various functions including gastrointestinal (GI) motility, metabolism, nutrition, immunity, and the neuroendocrine system in the host.  These effects are mediated by not only short-chain fatty acids produced by microbiota but also gut hormones and inflammatory signaling by enteroendocrine and immune cells under the influence of the microbiota.  GI motility is orchestrated by the enteric nervous system and hormonal networks, and disturbance of GI motility plays an important role in the pathophysiology of functional gastrointestinal disorders (FGIDs).  In this context, microbiota-associated mediators are considered to act on specific receptors, thus affecting the enteric nervous system and, subsequently, GI motility.  Thus, the pathophysiology of FGIDs is based on alterations of the gut microbiota/gut hormone axis, which have crucial effects on GI motility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRo9EiENZlhS2gRQsDqrjW_fW6udTcc2eZYJvqx6dxjCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FksFWrsw%253D%253D&md5=72cb1108ec86deed0e89dd39f4dc512e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.5056%2Fjnm18071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5056%252Fjnm18071%26sid%3Dliteratum%253Aachs%26aulast%3DFukui%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DMiwa%26aufirst%3DH.%26atitle%3DRole%2520of%2520gut%2520microbiota-gut%2520hormone%2520axis%2520in%2520the%2520pathophysiology%2520of%2520functional%2520gastrointestinal%2520disorders%26jtitle%3DJ.%2520Neurogastroenterol.%2520Motil.%26date%3D2018%26volume%3D24%26spage%3D367%26epage%3D386%26doi%3D10.5056%2Fjnm18071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. D.</span></span> <span> </span><span class="NLM_article-title">Gut microbiota: an integral moderator in health and disease</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">151</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.3389%2Ffmicb.2018.00151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29515527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BC1MroslKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=151&author=Q.+Fengauthor=W.+D.+Chenauthor=Y.+D.+Wang&title=Gut+microbiota%3A+an+integral+moderator+in+health+and+disease&doi=10.3389%2Ffmicb.2018.00151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Gut Microbiota: An Integral Moderator in Health and Disease</span></div><div class="casAuthors">Feng Qingqing; Wang Yan-Dong; Chen Wei-Dong; Chen Wei-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">The gut microbiota, as the main member in gut microecology, is an essential mediator in health and disease.  The gut microbiota interacts with various organs and systems in the body, including brain, lung, liver, bone, cardiovascular system, and others.  Microbiota-derived metabolites such as the short chain fatty acid (SCFA) butyrate are primary signals, which link the gut microbiota and physiology.  Recently, the gut microbiota has been identified as the origin of a number of diseases by influencing the related cell signaling pathways such as WNT/beta-catenin pathway in colorectal cancer and T cell receptor signaling in the central nervous system.  Moreover, several microRNAs participate in signaling networks through the intervention of the gut microbiota.  The interaction between the gut microbiota and miRNAs plays a crucial role in vascular dysfunction and hepatocellular carcinoma (HCC).  In this review, we will report and discuss recent findings about the crosstalk between the gut microbiota and physical organs and how the gut microbiota and miRNAs regulate each other while influencing the host via genes, proteins, or metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6VkEBjsea1SEJCPKhJPuqfW6udTcc2eZYJvqx6dxjCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MroslKqtQ%253D%253D&md5=0e4e44b329a8546c6628f71ecf03096a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00151%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DW.%2BD.%26aulast%3DWang%26aufirst%3DY.%2BD.%26atitle%3DGut%2520microbiota%253A%2520an%2520integral%2520moderator%2520in%2520health%2520and%2520disease%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D151%26doi%3D10.3389%2Ffmicb.2018.00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fyfe, M. C.</span></span> <span> </span><span class="NLM_article-title">Non-systemic intestine-targeted drugs</span>. In  <i>Progress in Medicinal Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawton, G.</span>, <span class="NLM_string-name">Witty, D. R.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier UK</span>, <span class="NLM_year">2016</span>,  <span class="NLM_volume">55</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">44</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1-44&author=M.+C.+Fyfeauthor=G.+Lawton&author=D.+R.+Witty&title=Progress+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFyfe%26aufirst%3DM.%2BC.%26atitle%3DNon-systemic%2520intestine-targeted%2520drugs%26btitle%3DProgress%2520in%2520Medicinal%2520Chemistry%26aulast%3DLawton%26aufirst%3DG.%26pub%3DElsevier%2520UK%26date%3D2016%26volume%3D55%26spage%3D1%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroso, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbins, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harston, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5094</span>– <span class="NLM_lpage">5114</span>, <span class="refDoi"> DOI: 10.1021/jm400459m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400459m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5094-5114&author=Y.+Wuauthor=C.+J.+Aquinoauthor=D.+J.+Cowanauthor=D.+L.+Andersonauthor=J.+L.+Ambrosoauthor=M.+J.+Bishopauthor=E.+E.+Borosauthor=L.+Chenauthor=A.+Cunninghamauthor=R.+L.+Dobbinsauthor=P.+L.+Feldmanauthor=L.+T.+Harstonauthor=I.+W.+Kaldorauthor=R.+Kleinauthor=X.+Liangauthor=M.+S.+McIntyreauthor=C.+L.+Merrillauthor=K.+M.+Pattersonauthor=J.+S.+Prescottauthor=J.+S.+Rayauthor=S.+G.+Rollerauthor=X.+Yaoauthor=A.+Youngauthor=J.+Yuenauthor=J.+L.+Collins&title=Discovery+of+a+highly+potent%2C+nonabsorbable+apical+sodium-dependent+bile+acid+transporter+inhibitor+%28GSK2330672%29+for+treatment+of+type+2+diabetes&doi=10.1021%2Fjm400459m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Wu, Yulin; Aquino, Christopher J.; Cowan, David J.; Anderson, Don L.; Ambroso, Jeff L.; Bishop, Michael J.; Boros, Eric E.; Chen, Lihong; Cunningham, Alan; Dobbins, Robert L.; Feldman, Paul L.; Harston, Lindsey T.; Kaldor, Istvan W.; Klein, Ryan; Liang, Xi; McIntyre, Maggie S.; Merrill, Christine L.; Patterson, Kristin M.; Prescott, Judith S.; Ray, John S.; Roller, Shane G.; Yao, Xiaozhou; Young, Andrew; Yuen, Josephine; Collins, Jon L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5094-5114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein.  Multiple pharmaceutical companies have exploited the physiol. link between ASBT and hepatic cholesterol metab., which led to the clin. investigation of ASBT inhibitors as lipid-lowering agents.  While modest lipid effects were demonstrated, the potential utility of ASBT inhibitors for treatment of type 2 diabetes has been relatively unexplored.  We initiated a lead optimization effort that focused on the identification of a potent, nonabsorbable ASBT inhibitor starting from the first-generation inhibitor 264W94 (1).  Extensive SAR studies culminated in the discovery of GSK2330672 (56) as a highly potent, nonabsorbable ASBT inhibitor which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJcOxeK4rL_LVg90H21EOLACvtfcHk0lgEpq8wlOZjdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGiur0%253D&md5=4eb5eb2acc34f96469e23987b224ca35</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm400459m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400459m%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DAquino%26aufirst%3DC.%2BJ.%26aulast%3DCowan%26aufirst%3DD.%2BJ.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DAmbroso%26aufirst%3DJ.%2BL.%26aulast%3DBishop%26aufirst%3DM.%2BJ.%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCunningham%26aufirst%3DA.%26aulast%3DDobbins%26aufirst%3DR.%2BL.%26aulast%3DFeldman%26aufirst%3DP.%2BL.%26aulast%3DHarston%26aufirst%3DL.%2BT.%26aulast%3DKaldor%26aufirst%3DI.%2BW.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DMcIntyre%26aufirst%3DM.%2BS.%26aulast%3DMerrill%26aufirst%3DC.%2BL.%26aulast%3DPatterson%26aufirst%3DK.%2BM.%26aulast%3DPrescott%26aufirst%3DJ.%2BS.%26aulast%3DRay%26aufirst%3DJ.%2BS.%26aulast%3DRoller%26aufirst%3DS.%2BG.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DYuen%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520potent%252C%2520nonabsorbable%2520apical%2520sodium-dependent%2520bile%2520acid%2520transporter%2520inhibitor%2520%2528GSK2330672%2529%2520for%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5094%26epage%3D5114%26doi%3D10.1021%2Fjm400459m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span> <span> </span><span class="NLM_article-title">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3982</span>– <span class="NLM_lpage">3999</span>, <span class="refDoi"> DOI: 10.2174/092986712802002491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2174%2F092986712802002491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=22709010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3982-3999&author=Y.+Liuauthor=Y.+Huauthor=T.+Liu&title=Recent+advances+in+non-peptidomimetic+dipeptidyl+peptidase+4+inhibitors%3A+medicinal+chemistry+and+preclinical+aspects&doi=10.2174%2F092986712802002491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span></div><div class="casAuthors">Liu, Y.; Hu, Y.; Liu, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3982-3999</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase 4 (DPP-4), a substrate-specific serine protease, has been validated as a promising drug target for the treatment of type 2 diabetes.  DPP-4 inhibitors significantly lowered blood glucose levels in patients with type 2 diabetes without common body wt. gain, hypoglycemia and gastrointestinal disturbance side effects.  Therefore, DPP-4 inhibitors attracted more and more attention.  In particular, non-peptidomimetic DPP-4 inhibitors have been a focus of research and development and made great progress in recent years, which resulted in the discovery of a wide variety of potent non-peptidomimetic DPP-4 inhibitors.  Some of them, such as sitagliptin, alogliptin and linagliptin have already been used as marketed drugs, while others have been into clin. trials.  Based on the core structural features of non-peptidomimetic DPP-4 inhibitors, seven types were classified in the article.  For each type, we focused on the description of strategies for design and optimization, together with a discussion on concluded structure-activity relationships (SAR).  In addn., the contribution of specific substituents to the inhibition of DPP-4 was summarized.  Selectivity towards the inhibition of DPP-4 over dipeptidyl peptidase 8 (DPP-8) and dipeptidyl peptidase 9 (DPP-9) was also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLqQuB1LrfarVg90H21EOLACvtfcHk0lgEpq8wlOZjdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI&md5=3ad3980483dcdcb29868b34a8bf77e6b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F092986712802002491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712802002491%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26atitle%3DRecent%2520advances%2520in%2520non-peptidomimetic%2520dipeptidyl%2520peptidase%25204%2520inhibitors%253A%2520medicinal%2520chemistry%2520and%2520preclinical%2520aspects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3982%26epage%3D3999%26doi%3D10.2174%2F092986712802002491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumagai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, H.</span></span> <span> </span><span class="NLM_article-title">(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl ]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5435</span>– <span class="NLM_lpage">5438</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.09.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.bmcl.2008.09.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=18819797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cqs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5435-5438&author=A.+Nittaauthor=H.+Fujiiauthor=S.+Sakamiauthor=Y.+Nishimuraauthor=T.+Ohyamaauthor=M.+Satohauthor=J.+Nakakiauthor=S.+Satohauthor=C.+Inadaauthor=H.+Kozonoauthor=H.+Kumagaiauthor=M.+Shimamuraauthor=T.+Fukazawaauthor=H.+Kawai&title=%283R%29-3-amino-4-%282%2C4%2C5-trifluorophenyl%29-N-%7B4-%5B6-%282-methoxyethoxy%29benzothiazol-2-yl+%5Dtetrahydropyran-4-yl%7Dbutanamide+as+a+potent+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes&doi=10.1016%2Fj.bmcl.2008.09.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">(3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Nitta, Aiko; Fujii, Hideaki; Sakami, Satoshi; Nishimura, Yutaka; Ohyama, Tomofumi; Satoh, Mikiya; Nakaki, Junko; Satoh, Shiho; Inada, Chifumi; Kozono, Hideki; Kumagai, Hiroki; Shimamura, Masahiro; Fukazawa, Tominaga; Kawai, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5435-5438</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides and 3-amino-N-(4-aryltetrahydropyran-4-yl)butanamides were synthesized and evaluated as dipeptidyl peptidase IV (DPP-IV) inhibitors.  Derivs. incorporating the 6-substituted benzothiazole group showed highly potent DPP-IV inhibitory activity.  Oral administration of (3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide reduced blood glucose excursion in an oral glucose tolerance test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrObdiSLW27ZbVg90H21EOLACvtfcHk0lgEpq8wlOZjdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cqs77K&md5=a47b223cce3a0848638cb8b9a479df46</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.09.042%26sid%3Dliteratum%253Aachs%26aulast%3DNitta%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DH.%26aulast%3DSakami%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DOhyama%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DM.%26aulast%3DNakaki%26aufirst%3DJ.%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DInada%26aufirst%3DC.%26aulast%3DKozono%26aufirst%3DH.%26aulast%3DKumagai%26aufirst%3DH.%26aulast%3DShimamura%26aufirst%3DM.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DH.%26atitle%3D%25283R%2529-3-amino-4-%25282%252C4%252C5-trifluorophenyl%2529-N-%257B4-%255B6-%25282-methoxyethoxy%2529benzothiazol-2-yl%2520%255Dtetrahydropyran-4-yl%257Dbutanamide%2520as%2520a%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5435%26epage%3D5438%26doi%3D10.1016%2Fj.bmcl.2008.09.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampietro, O.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2943</span>– <span class="NLM_lpage">2951</span>, <span class="refDoi"> DOI: 10.2174/092986709788803114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2174%2F092986709788803114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=19689275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2943-2951&author=E.+Matteucciauthor=O.+Giampietro&title=Dipeptidyl+peptidase-4+%28CD26%29%3A+knowing+the+function+before+inhibiting+the+enzyme&doi=10.2174%2F092986709788803114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme</span></div><div class="casAuthors">Matteucci, E.; Giampietro, O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2943-2951</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase-4 (DPP4) or adenosine deaminase complexing protein 2 (ADCP 2) or T-cell activation antigen CD26 (EC 3.4.14.5.) is a serine exopeptidase belonging to the S9B protein family that cleaves X-proline dipeptides from the N-terminus of polypeptides, such as chemokines, neuropeptides, and peptide hormones.  The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types, whose physiol. functions are largely unknown.  Protein dimerization should be required for catalytic activity and glycosylation of the enzyme could impact on its physiol. functions.  The dimeric glycoprotein ADCP has been found linked to adenosine deaminase (ADA) whose relation with lymphocyte maturation-differentiation is well-established.  Since implicated in the regulation of the biol. activity of hormones and chemokines, such as glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, DPP4 inhibition offers a new potential therapeutic approach for type 2 diabetes mellitus, as monotherapy and adjunct therapy to other oral agents.  The clin. use of presently available orally active inhibitors of DPP4, however, has been assocd. with side effects that have been in part attributed to the inhibition of related serine proteases, such as DPP8 and DPP9.  Indeed, it is noteworthy that CD26 has a key role in immune regulation as a T cell activation mol. and in immune-mediated disorder.  All-cause infections were increased after sitagliptin treatment.  It is noteworthy that the effects of DPP4 inhibition on the immune system have not been extensively investigated.  So far, only routine lab. safety variables have been measured in published randomized controlled trials.  The review summarizes present knowledge in the field and suggests some potential directions of future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWf-vE1Djk0rVg90H21EOLACvtfcHk0lhkOQdA72r4eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLg%253D&md5=c183b2b0410a92c1b9e35dc3fcb369f7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F092986709788803114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803114%26sid%3Dliteratum%253Aachs%26aulast%3DMatteucci%26aufirst%3DE.%26aulast%3DGiampietro%26aufirst%3DO.%26atitle%3DDipeptidyl%2520peptidase-4%2520%2528CD26%2529%253A%2520knowing%2520the%2520function%2520before%2520inhibiting%2520the%2520enzyme%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2943%26epage%3D2951%26doi%3D10.2174%2F092986709788803114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braunstein, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span> <span> </span><span class="NLM_article-title">Role of incretin axis in inflammatory bowel disease</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1734</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.01734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.3389%2Ffimmu.2017.01734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29270177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOhu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1734&author=L.+Duanauthor=X.+Raoauthor=Z.+Braunsteinauthor=A.+C.+Toomeyauthor=J.+Zhong&title=Role+of+incretin+axis+in+inflammatory+bowel+disease&doi=10.3389%2Ffimmu.2017.01734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Role of incretin axis in inflammatory bowel disease</span></div><div class="casAuthors">Duan, Lihua; Rao, Xiaoquan; Braunstein, Zachary; Toomey, Amelia C.; Zhong, Jixin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1734/1-1734/7</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract and involve a complicated reciprocity of environmental, genetic, and immunol. factors.  Despite substantial advances in the foundational understanding of the immunol. pathogenesis of IBD, the detailed mechanism of the pathol. progression in IBD remains unknown.  In addn. to Th1/Th2 cells, whose role in IBD has been previously well defined, recent evidence indicates that Th17 cells and Tregs also play a crucial role in the development of IBD.  Diets which contain excess sugars, salt, and fat may also be important actors in the pathogenesis of IBD, which may be the cause of high IBD incidence in western developed and industrialized countries.  Up until now, the reason for the variance in prevalence of IBD between developed and developing countries has been unknown.  This is partly due to the increasing popularity of western diets in developing countries, which makes the data harder to interpret.  The enterocrinins glucagon-like peptides (GLPs), including GLP-1 and GLP-2, exhibit notable benefits on lipid metab., atherosclerosis formation, plasma glucose levels, and maintenance of gastric mucosa integrity.  In addn. to the regulation of nutrient metab., the emerging role of GLPs and their degrading enzyme dipeptidyl peptidase-4 (DPP-4) in gastrointestinal diseases has gained increasing attention.  Therefore, here we review the function of the DPP-4/GLP axis in IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6F8S1rH9bC7Vg90H21EOLACvtfcHk0lhkOQdA72r4eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOhu7bM&md5=62be86da06683351d91ca8907f6b20b3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.01734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.01734%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DRao%26aufirst%3DX.%26aulast%3DBraunstein%26aufirst%3DZ.%26aulast%3DToomey%26aufirst%3DA.%2BC.%26aulast%3DZhong%26aufirst%3DJ.%26atitle%3DRole%2520of%2520incretin%2520axis%2520in%2520inflammatory%2520bowel%2520disease%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D1734%26doi%3D10.3389%2Ffimmu.2017.01734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Detel, D.</span>; <span class="NLM_string-name">Batii, L.</span>; <span class="NLM_string-name">Pernjak, E.</span>; <span class="NLM_string-name">Kui, N.</span>; <span class="NLM_string-name">Buljevi, S.</span>; <span class="NLM_string-name">Mijandrui, B.</span>; <span class="NLM_string-name">Peri, M.</span>; <span class="NLM_string-name">Varlje, J.</span></span> <span> </span><span class="NLM_article-title">Role of dipeptidyl peptidase IV/CD26 in inflammatory bowel disease</span>. In  <i>Inflammatory Bowel Disease—Advances in Pathogenesis and Management</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karoui, S.</span></span>, Eds.; <span class="NLM_publisher-name">IntechOpen</span>: <span class="NLM_publisher-loc">Rijeka, Croatia</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">88</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.5772%2F29285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=59-88&author=D.+Detel&author=L.+Batii&author=E.+Pernjak&author=N.+Kui&author=S.+Buljevi&author=B.+Mijandrui&author=M.+Peri&author=J.+Varljeauthor=S.+Karoui&title=Inflammatory+Bowel+Disease%E2%80%94Advances+in+Pathogenesis+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.5772%2F29285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F29285%26sid%3Dliteratum%253Aachs%26aulast%3DDetel%26aufirst%3DD.%26atitle%3DRole%2520of%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520in%2520inflammatory%2520bowel%2520disease%26btitle%3DInflammatory%2520Bowel%2520Disease%25E2%2580%2594Advances%2520in%2520Pathogenesis%2520and%2520Management%26aulast%3DKaroui%26aufirst%3DS.%26pub%3DIntechOpen%26date%3D2012%26spage%3D59%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abrahami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, O. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renoux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azoulay, L.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study</span>. <i>B. M. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>, <span class="NLM_elocation-id">k872</span> <span class="refDoi"> DOI: 10.1136/bmj.k872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1136%2Fbmj.k872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29563098" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&author=D.+Abrahamiauthor=A.+Dourosauthor=H.+Yinauthor=O.+H.+Y.+Yuauthor=C.+Renouxauthor=A.+Bittonauthor=L.+Azoulay&title=Dipeptidyl+peptidase-4+inhibitors+and+incidence+of+inflammatory+bowel+disease+among+patients+with+type+2+diabetes%3A+population+based+cohort+study&doi=10.1136%2Fbmj.k872"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fbmj.k872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.k872%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahami%26aufirst%3DD.%26aulast%3DDouros%26aufirst%3DA.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DO.%2BH.%2BY.%26aulast%3DRenoux%26aufirst%3DC.%26aulast%3DBitton%26aufirst%3DA.%26aulast%3DAzoulay%26aufirst%3DL.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520and%2520incidence%2520of%2520inflammatory%2520bowel%2520disease%2520among%2520patients%2520with%2520type%25202%2520diabetes%253A%2520population%2520based%2520cohort%2520study%26jtitle%3DB.%2520M.%2520J.%26date%3D2018%26volume%3D360%26doi%3D10.1136%2Fbmj.k872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sueyoshi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods Ignatoski, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitelbaum, D. H.</span></span> <span> </span><span class="NLM_article-title">Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model</span>. <i>Am. J. Physiol. Gastrointest Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">G410</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00363.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1152%2Fajpgi.00363.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=24970775" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2014&pages=G410-419&author=R.+Sueyoshiauthor=K.+M.+Woods+Ignatoskiauthor=M.+Okawadaauthor=B.+Hartmannauthor=J.+Holstauthor=D.+H.+Teitelbaum&title=Stimulation+of+intestinal+growth+and+function+with+DPP4+inhibition+in+a+mouse+short+bowel+syndrome+model&doi=10.1152%2Fajpgi.00363.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00363.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00363.2013%26sid%3Dliteratum%253Aachs%26aulast%3DSueyoshi%26aufirst%3DR.%26aulast%3DWoods%2BIgnatoski%26aufirst%3DK.%2BM.%26aulast%3DOkawada%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DB.%26aulast%3DHolst%26aufirst%3DJ.%26aulast%3DTeitelbaum%26aufirst%3DD.%2BH.%26atitle%3DStimulation%2520of%2520intestinal%2520growth%2520and%2520function%2520with%2520DPP4%2520inhibition%2520in%2520a%2520mouse%2520short%2520bowel%2520syndrome%2520model%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest%2520Liver%2520Physiol.%26date%3D2014%26volume%3D307%26spage%3DG410%26epage%3D419%26doi%3D10.1152%2Fajpgi.00363.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baticic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Detel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buljevic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugel, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varljen, J.</span></span> <span> </span><span class="NLM_article-title">Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">3322</span>– <span class="NLM_lpage">3333</span>, <span class="refDoi"> DOI: 10.1002/jcb.23261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1002%2Fjcb.23261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=21751235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlagur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2011&pages=3322-3333&author=L.+Baticicauthor=D.+Detelauthor=N.+Kucicauthor=S.+Buljevicauthor=E.+P.+Pugelauthor=J.+Varljen&title=Neuroimmunomodulative+properties+of+dipeptidyl+peptidase+IV%2FCD26+in+a+TNBS-induced+model+of+colitis+in+mice&doi=10.1002%2Fjcb.23261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice</span></div><div class="casAuthors">Baticic, Lara; Detel, Dijana; Kucic, Natalia; Buljevic, Suncica; Pugel, Ester Pernjak; Varljen, Jadranka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3322-3333</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Causal connections between dipeptidyl peptidase IV, also known as CD26 mol. (DPP IV/CD26) and inflammatory bowel disease (IBD) have been shown, but mechanisms of these interactions are unclear.  Our hypothesis was that DPP IV/CD26 could affect the neuroimmune response during inflammatory events.  Therefore, we aimed to evaluate its possible role and the relevance of the gut-brain axis in a model of IBD in mice.  Trinitrobenzenesulfonic acid-induced (TNBS) colitis was induced in CD26-deficient (CD26-/-) and wild-type (C57BL/6) mice.  Pathohistol. and histomorphometrical measurements were done.  Concns. and protein expressions of DPP IV/CD26 substrates neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) were detd.  Concns. of IL-6 and IL-10 were evaluated.  Investigations were conducted at systemic and local levels.  Acute inflammation induced increased serum NPY concns. in both mice strains, more enhanced in CD26-/- mice.  Increased NPY concns. were found in colon and brain of C57BL/6 mice, while in CD26-/- animals only in colon.  VIP and IL-6 serum and tissue concns. were increased in both mice strains in acute inflammation, more pronouncedly in CD26-/- mice.  IL-10 concns., after a decrease in serum of both mice strains, increased promptly in CD26-/- mice.  Decreased IL-10 concn. was found in brain of C57BL/6 mice, while it was increased in colon of CD26-/- mice in acute inflammation.  DPP IV/CD26 deficiency affects the neuroimmune response at systemic and local levels during colitis development and resoln. in mice.  Inflammatory changes in the colon reflected on investigated parameters in the brain, suggesting an important role of the gut-brain axis in IBD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAmlJ2ctLOhrVg90H21EOLACvtfcHk0lgM_48Hv4OBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlagur7J&md5=ebc65552d18a150bc9a55847f7e32aab</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcb.23261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.23261%26sid%3Dliteratum%253Aachs%26aulast%3DBaticic%26aufirst%3DL.%26aulast%3DDetel%26aufirst%3DD.%26aulast%3DKucic%26aufirst%3DN.%26aulast%3DBuljevic%26aufirst%3DS.%26aulast%3DPugel%26aufirst%3DE.%2BP.%26aulast%3DVarljen%26aufirst%3DJ.%26atitle%3DNeuroimmunomodulative%2520properties%2520of%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520in%2520a%2520TNBS-induced%2520model%2520of%2520colitis%2520in%2520mice%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D112%26spage%3D3322%26epage%3D3333%26doi%3D10.1002%2Fjcb.23261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrowiecka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malecka-Panas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamysz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichna, J.</span></span> <span> </span><span class="NLM_article-title">New peptide inhibitor of dipeptidyl peptidase IV, EMDB-1 extends the half-Life of GLP-2 and attenuates colitis in mice after topical administration</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.242586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1124%2Fjpet.117.242586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=28724693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVWgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2017&pages=92-103&author=M.+Salagaauthor=A.+Mokrowieckaauthor=M.+Zielinskaauthor=E.+Malecka-Panasauthor=R.+Kordekauthor=E.+Kamyszauthor=J.+Fichna&title=New+peptide+inhibitor+of+dipeptidyl+peptidase+IV%2C+EMDB-1+extends+the+half-Life+of+GLP-2+and+attenuates+colitis+in+mice+after+topical+administration&doi=10.1124%2Fjpet.117.242586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New peptide inhibitor of dipeptidyl peptidase IV, EMDB-1 extends the half-life of GLP-2 and attenuates colitis in mice after topical administration</span></div><div class="casAuthors">Salaga, Maciej; Mokrowiecka, Anna; Zielinska, Marta; Malecka-Panas, Ewa; Kordek, Radzislaw; Kamysz, Elzbieta; Fichna, Jakub</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-103</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Protease inhibition has become a possible new approach in inflammatory bowel disease (IBD) therapy.  A serine exopeptidase, dipeptidyl peptidase IV (DPP IV), is responsible for the inactivation of incretin hormone, glucagon-like peptide 2 (GLP-2), a potent stimulator of intestinal epithelium regeneration and growth.  Recently, we showed that the novel peptide analog of endomorphin-2, Tyr-Pro-D-ClPhe-Phe-NH2 (EMDB-1) is a potent blocker of DPP IV and has an inhibitory effect on gastrointestinal (GI) smooth muscle contractility.  The aim of this study was to characterize the anti-inflammatory effect and mechanism of action of EMDB-1 in the mouse GI tract.  We used two models of exptl. colitis (induced by TNBS and DSS).  The anti-inflammatory effect of EMDB-1 was assessed by the detn. of macroscopic score, ulcer score, colonic wall thickness, as well as myeloperoxidase activity.  Addnl., we measured the expression of GLP-2, GLP2R, and DPP IV in the colon of control and colitic animals treated with the test compd.  The expression of GLP-2 and GLP2R in the serum and colon of IBD patients and healthy control subjects has been assessed.  We showed that EMDB-1 elevates the half-life of GLP- 2 in vitro and attenuates acute, semichronic, and relapsing TNBS as well as DSS-induced colitis in mice after topical administration.  The anti-inflammatory action of EMDB-1 is assocd. with changes in the level of colonic GLP-2 but not DPP IV expression.  Our results validate DPP IV as a pharmacol. target for the anti-IBD drugs, and its inhibitors based on natural substrates, such as EMDB-1, have the potential to become valuable antiinflammatory therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkAWkaxVrLg7Vg90H21EOLACvtfcHk0lgM_48Hv4OBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVWgur4%253D&md5=d6bccbaf92a5875bb6c4c6f396f6b0a4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.242586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.242586%26sid%3Dliteratum%253Aachs%26aulast%3DSalaga%26aufirst%3DM.%26aulast%3DMokrowiecka%26aufirst%3DA.%26aulast%3DZielinska%26aufirst%3DM.%26aulast%3DMalecka-Panas%26aufirst%3DE.%26aulast%3DKordek%26aufirst%3DR.%26aulast%3DKamysz%26aufirst%3DE.%26aulast%3DFichna%26aufirst%3DJ.%26atitle%3DNew%2520peptide%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%252C%2520EMDB-1%2520extends%2520the%2520half-Life%2520of%2520GLP-2%2520and%2520attenuates%2520colitis%2520in%2520mice%2520after%2520topical%2520administration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D363%26spage%3D92%26epage%3D103%26doi%3D10.1124%2Fjpet.117.242586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yazbeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geier, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, C. A.</span></span> <span> </span><span class="NLM_article-title">Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">6850</span>– <span class="NLM_lpage">6858</span>, <span class="refDoi"> DOI: 10.2741/3193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2741%2F3193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=18508699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=6850-6858&author=R.+Yazbeckauthor=G.+S.+Howarthauthor=M.+S.+Geierauthor=H.-U.+Demuthauthor=C.+A.+Abbott&title=Inhibiting+dipeptidyl+peptidase+activity+partially+ameliorates+colitis+in+mice&doi=10.2741%2F3193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice</span></div><div class="casAuthors">Yazbeck, Roger; Howarth, Gordon S.; Geier, Mark S.; Demuth, Hans-Ulrich; Abbott, Catherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6850-6858</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">New treatment strategies are required for the debilitating inflammatory bowel diseases (IBD), Crohn's Disease and Ulcerative Colitis.  DP inhibitors can prolong the bioactivity of the potent intestinotrophic growth factor glucagon-like peptide-2 (GLP-21-33).  We investigated whether novel inhibitors of DP activity could modify the course of disease activity in the dextran sulfate sodium (DSS) model of colitis.  C57BL/6 mice consumed 2% DSS in drinking water for 6 days.  Mice were orally gavaged twice daily with 0.9% saline, 10mg/kg isoleucyl-cyano-pyrrolidine (P59/99) or isoleucyl-thiazolidine (P32/98).  Assessment of disease severity incorporated a disease activity index (DAI), together with histol. assessment of crypt area and depth in the distal colon.  DP activity was significantly inhibited at all time points.  The DAI was significantly lower in the P59/99 and P32/98 treatment groups compared to saline treatment in all three time courses.  Crypt hyperplasia (p<0.05) was obsd. in the saline group compared to P32/98 treatment at day 9.  This preliminary study shows that novel inhibitors of DP activity may provide a new treatment strategy for IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSueeEb4t-0LVg90H21EOLACvtfcHk0lgM_48Hv4OBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOiur4%253D&md5=15b8b06bfd37689a90c2096d5c18561e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2741%2F3193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3193%26sid%3Dliteratum%253Aachs%26aulast%3DYazbeck%26aufirst%3DR.%26aulast%3DHowarth%26aufirst%3DG.%2BS.%26aulast%3DGeier%26aufirst%3DM.%2BS.%26aulast%3DDemuth%26aufirst%3DH.-U.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26atitle%3DInhibiting%2520dipeptidyl%2520peptidase%2520activity%2520partially%2520ameliorates%2520colitis%2520in%2520mice%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2008%26volume%3D13%26spage%3D6850%26epage%3D6858%26doi%3D10.2741%2F3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morise, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funasaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, H.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis</span>. <i>Scand. J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.3109/00365521.2013.832366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.3109%2F00365521.2013.832366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=24047394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyrurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=1152-1159&author=S.+Mimuraauthor=T.+Andoauthor=K.+Ishiguroauthor=O.+Maedaauthor=O.+Watanabeauthor=M.+Ujiharaauthor=Y.+Hirayamaauthor=K.+Moriseauthor=K.+Maedaauthor=M.+Matsushitaauthor=K.+Funasakaauthor=M.+Nakamuraauthor=R.+Miyaharaauthor=N.+Ozakiauthor=H.+Goto&title=Dipeptidyl+peptidase-4+inhibitor+anagliptin+facilitates+restoration+of+dextran+sulfate+sodium-induced+colitis&doi=10.3109%2F00365521.2013.832366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis</span></div><div class="casAuthors">Mimura, Shunya; Ando, Takafumi; Ishiguro, Kazuhiro; Maeda, Osamu; Watanabe, Osamu; Ujihara, Masaki; Hirayama, Yutaka; Morise, Kazuhiro; Maeda, Keiko; Matsushita, Masanobu; Funasaka, Kohei; Nakamura, Masanao; Miyahara, Ryoji; Ozaki, Nobuaki; Goto, Hidemi</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1152-1159</span>CODEN:
                <span class="NLM_cas:coden">SJGRA4</span>;
        ISSN:<span class="NLM_cas:issn">0036-5521</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Objective: Inflammatory bowel disease (IBD) is a chronic debilitating disease assocd. with severe damage to the intestinal mucosa.  Glucagon-like peptide-2 (GLP-2) is a potent and specific gastrointestinal growth factor.  GLP-2 released from enteroendocrine cells is inactivated by dipeptidyl peptidase-4 (DPP-4).  The aim of this study was to examine whether the DPP-4 inhibitor anagliptin improves exptl. murine colitis.  Material and methods: Male C57BL/6 mice aged 8 wk were exposed to 1.5% dextran sulfate sodium (DSS) in drinking water for 7 days to induce exptl. colitis.  Anagliptin (0.1% in diet) was administrated from 2 days before the beginning of DSS to 7 days after the end of DSS.  Changes in body wt. and disease activity index were evaluated daily.  Histol. colitis severity, cellular proliferation and gene expression were detd. in colonic tissues.  Results: Treatment with anagliptin clearly improved body wt. loss and disease activity index in the recovery phase.  Histol. score in the DSS + anagliptin group at day 14 was significantly lower than that in the DSS alone group.  Treatment with anagliptin increased the Ki67-pos. rate at days 10 and 14, and tended to increase insulin-like growth factor-1 mRNA expression in the DSS + anagliptin group.  Conclusion: In this model of exptl. colitis, the DPP-4 inhibitor anagliptin facilitated the restoration of mucosal damage, thereby resulting in the acceleration of healing.  These findings suggest a new and novel therapeutic approach for the treatment of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPcEVGLp6qnLVg90H21EOLACvtfcHk0liV-BKI9jLJ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyrurzE&md5=108391c0ec4a80f8b127d92195b78cb9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3109%2F00365521.2013.832366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00365521.2013.832366%26sid%3Dliteratum%253Aachs%26aulast%3DMimura%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DO.%26aulast%3DWatanabe%26aufirst%3DO.%26aulast%3DUjihara%26aufirst%3DM.%26aulast%3DHirayama%26aufirst%3DY.%26aulast%3DMorise%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DFunasaka%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMiyahara%26aufirst%3DR.%26aulast%3DOzaki%26aufirst%3DN.%26aulast%3DGoto%26aufirst%3DH.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitor%2520anagliptin%2520facilitates%2520restoration%2520of%2520dextran%2520sulfate%2520sodium-induced%2520colitis%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D2013%26volume%3D48%26spage%3D1152%26epage%3D1159%26doi%3D10.3109%2F00365521.2013.832366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olivares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyrinck, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potgens, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindels, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delzenne, N. M.</span></span> <span> </span><span class="NLM_article-title">The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1848</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4647-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1007%2Fs00125-018-4647-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29797022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGjtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1838-1848&author=M.+Olivaresauthor=A.+M.+Neyrinckauthor=S.+A.+Potgensauthor=M.+Beaumontauthor=N.+Salazarauthor=P.+D.+Caniauthor=L.+B.+Bindelsauthor=N.+M.+Delzenne&title=The+DPP-4+inhibitor+vildagliptin+impacts+the+gut+microbiota+and+prevents+disruption+of+intestinal+homeostasis+induced+by+a+Western+diet+in+mice&doi=10.1007%2Fs00125-018-4647-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice</span></div><div class="casAuthors">Olivares, Marta; Neyrinck, Audrey M.; Potgens, Sarah A.; Beaumont, Martin; Salazar, Nuria; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1848</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: Dipeptidyl peptidase 4 (DPP-4) inhibitors are agents designed to increase the half-life of incretins.  Although they are administered orally, little is known about their effects on the gut microbiota and functions, despite the fact that some bacteria present in the gut microbiota exhibit DPP-4-like activity.  Our objective was to study the impact of the DPP-4 inhibitor vildagliptin on gut functions and the intestinal ecosystem in a murine model of obesity induced by a Western diet (WD).  Methods: Twenty seven male C57BL/6J mice were randomised to receive a control diet, a WD (45% kJ from fat and 17% kJ from sucrose) or a WD + vildagliptin (0.6 mg/mL in drinking water) for 8 wk.  Results: Vildagliptin significantly reduced DPP-4 activity in the caecal content and faeces.  Vildagliptin impacted on the compn. of the gut microbiota and its metabolic activity.  It mainly decreased Oscillibacter spp. (a direct effect independent of DPP-4 activity was shown on cultured O. valericigenes), increased Lactobacillus spp. and propionate, and reduced the ligands of Toll-like receptors 2 and 4.  Vildagliptin protected against the redns. in crypt depth and ileal expression of antimicrobial peptides induced by the WD.  In the liver, the expression of immune cell populations (Cd3g and Cd11c [also known as Itgax]) and cytokines was decreased in the WD + vildagliptin-fed mice compared with the WD-fed group.  Ex vivo exposure of precision-cut liver slices to vildagliptin showed that this response was not related to a direct effect of the drug on the liver tissue.  Conclusions/interpretation: Our study is the first to consider the DPP-4-like activity of the gut microbiota as a target of DPP-4 inhibition.  We propose that vildagliptin exerts beneficial effects at the intestinal level in assocn. with modulation of gut microbiota, with consequences for hepatic immunity.  If relevant in humans, this could open new therapeutic uses of DPP-4 inhibition to tackle gut dysfunctions in different pathophysiol. contexts.  Data availability: The sequences used for anal. can be found in the MG-RAST database under the project name MYNEWGUT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFyUQGk9n2bbVg90H21EOLACvtfcHk0liV-BKI9jLJ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGjtLnN&md5=9eefa83cf60c502c959e85473b27978c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4647-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4647-6%26sid%3Dliteratum%253Aachs%26aulast%3DOlivares%26aufirst%3DM.%26aulast%3DNeyrinck%26aufirst%3DA.%2BM.%26aulast%3DPotgens%26aufirst%3DS.%2BA.%26aulast%3DBeaumont%26aufirst%3DM.%26aulast%3DSalazar%26aufirst%3DN.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DBindels%26aufirst%3DL.%2BB.%26aulast%3DDelzenne%26aufirst%3DN.%2BM.%26atitle%3DThe%2520DPP-4%2520inhibitor%2520vildagliptin%2520impacts%2520the%2520gut%2520microbiota%2520and%2520prevents%2520disruption%2520of%2520intestinal%2520homeostasis%2520induced%2520by%2520a%2520Western%2520diet%2520in%2520mice%26jtitle%3DDiabetologia%26date%3D2018%26volume%3D61%26spage%3D1838%26epage%3D1848%26doi%3D10.1007%2Fs00125-018-4647-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span> <span> </span><span class="NLM_article-title">Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2019.03.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.ebiom.2019.03.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30922964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3cbpt1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2019&pages=665-674&author=X.+Liaoauthor=L.+Songauthor=B.+Zengauthor=B.+Liuauthor=Y.+Qiuauthor=H.+Quauthor=Y.+Zhengauthor=M.+Longauthor=H.+Zhouauthor=Y.+Wangauthor=Y.+Duauthor=J.+Xuauthor=R.+Shenauthor=Q.+Tongauthor=L.+Caiauthor=X.+Liauthor=S.+Guoauthor=G.+Yangauthor=Z.+Zhuauthor=X.+Puauthor=H.+Weiauthor=H.+Zheng&title=Alteration+of+gut+microbiota+induced+by+DPP-4i+treatment+improves+glucose+homeostasis&doi=10.1016%2Fj.ebiom.2019.03.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis</span></div><div class="casAuthors">Liao Xiaoyu; Liu Bingyao; Qiu Yuyang; Qu Hua; Zheng Yi; Long Min; Zhou Houdi; Wang Yuan; Du Yingxuan; Xu Jing; Shen Rufei; Tong Qiang; Cai Leiqin; Li Xing; Song Lingyu; Zeng Benhua; Guo Shaodong; Yang Gangyi; Zhu Zhiming; Pu Xiaoyun; Wei Hong; Zheng Hongting</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">665-674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Increasing evidence indicates that the gut microbiota contributes to the occurrence and development of metabolic diseases.  However, little is known about the effects of commonly used antidiabetic agents on the gut microbiota.  In this study, we investigated the roles of dipeptidyl peptidase-4 inhibitors (DPP-4i) and α-glucosidase inhibitor in modulating the gut microbiota.  METHODS:  16S-rDNA sequencing was performed to analyse the effects of DPP-4i and acarbose on the gut microbiota in mice fed a high-fat diet (HFD).  Fecal microbiota transplantation (FMT) from type 2 diabetes patients to germ-free mice was performed to investigate the contribution of the altered microbiome to antidiabetic effects of the drugs.  Fecal metabolomics was also analysed by untargeted and targeted GC-MS systems.  FINDINGS:  Although DPP-4i and α-glucosidase inhibitor both altered the gut microbial composition, only the microbiome modulation of DPP-4i contributed to its hypoglycemic effect.  Specifically, the changes of 68.6% genera induced by HFD were rescued by DPP-4i.  FMT showed that the DPP-4i-altered microbiome improved glucose tolerance in colonized mice, while acarbose did not.  Moreover, DPP-4i increased the abundance of Bacteroidetes, and also promoted a functional shift in the gut microbiome, especially increasing the production of succinate.  INTERPRETATION:  Our findings demonstrate an important effect of DPP-4i on the gut microbiota, revealing a new hypoglycemic mechanism and an additional benefit of it.  Furthermore, modulating the microbial composition, and the functional shift arising from changes in the microbiome, might be a potential strategy for improving glucose homeostasis.  FUND: This work was supported by grants from the National Natural Science Foundation of China (No. 81700757, No. 81471039, No. 81700714 and No. 81770434), the National Key R&D Program of China (No. 2017YFC1309602, No. 2016YFC1101100, No. 2017YFD0500503 and No. 2017YFD0501001), and the Natural Science Foundation of Chongqing (No. cstc2014jcyjjq10006, No. cstc2016jcyjA0093 and No. cstc2016jcyjA0518).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2PvsVJttlHMScOqQTSkOffW6udTcc2eYg2KswWxe54rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbpt1Ojsw%253D%253D&md5=4fcbd9cae5fa47060a712a20f85d51e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2019.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2019.03.057%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPu%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520gut%2520microbiota%2520induced%2520by%2520DPP-4i%2520treatment%2520improves%2520glucose%2520homeostasis%26jtitle%3DEBioMedicine%26date%3D2019%26volume%3D44%26spage%3D665%26epage%3D674%26doi%3D10.1016%2Fj.ebiom.2019.03.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershwin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span> <span> </span><span class="NLM_article-title">Alterations of gut microbiome in autoimmune hepatitis</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">gutjnl-2018-317836</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2018-317836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1136%2Fgutjnl-2018-317836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=gutjnl-2018-317836&author=Y.+Weiauthor=Y.+Liauthor=L.+Yanauthor=C.+Sunauthor=Q.+Miaoauthor=Q.+Wangauthor=X.+Xiaoauthor=M.+Lianauthor=B.+Liauthor=Y.+Chenauthor=J.+Zhangauthor=Y.+Liauthor=B.+Huangauthor=Y.+Liauthor=Q.+Caoauthor=Z.+Fanauthor=X.+Chenauthor=J.+Y.+Fangauthor=M.+E.+Gershwinauthor=R.+Tangauthor=X.+Ma&title=Alterations+of+gut+microbiome+in+autoimmune+hepatitis&doi=10.1136%2Fgutjnl-2018-317836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2018-317836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2018-317836%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DLian%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%2BY.%26aulast%3DGershwin%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DX.%26atitle%3DAlterations%2520of%2520gut%2520microbiome%2520in%2520autoimmune%2520hepatitis%26jtitle%3DGut%26date%3D2019%26spage%3Dgutjnl-2018-317836%26doi%3D10.1136%2Fgutjnl-2018-317836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1038/s41422-019-0190-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1038%2Fs41422-019-0190-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=31201384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3M3mvFOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=516-532&author=Q.+Zhangauthor=Y.+Panauthor=B.+Zengauthor=X.+Zhengauthor=H.+Wangauthor=X.+Shenauthor=H.+Liauthor=Q.+Jiangauthor=J.+Zhaoauthor=Z.+X.+Mengauthor=P.+Liauthor=Z.+Chenauthor=H.+Weiauthor=Z.+Liu&title=Intestinal+lysozyme+liberates+Nod1+ligands+from+microbes+to+direct+insulin+trafficking+in+pancreatic+beta+cells&doi=10.1038%2Fs41422-019-0190-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells</span></div><div class="casAuthors">Zhang Qin; Pan Ying; Zheng Xiaojiao; Wang Haifang; Shen Xueying; Li Hui; Liu Zhihua; Zeng Benhua; Shen Xueying; Li Hui; Jiang Qian; Li Pingping; Zhao Jiaxu; Chen Zhengjun; Zhao Jiaxu; Chen Zhengjun; Meng Zhuo-Xian; Chen Zhengjun; Wei Hong; Liu Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Cell research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">516-532</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Long-range communication between intestinal symbiotic bacteria and extra-intestinal organs can occur through circulating bacterial signal molecules, through neural circuits, or through cytokines or hormones from host cells.  Here we report that Nod1 ligands derived from intestinal bacteria act as signal molecules and directly modulate insulin trafficking in pancreatic beta cells.  The cytosolic peptidoglycan receptor Nod1 and its downstream adapter Rip2 are required for insulin trafficking in beta cells in a cell-autonomous manner.  Mechanistically, upon recognizing cognate ligands, Nod1 and Rip2 localize to insulin vesicles, recruiting Rab1a to direct insulin trafficking through the cytoplasm.  Importantly, intestinal lysozyme liberates Nod1 ligands into the circulation, thus enabling long-range communication between intestinal microbes and islets.  The intestine-islet crosstalk bridged by Nod1 ligands modulates host glucose tolerance.  Our study defines a new type of inter-organ communication based on circulating bacterial signal molecules, which has broad implications for understanding the mutualistic relationship between microbes and host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE2A638uprk8jl5L8hwNX0fW6udTcc2eZp4CSReY1Pcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3mvFOjug%253D%253D&md5=d25136abde7538f84c4bfa24c599faf1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41422-019-0190-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-019-0190-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DZ.%2BX.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DIntestinal%2520lysozyme%2520liberates%2520Nod1%2520ligands%2520from%2520microbes%2520to%2520direct%2520insulin%2520trafficking%2520in%2520pancreatic%2520beta%2520cells%26jtitle%3DCell%2520Res.%26date%3D2019%26volume%3D29%26spage%3D516%26epage%3D532%26doi%3D10.1038%2Fs41422-019-0190-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandal, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bramer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isern, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noecker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweredoski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moradian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borenstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwind, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajmalnik-Brown, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazmanian, S. K.</span></span> <span> </span><span class="NLM_article-title">Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">1600</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2019.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.cell.2019.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=31150625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVygu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2019&pages=1600&author=G.+Sharonauthor=N.+J.+Cruzauthor=D.+W.+Kangauthor=M.+J.+Gandalauthor=B.+Wangauthor=Y.+M.+Kimauthor=E.+M.+Zinkauthor=C.+P.+Caseyauthor=B.+C.+Taylorauthor=C.+J.+Laneauthor=L.+M.+Bramerauthor=N.+G.+Isernauthor=D.+W.+Hoytauthor=C.+Noeckerauthor=M.+J.+Sweredoskiauthor=A.+Moradianauthor=E.+Borensteinauthor=J.+K.+Janssonauthor=R.+Knightauthor=T.+O.+Metzauthor=C.+Loisauthor=D.+H.+Geschwindauthor=R.+Krajmalnik-Brownauthor=S.+K.+Mazmanian&title=Human+gut+microbiota+from+autism+spectrum+disorder+promote+behavioral+symptoms+in+mice&doi=10.1016%2Fj.cell.2019.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice</span></div><div class="casAuthors">Sharon, Gil; Cruz, Nikki Jamie; Kang, Dae-Wook; Gandal, Michael J.; Wang, Bo; Kim, Young-Mo; Zink, Erika M.; Casey, Cameron P.; Taylor, Bryn C.; Lane, Christianne J.; Bramer, Lisa M.; Isern, Nancy G.; Hoyt, David W.; Noecker, Cecilia; Sweredoski, Michael J.; Moradian, Annie; Borenstein, Elhanan; Jansson, Janet K.; Knight, Rob; Metz, Thomas O.; Lois, Carlos; Geschwind, Daniel H.; Krajmalnik-Brown, Rosa; Mazmanian, Sarkis K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1600-1618.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) manifests as alterations in complex human behaviors including social communication and stereotypies.  In addn. to genetic risks, the gut microbiome differs between typically developing (TD) and ASD individuals, though it remains unclear whether the microbiome contributes to symptoms.  We transplanted gut microbiota from human donors with ASD or TD controls into germ-free mice and reveal that colonization with ASD microbiota is sufficient to induce hallmark autistic behaviors.  The brains of mice colonized with ASD microbiota display alternative splicing of ASD-relevant genes.  Microbiome and metabolome profiles of mice harboring human microbiota predict that specific bacterial taxa and their metabolites modulate ASD behaviors.  Indeed, treatment of an ASD mouse model with candidate microbial metabolites improves behavioral abnormalities and modulates neuronal excitability in the brain.  We propose that the gut microbiota regulates behaviors in mice via prodn. of neuroactive metabolites, suggesting that gut-brain connections contribute to the pathophysiol. of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzd73CRYRT7Vg90H21EOLACvtfcHk0lipqiduJnP5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVygu7jM&md5=3b84255db0d5e465e480537a4f8084cc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2019.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2019.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DSharon%26aufirst%3DG.%26aulast%3DCruz%26aufirst%3DN.%2BJ.%26aulast%3DKang%26aufirst%3DD.%2BW.%26aulast%3DGandal%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DZink%26aufirst%3DE.%2BM.%26aulast%3DCasey%26aufirst%3DC.%2BP.%26aulast%3DTaylor%26aufirst%3DB.%2BC.%26aulast%3DLane%26aufirst%3DC.%2BJ.%26aulast%3DBramer%26aufirst%3DL.%2BM.%26aulast%3DIsern%26aufirst%3DN.%2BG.%26aulast%3DHoyt%26aufirst%3DD.%2BW.%26aulast%3DNoecker%26aufirst%3DC.%26aulast%3DSweredoski%26aufirst%3DM.%2BJ.%26aulast%3DMoradian%26aufirst%3DA.%26aulast%3DBorenstein%26aufirst%3DE.%26aulast%3DJansson%26aufirst%3DJ.%2BK.%26aulast%3DKnight%26aufirst%3DR.%26aulast%3DMetz%26aufirst%3DT.%2BO.%26aulast%3DLois%26aufirst%3DC.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DKrajmalnik-Brown%26aufirst%3DR.%26aulast%3DMazmanian%26aufirst%3DS.%2BK.%26atitle%3DHuman%2520gut%2520microbiota%2520from%2520autism%2520spectrum%2520disorder%2520promote%2520behavioral%2520symptoms%2520in%2520mice%26jtitle%3DCell%26date%3D2019%26volume%3D177%26spage%3D1600%26doi%3D10.1016%2Fj.cell.2019.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomaeus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakoub, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoges, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsvetkov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krannich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wundersitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusche-Vihrog, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollasch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhumadilov, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozhakhmetov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushugulova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rump, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forslund, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegbauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilck, N.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acid propionate protects from hypertensive cardiovascular damage</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">1407</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.118.036652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1161%2FCIRCULATIONAHA.118.036652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30586752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks1altrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2019&pages=1407-1421&author=H.+Bartolomaeusauthor=A.+Baloghauthor=M.+Yakoubauthor=S.+Homannauthor=L.+Markoauthor=S.+Hogesauthor=D.+Tsvetkovauthor=A.+Krannichauthor=S.+Wundersitzauthor=E.+G.+Averyauthor=N.+Haaseauthor=K.+Krakerauthor=L.+Heringauthor=M.+Maaseauthor=K.+Kusche-Vihrogauthor=M.+Grandochauthor=J.+Fielitzauthor=S.+Kempaauthor=M.+Gollaschauthor=Z.+Zhumadilovauthor=S.+Kozhakhmetovauthor=A.+Kushugulovaauthor=K.+U.+Eckardtauthor=R.+Dechendauthor=L.+C.+Rumpauthor=S.+K.+Forslundauthor=D.+N.+Mullerauthor=J.+Stegbauerauthor=N.+Wilck&title=Short-chain+fatty+acid+propionate+protects+from+hypertensive+cardiovascular+damage&doi=10.1161%2FCIRCULATIONAHA.118.036652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage</span></div><div class="casAuthors">Bartolomaeus, Hendrik; Balogh, Andras; Yakoub, Mina; Homann, Susanne; Marko, Lajos; Hoeges, Sascha; Tsvetkov, Dmitry; Krannich, Alexander; Wundersitz, Sebastian; Avery, Ellen G.; Haase, Nadine; Kraeker, Kristin; Hering, Lydia; Maase, Martina; Kusche-Vihrog, Kristina; Grandoch, Maria; Fielitz, Jens; Kempa, Stefan; Gollasch, Maik; Zhumadilov, Zhaxybay; Kozhakhmetov, Samat; Kushugulova, Almagul; Eckardt, Kai-Uwe; Dechend, Ralf; Rump, Lars Christian; Forslund, Sofia K.; Mueller, Dominik N.; Stegbauer, Johannes; Wilck, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1407-1421</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Arterial hypertension and its organ sequelae show characteristics of T cell-mediated inflammatory diseases.  Exptl. anti-inflammatory therapies have been shown to ameliorate hypertensive end-organ damage.  Recently, the CANTOS study (Canakinumab Antiinflammatory Thrombosis Outcome Study) targeting interleukin-1β demonstrated that anti-inflammatory therapy reduces cardiovascular risk.  The gut microbiome plays a pivotal role in immune homeostasis and cardiovascular health.  Short-chain fatty acids (SCFAs) are produced from dietary fiber by gut bacteria and affect host immune homeostasis.  Here, we investigated effects of the SCFA propionate in 2 different mouse models of hypertensive cardiovascular damage.  Methods: To investigate the effect of SCFAs on hypertensive cardiac damage and atherosclerosis, wild-type NMRI or apolipoprotein E knockout-deficient mice received propionate (200 mmol/L) or control in the drinking water.  To induce hypertension, wild-type NMRI mice were infused with angiotensin II (1.44 mg·kg·d s.c.) for 14 days.  To accelerate the development of atherosclerosis, apolipoprotein E knockout mice were infused with angiotensin II (0.72 mg·kg·d s.c.) for 28 days.  Cardiac damage and atherosclerosis were assessed using histol., echocardiog., in vivo electrophysiol., immunofluorescence, and flow cytometry.  Blood pressure was measured by radiotelemetry.  Regulatory T cell depletion using PC61 antibody was used to examine the mode of action of propionate.  Results: Propionate significantly attenuated cardiac hypertrophy, fibrosis, vascular dysfunction, and hypertension in both models.  Susceptibility to cardiac ventricular arrhythmias was significantly reduced in propionate-treated angiotensin II-infused wild-type NMRI mice.  Aortic atherosclerotic lesion area was significantly decreased in propionate-treated apolipoprotein E knockout-deficient mice.  Systemic inflammation was mitigated by propionate treatment, quantified as a redn. in splenic effector memory T cell frequencies and splenic T helper 17 cells in both models, and a decrease in local cardiac immune cell infiltration in wild-type NMRI mice.  Cardioprotective effects of propionate were abrogated in regulatory T cell-depleted angiotensin II-infused mice, suggesting the effect is regulatory T cell-dependent.  Conclusions: Our data emphasize an immune-modulatory role of SCFAs and their importance for cardiovascular health.  The data suggest that lifestyle modifications leading to augmented SCFA prodn. could be a beneficial nonpharmacol. preventive strategy for patients with hypertensive cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI9q2pZMnlX7Vg90H21EOLACvtfcHk0liUQgX3HwQRbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks1altrg%253D&md5=55c35a8a7aba56286ce1606c78d17c90</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.118.036652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.118.036652%26sid%3Dliteratum%253Aachs%26aulast%3DBartolomaeus%26aufirst%3DH.%26aulast%3DBalogh%26aufirst%3DA.%26aulast%3DYakoub%26aufirst%3DM.%26aulast%3DHomann%26aufirst%3DS.%26aulast%3DMarko%26aufirst%3DL.%26aulast%3DHoges%26aufirst%3DS.%26aulast%3DTsvetkov%26aufirst%3DD.%26aulast%3DKrannich%26aufirst%3DA.%26aulast%3DWundersitz%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DE.%2BG.%26aulast%3DHaase%26aufirst%3DN.%26aulast%3DKraker%26aufirst%3DK.%26aulast%3DHering%26aufirst%3DL.%26aulast%3DMaase%26aufirst%3DM.%26aulast%3DKusche-Vihrog%26aufirst%3DK.%26aulast%3DGrandoch%26aufirst%3DM.%26aulast%3DFielitz%26aufirst%3DJ.%26aulast%3DKempa%26aufirst%3DS.%26aulast%3DGollasch%26aufirst%3DM.%26aulast%3DZhumadilov%26aufirst%3DZ.%26aulast%3DKozhakhmetov%26aufirst%3DS.%26aulast%3DKushugulova%26aufirst%3DA.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DRump%26aufirst%3DL.%2BC.%26aulast%3DForslund%26aufirst%3DS.%2BK.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26aulast%3DStegbauer%26aufirst%3DJ.%26aulast%3DWilck%26aufirst%3DN.%26atitle%3DShort-chain%2520fatty%2520acid%2520propionate%2520protects%2520from%2520hypertensive%2520cardiovascular%2520damage%26jtitle%3DCirculation%26date%3D2019%26volume%3D139%26spage%3D1407%26epage%3D1421%26doi%3D10.1161%2FCIRCULATIONAHA.118.036652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghar-Jaffar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shun-Shin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeran, K.</span></span> <span> </span><span class="NLM_article-title">Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and meta-analysis</span>. <i>J. A. M. A</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1580</span>– <span class="NLM_lpage">1591</span>, <span class="refDoi"> DOI: 10.1001/jama.2018.3024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1001%2Fjama.2018.3024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29677303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVCmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2018&pages=1580-1591&author=S.+L.+Zhengauthor=A.+J.+Roddickauthor=R.+Aghar-Jaffarauthor=M.+J.+Shun-Shinauthor=D.+Francisauthor=N.+Oliverauthor=K.+Meeran&title=Association+between+use+of+sodium-glucose+cotransporter+2+inhibitors%2C+glucagon-like+peptide+1+agonists%2C+and+dipeptidyl+peptidase+4+inhibitors+with+all-cause+mortality+in+patients+with+type+2+diabetes%3A+A+systematic+review+and+meta-analysis&doi=10.1001%2Fjama.2018.3024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis</span></div><div class="casAuthors">Zheng, Sean L.; Roddick, Alistair J.; Aghar-Jaffar, Rochan; Shun-Shin, Matthew J.; Francis, Darrel; Oliver, Nick; Meeran, Karim</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1580-1591</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Importance The comparative clin. efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors for treatment of type 2 diabetes is unknown. objective To compare the efficacies of SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors on mortality and cardiovascular end points using network meta-anal. data sources MEDLINE, Embase, Cochrane Library Central Register of Controlled Trials, and published meta-analyses from inception through Oct. 11, 2017. study selection Randomized clin. trials enrolling participants with type 2 diabetes and a follow-up of at least 12 wk were included, for which SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors were compared with either each other or placebo or no treatment. data extn. and synthesis Data were screened by 1 investigator and extd. in duplicate by 2 investigators.  A Bayesian hierarchical network meta-anal. was performed. main outcomes and measures The primary outcome: all-cause mortality; secondary outcomes: cardiovascular (CV) mortality, heart failure (HF) events, myocardial infarction (MI), unstable angina, and stroke; safety end points: adverse events and hypoglycemia. results This network meta-anal. of 236 trials randomizing 176310 participants found SGLT-2 inhibitors (abs. risk difference [RD], -1.0%; hazard ratio [HR], 0.80 [95% credible interval {CrI}, 0.71 to 0.89]) and GLP-1 agonists (abs. RD, -0.6%; HR, 0.88 [95% CrI, 0.81 to 0.94]) were assocd. with significantly lower all-cause mortality than the control groups.  SGLT-2 inhibitors (abs. RD, -0.9%; HR, 0.78 [95% CrI, 0.68 to 0.90]) and GLP-1 agonists (abs. RD, -0.5%; HR, 0.86 [95% CrI, 0.77 to 0.96]) were assocd. with lower mortality than were DPP-4 inhibitors.  DPP-4 inhibitors were not significantly assocd. with lower all-cause mortality (abs. RD, 0.1%; HR, 1.02 [95% CrI, 0.94 to 1.11]) than were the control groups.  SGLT-2 inhibitors (abs. RD, -0.8%; HR, 0.79 [95% CrI, 0.69 to 0.91]) and GLP-1 agonists (abs. RD, -0.5%; HR, 0.85 [95% CrI, 0.77 to 0.94]) were significantly assocd. with lower CV mortality than were the control groups.  SGLT-2 inhibitors were significantly assocd. with lower rates of HF events (abs. RD, -1.1%; HR, 0.62 [95% CrI, 0.54 to 0.72]) and MI (abs. RD, -0.6%; HR, 0.86 [95% CrI, 0.77 to 0.97]) than were the control groups.  GLP-1 agonists were assocd. with a higher risk of adverse events leading to trial withdrawal than were SGLT-2 inhibitors (abs. RD, 5.8%; HR, 1.80 [95% CrI, 1.44 to 2.25]) and DPP-4 inhibitors (abs. RD, 3.1%; HR, 1.93 [95% CrI, 1.59 to 2.35]). conclusions and relevance In this network meta-anal., the use of SGLT-2 inhibitors or GLP-1 agonists was assocd. with lower mortality than DPP-4 inhibitors or placebo or no treatment.  Use of DPP-4 inhibitors was not assocd. with lower mortality than placebo or no treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJe1Scr94JCLVg90H21EOLACvtfcHk0liUQgX3HwQRbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVCmsLY%253D&md5=b6922dbdcf25ea4580fde2e1498f8b9c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1001%2Fjama.2018.3024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2018.3024%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%2BL.%26aulast%3DRoddick%26aufirst%3DA.%2BJ.%26aulast%3DAghar-Jaffar%26aufirst%3DR.%26aulast%3DShun-Shin%26aufirst%3DM.%2BJ.%26aulast%3DFrancis%26aufirst%3DD.%26aulast%3DOliver%26aufirst%3DN.%26aulast%3DMeeran%26aufirst%3DK.%26atitle%3DAssociation%2520between%2520use%2520of%2520sodium-glucose%2520cotransporter%25202%2520inhibitors%252C%2520glucagon-like%2520peptide%25201%2520agonists%252C%2520and%2520dipeptidyl%2520peptidase%25204%2520inhibitors%2520with%2520all-cause%2520mortality%2520in%2520patients%2520with%2520type%25202%2520diabetes%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJ.%2520A.%2520M.%2520A%26date%3D2018%26volume%3D319%26spage%3D1580%26epage%3D1591%26doi%3D10.1001%2Fjama.2018.3024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomovic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarevic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deljanin-Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderluh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smelcerovic, A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1002/med.21513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1002%2Fmed.21513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29806214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVylsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=404-422&author=K.+Tomovicauthor=J.+Lazarevicauthor=G.+Kocicauthor=M.+Deljanin-Ilicauthor=M.+Anderluhauthor=A.+Smelcerovic&title=Mechanisms+and+pathways+of+anti-inflammatory+activity+of+DPP-4+inhibitors+in+cardiovascular+and+renal+protection&doi=10.1002%2Fmed.21513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection</span></div><div class="casAuthors">Tomovic, Katarina; Lazarevic, Jelena; Kocic, Gordana; Deljanin-Ilic, Marina; Anderluh, Marko; Smelcerovic, Andrija</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">404-422</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase-4 (DPP-4) cleaves N-terminal dipeptides, with Pro, Ala or Ser at the penultimate position, and, in that way, modulates biol. activity of certain polypeptides.  Due to its ubiquitous distribution, many pathol. processes are assocd. with altered DPP-4 expression and activity.  Besides the regulation of glucose metab., DPP-4 also exhibits many other systemic effects, and the inhibition of its activity might lead to cardiovascular and renal protection.  Mechanisms underlying these protective effects of DPP-4 inhibition are ascribed to elevated bioavailability of its substrates, to impacts on mediators and signaling pathways that ameliorate cardiovascular and renal function through the suppression of oxidative stress, inflammation, fibrosis and apoptosis, improved endothelial function and tissue reparation.  Inflammation contributes to and promotes progression of cardiovascular and renal disorders.  Herein, we discuss cellular and mol. mechanisms mediating the anti-inflammatory activity of clin. used DPP-4 inhibitors in cardiovascular and renal protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Su3xWAKUWbVg90H21EOLACvtfcHk0ljPZpSDzUfPXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVylsLnP&md5=87a742ddc5cbf260ea34dc2140f411e6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fmed.21513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21513%26sid%3Dliteratum%253Aachs%26aulast%3DTomovic%26aufirst%3DK.%26aulast%3DLazarevic%26aufirst%3DJ.%26aulast%3DKocic%26aufirst%3DG.%26aulast%3DDeljanin-Ilic%26aufirst%3DM.%26aulast%3DAnderluh%26aufirst%3DM.%26aulast%3DSmelcerovic%26aufirst%3DA.%26atitle%3DMechanisms%2520and%2520pathways%2520of%2520anti-inflammatory%2520activity%2520of%2520DPP-4%2520inhibitors%2520in%2520cardiovascular%2520and%2520renal%2520protection%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D404%26epage%3D422%26doi%3D10.1002%2Fmed.21513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, C. F.</span></span> <span> </span><span class="NLM_article-title">A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/dom.13135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1111%2Fdom.13135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=34-46&author=C.+F.+Deacon&title=A+review+of+dipeptidyl+peptidase-4+inhibitors.+Hot+topics+from+randomized+controlled+trials&doi=10.1111%2Fdom.13135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Do we know the true mechanism of action of the DPP-4 inhibitors?</span></div><div class="casAuthors">Andersen, Emilie S.; Deacon, Carolyn F.; Holst, Jens J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The prevalence of type 2 diabetes is increasing, which is alarming because of its serious complications.  Anti-diabetic treatment aims to control glucose homeostasis as tightly as possible in order to reduce these complications.  Dipeptidyl peptidase-4 (DPP-4) inhibitors are a recent addn. to the anti-diabetic treatment modalities, and have become widely accepted because of their good efficacy, their benign side-effect profile and their low hypoglycemia risk.  The actions of DPP-4 inhibitors are not direct, but rather are mediated indirectly through preservation of the substrates they protect from degrdn.  The two incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, are known substrates, but other incretin-independent mechanisms may also be involved.  It seems likely therefore that the mechanisms of action of DPP-4 inhibitors are more complex than originally thought, and may involve several substrates and encompass local paracrine, systemic endocrine and neural pathways, which are discussed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriEo3tDF-sUbVg90H21EOLACvtfcHk0ljPZpSDzUfPXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL&md5=2d2783806da287d3bb50b932056fb5d2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fdom.13135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13135%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DA%2520review%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors.%2520Hot%2520topics%2520from%2520randomized%2520controlled%2520trials%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2018%26volume%3D20%26spage%3D34%26epage%3D46%26doi%3D10.1111%2Fdom.13135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Home, P.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular outcome trials of glucose-lowering medications: an update</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4801-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1007%2Fs00125-018-4801-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30607467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyrsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=357-369&author=P.+Home&title=Cardiovascular+outcome+trials+of+glucose-lowering+medications%3A+an+update&doi=10.1007%2Fs00125-018-4801-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular outcome trials of glucose-lowering medications: an update</span></div><div class="casAuthors">Home, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-369</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Three further cardiovascular (CV) outcome studies of glucose-lowering drugs (linagliptin, albiglutide and dapagliflozin) have recently been published, adding to the twelve earlier within-class studies.  The linagliptin study (CARMELINA) recruited people with renal disease as well as prior CV events and confirms the overall CV safety (and other safety) of the dipeptidylpeptidase-4 (DPP4) inhibitors, with no heart failure risk assocd. with this agent.  However, taken together with the findings from two previous studies of DPP4 inhibitors (sitagliptin and saxagliptin), the three DPP4 inhibitor CV outcome trials (CVOTs) have highlighted a safety signal regarding risk of pancreatitis.  Like CARMELINA, the albiglutide study (Harmony Outcome) had a very high CV event rate.  Despite being a short duration study, albiglutide showed strong superiority for redn. in the major adverse CV events (MACE) composite in people with extant cardiovascular disease (CVD), in line with the earlier studies on the GLP-1 receptor agonists (GLP-1RAs) liraglutide and semaglutide.  Pos. effects can be detected for all these medications from before 12 mo and continue for the whole study duration.  No new safety issues for albiglutide are identified and the lack of a pancreatitis or a pancreatic cancer signal for this class is now clear.  For the sodium-glucose cotransporter-2 (SGLT2) inhibitor class, the DECLARE-TIMI 58 study (of dapagliflozin) clearly indicates strong protection for heart failure in those with CVD, and probably in those with no prior CVD.  There is also strong protection against renal decline with dapagliflozin, with similar risk ests. in DECLARE as previously reported for empagliflozin and canagliflozin.  However, findings for MACE outcomes with dapagliflozin are not concordant with the empagliflozin and canagliflozin studies, and are not convincingly superior across class and for the longer term.  Care is required when prescribing the SGLT2 inhibitor class of medications to people with foot vascular issues or prior amputation, and to insulin users in regard of ketoacidosis.  In summary, taking into account the findings from these new studies, it is suggested that a GLP-1RA should be offered to all people with CVD and type 2 diabetes, and SGLT2 inhibitors should be prescribed for those at high risk of heart failure or with progressive decline in eGFR.  DPP4 inhibitors are a safe choice within the glucose-lowering stepped algorithm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPxrbhQh-aCbVg90H21EOLACvtfcHk0ljPZpSDzUfPXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyrsLjO&md5=e3685b3b5094e126fd118737e1ed6c60</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4801-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4801-1%26sid%3Dliteratum%253Aachs%26aulast%3DHome%26aufirst%3DP.%26atitle%3DCardiovascular%2520outcome%2520trials%2520of%2520glucose-lowering%2520medications%253A%2520an%2520update%26jtitle%3DDiabetologia%26date%3D2019%26volume%3D62%26spage%3D357%26epage%3D369%26doi%3D10.1007%2Fs00125-018-4801-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheen, A. J.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies</span>. <i>Diabetes Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1016/j.diabet.2018.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.diabet.2018.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30126735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtV2lsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2018&pages=386-392&author=A.+J.+Scheen&title=Cardiovascular+safety+of+DPP-4+inhibitors+compared+with+sulphonylureas%3A+Results+of+randomized+controlled+trials+and+observational+studies&doi=10.1016%2Fj.diabet.2018.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies</span></div><div class="casAuthors">Scheen, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes & Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">DIMEFW</span>;
        ISSN:<span class="NLM_cas:issn">1262-3636</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">After failure of metformin monotherapy, another glucose-lowering agent should be added to improve glucose control.  The clinician has several pharmacol. choices, including the addn. of a sulfonylurea (SU) or a dipeptidyl peptidase-4 inhibitor (DPP-4i).  While the cardiovascular safety of SUs remains a matter of controversy, DPP-4is have proven their non-inferiority vs placebo in recent cardiovascular (CV) outcome trials.  In the absence of a head-to-head CV outcome trial-the CAROLINA, comparing linagliptin with glimepiride, is still ongoing-only indirect information can be found in the literature to compare CV outcomes (major CV events, myocardial infarction, ischemic stroke, CV death and all-cause mortality) in patients with type 2 diabetes mellitus (T2DM) treated with SUs or DPP-4is.  Thus, this comprehensive review summarizes the CV outcomes (excluding heart failure) reported in meta-analyses of randomized controlled trials (RCTs) of SUs vs placebo or other glucose-lowering agents, DPP-4is vs placebo or other glucose-lowering agents and SUs vs DPP-4is in phase-II/III studies.  Also, the results of observational studies reporting CV events in patients treated with either SUs or DPP-4is have been carefully examd.  Overall, the CV safety of SUs appears to be poorer than that of DPP-4is in both RCTs and cohort studies.  However, the results are somewhat disparate, and such heterogeneity may be explained by different patient characteristics across studies, but also perhaps by differences between various mols. in each pharmacol. class.  In particular, some doubt about a class effect affecting SU CV safety has been raised.  The results of CAROLINA are expected to shed more light on SU CV concerns, esp. compared with DPP-4is.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj98Szvgx5PbVg90H21EOLACvtfcHk0lid8iUB8vpuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtV2lsLbP&md5=700ccc408771016bc561b8e69ba0039d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.diabet.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabet.2018.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DScheen%26aufirst%3DA.%2BJ.%26atitle%3DCardiovascular%2520safety%2520of%2520DPP-4%2520inhibitors%2520compared%2520with%2520sulphonylureas%253A%2520Results%2520of%2520randomized%2520controlled%2520trials%2520and%2520observational%2520studies%26jtitle%3DDiabetes%2520Metab.%26date%3D2018%26volume%3D44%26spage%3D386%26epage%3D392%26doi%3D10.1016%2Fj.diabet.2018.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M.</span></span> <span> </span><span class="NLM_article-title">The alchemist’s nightmare: Might mesenchymal stem cells that are recruited to repair the injured heart be transformed into fibroblasts rather than cardiomyocytes?</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.117.032190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1161%2FCIRCULATIONAHA.117.032190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29735591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVOisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2018&pages=2068-2073&author=M.+Packer&title=The+alchemist%E2%80%99s+nightmare%3A+Might+mesenchymal+stem+cells+that+are+recruited+to+repair+the+injured+heart+be+transformed+into+fibroblasts+rather+than+cardiomyocytes%3F&doi=10.1161%2FCIRCULATIONAHA.117.032190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The Alchemist's Nightmare: Might Mesenchymal Stem Cells That Are Recruited to Repair the Injured Heart Be Transformed Into Fibroblasts Rather Than Cardiomyocytes?</span></div><div class="casAuthors">Packer, Milton</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2068-2073</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The injection of mesenchymal stem cells into the injured myocardium to induce cardiac regeneration has yielded disappointing results, conceivably because cells with cardioreparative potential must be supplied for long periods of time to produce a salutary effect.  Accordingly, investigators have devised ways of directing such cells to the heart on an ongoing basis: by enhancing the action of endogenous peptides that function as cardiac homing signals (eg, stromal cell-derived factor-1).  Stromal cell-derived factor-1 is released during acute cardiac injury and heart failure, but it has a short half-life because of degrdn. by dipeptidyl peptidase-4.  Inhibition of dipeptidyl peptidase-4 potentiates the actions of stromal cell-derived factor-1 and, theor., could enhance cardiac recovery.  However, in large-scale trials in patients with type 2 diabetes mellitus, dipeptidyl peptidase-4 inhibitors have not reduced the risk of atherosclerotic ischemic events, and they have unexpectedly increased the risk of heart failure, most probably heart failure with a preserved ejection fraction.  Such an outcome might be explained if the channeling of mesenchymal stem cells to the heart by the actions of stromal cell-derived factor-1 (esp. from nearby adipose tissue) were followed by the transformation of these cells into fibroblasts rather than cardiomyocytes.  This concern has been supported by exptl. studies; the resulting fibrosis would be expected to exacerbate the pathophysiol. derangements that lead to heart failure with a preserved ejection fraction.  Given the widespread use of dipeptidyl peptidase-4 inhibitors, the possibility that these drugs potentiate the cardiac homing of mesenchymal stem cells that cause myocardial fibrosis (rather than repair) warrants further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq08vqDhxkmobVg90H21EOLACvtfcHk0lid8iUB8vpuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVOisbw%253D&md5=38b134ebee9403f29dc75f68b99928cf</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.117.032190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.117.032190%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DM.%26atitle%3DThe%2520alchemist%25E2%2580%2599s%2520nightmare%253A%2520Might%2520mesenchymal%2520stem%2520cells%2520that%2520are%2520recruited%2520to%2520repair%2520the%2520injured%2520heart%2520be%2520transformed%2520into%2520fibroblasts%2520rather%2520than%2520cardiomyocytes%253F%26jtitle%3DCirculation%26date%3D2018%26volume%3D137%26spage%3D2068%26epage%3D2073%26doi%3D10.1161%2FCIRCULATIONAHA.117.032190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M.</span></span> <span> </span><span class="NLM_article-title">Do DPP-4 inhibitors cause heart failure events by promoting adrenergically mediated cardiotoxicity? Clues from laboratory models and clinical trials</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.118.312673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1161%2FCIRCRESAHA.118.312673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29436388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2018&pages=928-932&author=M.+Packer&title=Do+DPP-4+inhibitors+cause+heart+failure+events+by+promoting+adrenergically+mediated+cardiotoxicity%3F+Clues+from+laboratory+models+and+clinical+trials&doi=10.1161%2FCIRCRESAHA.118.312673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically Mediated Cardiotoxicity?: Clues From Laboratory Models and Clinical Trials</span></div><div class="casAuthors">Packer, Milton</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">928-932</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: DPP-4 (dipeptidyl peptidase-4) inhibitors have increased the risk of heart failure events in both randomized clin. trials and observational studies, but the mechanisms that underlie their deleterious effect remain to be elucidated.  Previous work has implicated a role of these drugs to promote cardiac fibrosis.  Objective: This article postulates that DPP-4 inhibitors increase the risk of heart failure events by activating the sympathetic nervous system to stimulate cardiomyocyte cell death, and it crystallizes the findings from both exptl. studies and clin. trials that support the hypothesis.  Methods and results: Inhibition of DPP-4 not only potentiates the actions of GLP-1 (glucagon-like peptide-1; which can increase myocardial cAMP) but also potentiates the actions of SDF-1 (stromal cell-derived factor 1), NPY (neuropeptide Y), and substance P to activate the sympathetic nervous system and stimulate β-adrenergic receptors to cause cardiomyocyte apoptosis, presumably through a CaMKII (Ca++/calmodulin-dependent protein kinase II) pathway.  An action of SDF-1 to interfere with cAMP and protein kinase A signaling may account for the absence of a clin. overt pos. chronotropic effect.  This conceptual framework is supported by the apparent ability of β-blocking drugs to attenuate the increased risk of DPP-4 inhibitors in a large-scale clin. trial.  Conclusions: Sympathetic activation may explain the increased risk of heart failure produced by DPP-4 inhibitors.  The proposed mechanism has major implications for clin. care because in the treatment of patients with type 2 diabetes mellitus, DPP-4 inhibitors are widely prescribed, but β-blockers are underutilized because of fears that they might mask hypoglycemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq68cYo2y1Ge7Vg90H21EOLACvtfcHk0lid8iUB8vpuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVGnsr0%253D&md5=65cc92af095cc92cc0605f193bac855c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.118.312673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.118.312673%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DM.%26atitle%3DDo%2520DPP-4%2520inhibitors%2520cause%2520heart%2520failure%2520events%2520by%2520promoting%2520adrenergically%2520mediated%2520cardiotoxicity%253F%2520Clues%2520from%2520laboratory%2520models%2520and%2520clinical%2520trials%26jtitle%3DCirc.%2520Res.%26date%3D2018%26volume%3D122%26spage%3D928%26epage%3D932%26doi%3D10.1161%2FCIRCRESAHA.118.312673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sano, M.</span></span> <span> </span><span class="NLM_article-title">Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk</span>. <i>J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.jjcc.2018.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.jjcc.2018.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30318179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3czptVCmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2019&pages=28-32&author=M.+Sano&title=Mechanism+by+which+dipeptidyl+peptidase-4+inhibitors+increase+the+risk+of+heart+failure+and+possible+differences+in+heart+failure+risk&doi=10.1016%2Fj.jjcc.2018.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk</span></div><div class="casAuthors">Sano Motoaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dipeptidyl peptidase-4 (DPP-4) inhibitors are oral antidiabetic drugs that safely reduce the blood glucose level over the long term.  In Japan, DPP-4 inhibitors have become the oral antidiabetic drugs most frequently prescribed for patients with type 2 diabetes.  However, the results of several cardiovascular outcomes studies have suggested that some DPP-4 inhibitors may increase the risk of hospitalization for heart failure.  In patients with diabetes, heart failure is the most frequent cardiovascular condition, and it has a negative impact on the quality of life as well as being a potentially fatal complication.  Therefore, it is important to determine whether an increased risk of heart failure is associated with certain DPP-4 inhibitors or is a class effect of these drugs.  This review explores the mechanism by which DPP-4 inhibitors may increase the risk of heart failure and possible differences among these drugs.  The available research suggests that DPP-4 inhibitors cause sympathetic activation as a class effect and this may increase the risk of heart failure.  Unlike other DPP-4 inhibitors, sitagliptin and alogliptin are mainly excreted in the urine and suppress renal sodium-hydrogen exchanger 3 activity.  These two drugs did not increase the risk of hospitalization for heart failure in large-scale cardiovascular outcomes studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3yJgEKIPSJkHdcurJClFcfW6udTcc2eYS9opSTNiCV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czptVCmtA%253D%253D&md5=dbbd6808a97a710648200652384836a7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jjcc.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jjcc.2018.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSano%26aufirst%3DM.%26atitle%3DMechanism%2520by%2520which%2520dipeptidyl%2520peptidase-4%2520inhibitors%2520increase%2520the%2520risk%2520of%2520heart%2520failure%2520and%2520possible%2520differences%2520in%2520heart%2520failure%2520risk%26jtitle%3DJ.%2520Cardiol.%26date%3D2019%26volume%3D73%26spage%3D28%26epage%3D32%26doi%3D10.1016%2Fj.jjcc.2018.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) The design of NSIT compounds with high polar moieties. (B) The design of the NSIT DPPIV inhibitors. The site where the highly polar moieties were introduced was labeled with a blue box. (C) The binding mode of β-homophenylalanine derivatives with DPPIV.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>4</b>–<b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, dry THF, rt; (b) dry THF, rt; (c) nBu-Li, dry THF, −78 °C; (d) acetyl chloride, EtOH, rt; (e) HATU, DIPEA, DMF, rt; (f) mCPBA, DCM; (g) K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (h) Pd/C, H<sub>2</sub>, MeOH, rt; (i) DCM/TFA (v/v = 5:1), rt.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/medium/jm9b01649_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Relative DPPIV activity in plasma (A) and the intestine (B) after oral administration 30 mg/kg of sitagliptin and compound <b>7</b> to mice. The intestinal DPPIV activity was tested at 8 h after oral administration (<i>n</i> = 6). The data are expressed as the mean ± SEM **<i>P</i> < 0.01, compared with control groups. Student’s <i>t</i>-test statistical analysis was used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01649/20191205/images/large/jm9b01649_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01649&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulvihill, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">1019</span>, <span class="refDoi"> DOI: 10.1210/er.2014-1035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1210%2Fer.2014-1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=25216328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslaitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=992-1019&author=E.+E.+Mulvihillauthor=D.+J.+Drucker&title=Pharmacology%2C+physiology%2C+and+mechanisms+of+action+of+dipeptidyl+peptidase-4+inhibitors&doi=10.1210%2Fer.2014-1035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors</span></div><div class="casAuthors">Mulvihill, Erin E.; Drucker, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">992-1019</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase-4 (DPP4) is a widely expressed enzyme transducing actions through an anchored transmembrane mol. and a sol. circulating protein.  Both membrane-assocd. and sol. DPP4 exert catalytic activity, cleaving proteins contg. a position 2 alanine or proline.  DPP4-mediated enzymic cleavage alternatively inactivates peptides or generates new bioactive moieties that may exert competing or novel activities.  The widespread use of selective DPP4 inhibitors for the treatment of type 2 diabetes has heightened interest in the mol. mechanisms through which DPP4 inhibitors exert their pleiotropic actions.  Here we review the biol. of DPP4 with a focus on: (1) identification of pharmacol. vs physiol. DPP4 substrates; and (2) elucidation of mechanisms of actions of DPP4 in studies employing genetic elimination or chem. redn. of DPP4 activity.  We review data identifying the roles of key DPP4 substrates in transducing the glucoregulatory, anti-inflammatory, and cardiometabolic actions of DPP4 inhibitors in both preclin. and clin. studies.  Finally, we highlight exptl. pitfalls and tech. challenges encountered in studies designed to understand the mechanisms of action and downstream targets activated by inhibition of DPP4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj5PTsXnHpF7Vg90H21EOLACvtfcHk0lgy1ASkiKcIQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslaitA%253D%253D&md5=af460e2173f81d832bbbeb0170b1ceef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2014-1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2014-1035%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DE.%2BE.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DPharmacology%252C%2520physiology%252C%2520and%2520mechanisms%2520of%2520action%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors%26jtitle%3DEndocr.%2520Rev.%26date%3D2014%26volume%3D35%26spage%3D992%26epage%3D1019%26doi%3D10.1210%2Fer.2014-1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span> <span> </span><span class="NLM_article-title">Cut to the chase: a review of CD26/dipeptidyl peptidase-4’s (DPP4) entanglement in the immune system</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>185</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1111/cei.12781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1111%2Fcei.12781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=26919392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFelu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2016&pages=1-21&author=C.+Klemannauthor=L.+Wagnerauthor=M.+Stephanauthor=S.+von+Horsten&title=Cut+to+the+chase%3A+a+review+of+CD26%2Fdipeptidyl+peptidase-4%E2%80%99s+%28DPP4%29+entanglement+in+the+immune+system&doi=10.1111%2Fcei.12781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system</span></div><div class="casAuthors">Klemann, C.; Wagner, L.; Stephan, M.; von Hoersten, S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : CD26/DPP4 (dipeptidyl peptidase 4/DP4/DPPIV) is a surface T cell activation antigen and has been shown to have DPP4 enzymic activity, cleaving-off amino-terminal dipeptides with either L-proline or L-alanine at the penultimate position.  It plays a major role in glucose metab. by N-terminal truncation and inactivation of the incretins glucagon-like peptide-1 (GLP) and gastric inhibitory protein (GIP).  In 2006, DPP4 inhibitors have been introduced to clinics and have been demonstrated to efficiently enhance the endogenous insulin secretion via prolongation of the half-life of GLP-1 and GIP in patients.  However, a large no. of studies demonstrate clearly that CD26/DPP4 also plays an integral role in the immune system, particularly in T cell activation.  Therefore, inhibition of DPP4 might represent a double-edged sword.  Apart from the metabolic benefit, the assocd. immunol. effects of long term DPP4 inhibition on regulatory processes such as T cell homeostasis, maturation and activation are not understood fully at this stage.  The current data point to an important role for CD26/DPP4 in maintaining lymphocyte compn. and function, T cell activation and co-stimulation, memory T cell generation and thymic emigration patterns during immune-senescence.  In rodents, crit. immune changes occur at baseline levels as well as after in-vitro and in-vivo challenge.  In patients receiving DPP4 inhibitors, evidence of immunol. side effects also became apparent.  The scope of this review is to recapitulate the role of CD26/DPP4 in the immune system regarding its pharmacol. inhibition and T cell-dependent immune regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0CXJvQ8yuG7Vg90H21EOLACvtfcHk0lgy1ASkiKcIQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFelu7o%253D&md5=db8f51db1d071a4c1b69d66f526e4b92</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fcei.12781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcei.12781%26sid%3Dliteratum%253Aachs%26aulast%3DKlemann%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DStephan%26aufirst%3DM.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26atitle%3DCut%2520to%2520the%2520chase%253A%2520a%2520review%2520of%2520CD26%252Fdipeptidyl%2520peptidase-4%25E2%2580%2599s%2520%2528DPP4%2529%2520entanglement%2520in%2520the%2520immune%2520system%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2016%26volume%3D185%26spage%3D1%26epage%3D21%26doi%3D10.1111%2Fcei.12781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambeir, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durinx, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV</span>. <i>Crit. Rev. Clin. Lab. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1080/713609354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1080%2F713609354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=12892317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVWhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=209-294&author=A.+M.+Lambeirauthor=C.+Durinxauthor=S.+Scharpeauthor=I.+De+Meester&title=Dipeptidyl-peptidase+IV+from+bench+to+bedside%3A+an+update+on+structural+properties%2C+functions%2C+and+clinical+aspects+of+the+enzyme+DPP+IV&doi=10.1080%2F713609354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV</span></div><div class="casAuthors">Lambeir, Anne-Marie; Durinx, Christine; Scharpe, Simon; De Meester, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-294</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">CRC Press LLC</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl-peptidase IV/CD26 (DPP IV) is a cell-surface protease belonging to the prolyloligopeptidase family.  It selectively removes the N-terminal dipeptide from peptides with proline or alanine in the second position.  Apart from its catalytic activity, it interacts with several proteins, for instance, adenosine deaminase, the HIV gp120 protein, fibronectin, collagen, the chemokine receptor CXCR4, and the tyrosine phosphatase CD45.  DPP IV is expressed on a specific set of T lymphocytes, where it is up-regulated after activation.  It is also expressed in a variety of tissues, primarily on endothelial and epithelial cells.  A sol. form is present in plasma and other body fluids.  DPP IV has been proposed as a diagnostic or prognostic marker for various tumors, hematol. malignancies, immunol., inflammatory, psychoneuroendocrine disorders, and viral infections.  DPP IV truncates many bioactive peptides of medical importance.  It plays a role in glucose homeostasis through proteolytic inactivation of the incretins.  DPP IV inhibitors improve glucose tolerance and pancreatic islet cell function in animal models of type 2 diabetes and in diabetic patients.  The role of DPP IV/CD26 within the immune system is a combination of its exopeptidase activity and its interactions with different mols.  This enables DPP IV/CD26 to serve as a co-stimulatory mol. to influence T cell activity and to modulate chemotaxis.  DPP IV is also implicated in HIV-1 entry, malignant transformation, and tumor invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHXuhbNS1H4rVg90H21EOLACvtfcHk0lhPsuYA6S_iEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVWhs70%253D&md5=623830d8e73b25e69a250fab0a79224f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F713609354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F713609354%26sid%3Dliteratum%253Aachs%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDurinx%26aufirst%3DC.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DDipeptidyl-peptidase%2520IV%2520from%2520bench%2520to%2520bedside%253A%2520an%2520update%2520on%2520structural%2520properties%252C%2520functions%252C%2520and%2520clinical%2520aspects%2520of%2520the%2520enzyme%2520DPP%2520IV%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2003%26volume%3D40%26spage%3D209%26epage%3D294%26doi%3D10.1080%2F713609354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vliegen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungraithmayr, W.</span></span> <span> </span><span class="NLM_article-title">CD26/DPP4 - a potential biomarker and target for cancer therapy</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.pharmthera.2019.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30822465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFKmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2019&pages=135-159&author=N.+Enzauthor=G.+Vliegenauthor=I.+De+Meesterauthor=W.+Jungraithmayr&title=CD26%2FDPP4+-+a+potential+biomarker+and+target+for+cancer+therapy&doi=10.1016%2Fj.pharmthera.2019.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">CD26/DPP4 - a potential biomarker and target for cancer therapy</span></div><div class="casAuthors">Enz, Njanja; Vliegen, Gwendolyn; De Meester, Ingrid; Jungraithmayr, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-159</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  CD26/dipeptidyl peptidase (DPP)4 is a membrane-bound protein found in many cell types of the body, and a sol. form is present in body fluids.  There is longstanding evidence that various primary tumors and also metastases express CD26/DPP4 to a variable extent.  By cleaving dipeptides from peptides with a proline or alanine in the penultimate position at the N-terminus, it regulates the activity of incretin hormones, chemokines and many other peptides.  Due to these effects and interactions with other mols., a tumor promoting or suppressing role can be attributed to CD26/DPP4.  In this review, we discuss the existing evidence on the expression of sol. or membrane-bound CD26/DPP4 in malignant diseases, along with the most recent findings on CD26/DPP4 as a therapeutic target in specific malignancies.  The expression and possible involvement of the related DPP8 and DPP9 in cancer are also reviewed.  A higher expression of CD26/DPP4 is found in a wide variety of tumor entities, however more research on CD26/DPP4 in the tumor microenvironment is needed to fully explore its use as a tumor biomarker.  Circulating sol. CD26/DPP4 has also been studied as a cancer biomarker, however, the obsd. decrease in most cancer patients does not seem to be cancer specific.  Encouraging results from exptl. work and a recently reported first phase clin. trial targeting CD26/DPP4 in mesothelioma, renal and urol. tumors pave the way for follow-up clin. studies, also in other tumor entities, possibly leading to the development of more effective complementary therapies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzB5zypDCnWrVg90H21EOLACvtfcHk0lhPsuYA6S_iEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFKmurY%253D&md5=dda5996f4532dc2f90257c1ea5e8dad4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DEnz%26aufirst%3DN.%26aulast%3DVliegen%26aufirst%3DG.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DJungraithmayr%26aufirst%3DW.%26atitle%3DCD26%252FDPP4%2520-%2520a%2520potential%2520biomarker%2520and%2520target%2520for%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D198%26spage%3D135%26epage%3D159%26doi%3D10.1016%2Fj.pharmthera.2019.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, N. H.</span></span> <span> </span><span class="NLM_article-title">CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.2174/138955707780059853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2174%2F138955707780059853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=17346218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=253-273&author=M.+A.+Thompsonauthor=K.+Ohnumaauthor=M.+Abeauthor=C.+Morimotoauthor=N.+H.+Dang&title=CD26%2Fdipeptidyl+peptidase+IV+as+a+novel+therapeutic+target+for+cancer+and+immune+disorders&doi=10.2174%2F138955707780059853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders</span></div><div class="casAuthors">Thompson, Michael A.; Ohnuma, Kei; Abe, Masako; Morimoto, Chikao; Dang, Nam H.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-273</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  CD26 is a 110 kDa surface glycoprotein with intrinsic dipeptidyl peptidase IV (DPPIV) activity that is expressed on numerous cell types and has a multitude of biol. functions.  An important aspect of CD26 biol. is its peptidase activity and its functional and phys. assocn. with mols. with key roles in various cellular pathways and biol. programs.  CD26 role in immune regulation was extensively characterized, with recent findings elucidating its linkage with signaling pathways and structures involved in T-lymphocyte activation as well as antigen presenting cell-T-cell interaction.  Recent work also suggests that CD26 has a significant role in tumor biol., being both a marker of disease behavior clin. as well as playing an important role in tumor pathogenesis and development.  In this paper, we will review emerging data that suggest CD26 may be an appropriate therapeutic target for the treatment of selected neoplasms and immune disorders.  Through the use of various exptl. approaches and agents to influence CD26/DPPIV expression and activity, such as anti-CD26 antibodies, CD26/DPPIV chem. inhibitors, siRNAs to inhibit CD26 expression, overexpressing CD26 transfectants and sol. CD26 mols., our group has shown that CD26 interacts with structures with essential cellular functions.  Its assocn. with such key mols. as topoisomerase IIα, p38 MAPK, and integrin β1, has important clin. implications, including its potential ability to regulate tumor sensitivity to selected chemotherapies and to influence tumor migration/metastases and tumorigenesis.  Importantly, our recent in vitro and in vivo data support the hypothesis that CD26 may indeed be an appropriate target for therapy for selected cancers and immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc8lHdX5wDwbVg90H21EOLACvtfcHk0lhPsuYA6S_iEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOitL4%253D&md5=661d69378a2cec8076f69ea3a013d9f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138955707780059853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955707780059853%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DM.%2BA.%26aulast%3DOhnuma%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DMorimoto%26aufirst%3DC.%26aulast%3DDang%26aufirst%3DN.%2BH.%26atitle%3DCD26%252Fdipeptidyl%2520peptidase%2520IV%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520cancer%2520and%2520immune%2520disorders%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D253%26epage%3D273%26doi%3D10.2174%2F138955707780059853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yazbeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, C. A.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2009.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.tips.2009.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=19837468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCku7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=600-607&author=R.+Yazbeckauthor=G.+S.+Howarthauthor=C.+A.+Abbott&title=Dipeptidyl+peptidase+inhibitors%2C+an+emerging+drug+class+for+inflammatory+disease%3F&doi=10.1016%2Fj.tips.2009.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?</span></div><div class="casAuthors">Yazbeck, Roger; Howarth, Gordon S.; Abbott, Catherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">600-607</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase (DPP)-4 is a member of the S9b serine protease family, which also includes DPP8 and DPP9.  DPP4 cleaves a no. of regulatory factors, including chemokines and growth factors.  DPP4 inhibitors have recently emerged as an effective treatment option for type 2 diabetes.  Early in vitro studies demonstrated that DPP4 inhibitors inhibit T-cell proliferation and cytokine prodn., leading to their investigation in numerous pre-clin. models of inflammatory diseases, including arthritis, multiple sclerosis and inflammatory bowel disease.  Recent data suggest that the early DPP4-specific inhibitors might also bind DPP8 and DPP9, thus exerting their effects through non-specific binding.  This review highlights recent insights into the applicability of DPP inhibitors as novel pharmacol. agents for inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2WLV8JySyLbVg90H21EOLACvtfcHk0lggt7RO3P3GiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCku7zJ&md5=e41944d63ac774802cc75abfe559cfde</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DYazbeck%26aufirst%3DR.%26aulast%3DHowarth%26aufirst%3DG.%2BS.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26atitle%3DDipeptidyl%2520peptidase%2520inhibitors%252C%2520an%2520emerging%2520drug%2520class%2520for%2520inflammatory%2520disease%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D600%26epage%3D607%26doi%3D10.1016%2Fj.tips.2009.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. Y.</span></span> <span> </span><span class="NLM_article-title">Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.ejmech.2018.03.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29609120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVemsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=145-157&author=N.+Liauthor=L.+J.+Wangauthor=B.+Jiangauthor=X.+Q.+Liauthor=C.+L.+Guoauthor=S.+J.+Guoauthor=D.+Y.+Shi&title=Recent+progress+of+the+development+of+dipeptidyl+peptidase-4+inhibitors+for+the+treatment+of+type+2+diabetes+mellitus&doi=10.1016%2Fj.ejmech.2018.03.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Li, Ning; Wang, Li-Jun; Jiang, Bo; Li, Xiang-qian; Guo, Chuan-long; Guo, Shu-ju; Shi, Da-Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-157</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Diabetes is a fast growing chronic metabolic disorder around the world.  Dipeptidyl peptidase-4 (DPP-4) is a new promising target during type 2 diabetes glycemic control.  Thus, a no. of potent DPP-4 inhibitors were developed and play a rapidly evolving role in the management of type 2 diabetes in recent years.  This article reviews the development of synthetic and natural DPP-4 inhibitors from 2012 to 2017 and provides their physico-chem. properties, biol. activities against DPP-4 and selectivity over dipeptidyl peptidase-8/9.  Moreover, the glucose-lowering mechanisms and the active site of DPP-4 are also discussed.  The authors also discuss strategies and structure-activity relationships for identifying potent DPP-4 inhibitors, which will provide useful information for developing potent DPP-4 drugs as type 2 diabetes treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_uDljP-EfLVg90H21EOLACvtfcHk0lggt7RO3P3GiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVemsbw%253D&md5=a1ab96e621c8712c3c9a03302384b5c1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.041%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DL.%2BJ.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%2BQ.%26aulast%3DGuo%26aufirst%3DC.%2BL.%26aulast%3DGuo%26aufirst%3DS.%2BJ.%26aulast%3DShi%26aufirst%3DD.%2BY.%26atitle%3DRecent%2520progress%2520of%2520the%2520development%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D151%26spage%3D145%26epage%3D157%26doi%3D10.1016%2Fj.ejmech.2018.03.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havale, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, M.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1802</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.bmc.2009.01.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=19217790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1Cjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1783-1802&author=S.+H.+Havaleauthor=M.+Pal&title=Medicinal+chemistry+approaches+to+the+inhibition+of+dipeptidyl+peptidase-4+for+the+treatment+of+type+2+diabetes&doi=10.1016%2Fj.bmc.2009.01.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes</span></div><div class="casAuthors">Havale, Shrikanth H.; Pal, Manojit</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1783-1802</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Emerging as an epidemic of the 21st century type 2 diabetes has become a major health problem throughout the globe.  The no. of deaths attributable to diabetes reflects the insufficient glycemic control achieved with the treatments used in recent past.  DPP-4 inhibitors have been investigated as a new therapy with novel mechanisms of action and improved tolerability.  DPP-4, a protease that specifically cleaves dipeptides from proteins and oligopeptides after a penultimate N-terminal proline or alanine, is involved in the degrdn. of a no. of neuropeptides, peptide hormones and cytokines, including the incretins GLP-1 and GIP.  As soon as released from the gut in response to food intake, GLP-1 and GIP exert a potent glucose-dependent insulinotropic action, thereby playing a key role in the maintenance of post-meal glycemic control.  Consequently, inhibiting DPP-4 prolongs the action of GLP-1 and GIP, which in turn improves glucose homeostasis with a low risk of hypoglycemia and potential for disease modification.  Indeed, clin. trials involving diabetic patients have shown improved glucose control by administering DPP-4 inhibitors, thus demonstrating the benefit of this promising new class of antidiabetics.  Intense research activities in this area have resulted in the launch of sitagliptin and vildagliptin (in Europe only) and the advancement of a few others into preregistration/phase 3, for example, saxagliptin, alogliptin and ABT-279.  Achieving desired selectivity for DPP-4 over other related peptidases such as DPP-8 and DPP-9 (inhibition of which was linked to toxicity in animal studies) and long-acting potential for maximal efficacy (particularly in more severe diabetic patients) were the major challenges.  Whether these goals are achieved with the present series of inhibitors in the advanced stages of clin. development is yet to be confirmed.  Nevertheless, treatment of this metabolic disorder esp. in the early stages of the disease via DPP-4 inhibition has been recognized as a validated principle and a large no. of inhibitors are presently in various stage of pre-clin./clin. development.  Sitagliptin is a new weapon in the arsenal of oral antihyperglycemic agents.  This review will focus on the journey of drug discovery of DPP-4 inhibitors for oral delivery covering a brief scientific background and medicinal chem. approaches along with the status of advanced clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokOQ7xVWB37LVg90H21EOLACvtfcHk0lggt7RO3P3GiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1Cjsb4%253D&md5=4d3aa42f3e5e3151c283b9287bb74154</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DHavale%26aufirst%3DS.%2BH.%26aulast%3DPal%26aufirst%3DM.%26atitle%3DMedicinal%2520chemistry%2520approaches%2520to%2520the%2520inhibition%2520of%2520dipeptidyl%2520peptidase-4%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1783%26epage%3D1802%26doi%3D10.1016%2Fj.bmc.2009.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J. J.</span></span> <span> </span><span class="NLM_article-title">Do we know the true mechanism of action of the DPP-4 inhibitors?</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1111/dom.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1111%2Fdom.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=28544214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=34-41&author=E.+S.+Andersenauthor=C.+F.+Deaconauthor=J.+J.+Holst&title=Do+we+know+the+true+mechanism+of+action+of+the+DPP-4+inhibitors%3F&doi=10.1111%2Fdom.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Do we know the true mechanism of action of the DPP-4 inhibitors?</span></div><div class="casAuthors">Andersen, Emilie S.; Deacon, Carolyn F.; Holst, Jens J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The prevalence of type 2 diabetes is increasing, which is alarming because of its serious complications.  Anti-diabetic treatment aims to control glucose homeostasis as tightly as possible in order to reduce these complications.  Dipeptidyl peptidase-4 (DPP-4) inhibitors are a recent addn. to the anti-diabetic treatment modalities, and have become widely accepted because of their good efficacy, their benign side-effect profile and their low hypoglycemia risk.  The actions of DPP-4 inhibitors are not direct, but rather are mediated indirectly through preservation of the substrates they protect from degrdn.  The two incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, are known substrates, but other incretin-independent mechanisms may also be involved.  It seems likely therefore that the mechanisms of action of DPP-4 inhibitors are more complex than originally thought, and may involve several substrates and encompass local paracrine, systemic endocrine and neural pathways, which are discussed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriEo3tDF-sUbVg90H21EOLACvtfcHk0ljbGtQuLTwQfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL&md5=2d2783806da287d3bb50b932056fb5d2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fdom.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13018%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DE.%2BS.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26atitle%3DDo%2520we%2520know%2520the%2520true%2520mechanism%2520of%2520action%2520of%2520the%2520DPP-4%2520inhibitors%253F%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2018%26volume%3D20%26spage%3D34%26epage%3D41%26doi%3D10.1111%2Fdom.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions</span>. <i>Indian J. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.4103/2230-8210.141319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.4103%2F2230-8210.141319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=25364668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=753-759&author=A.+K.+Singh&title=Dipeptidyl+peptidase-4+inhibitors%3A+Novel+mechanism+of+actions&doi=10.4103%2F2230-8210.141319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 inhibitors: novel mechanism of actions</span></div><div class="casAuthors">Singh, Awadhesh Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">753-759</span>CODEN:
                <span class="NLM_cas:coden">IJEMGB</span>;
        ISSN:<span class="NLM_cas:issn">2230-9500</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications and Media Pvt. Ltd.</span>)
        </div><div class="casAbstract">A review.  The pharmacol. actions of the glucagon-like peptide-1 receptor agonists (GLP-1RA) are largely predictable as they interact directly with GLP-1 receptors on beta cells to mediate their glucose lowering effects by increasing GLP-1 in pharmacol. range and not at all dependent upon endogenous GLP-1 secretion.  The mechanism of action of dipeptidyl peptidase-4 inhibitors (DPP-4I) are relatively less clear although classical mechanism is to inhibit the endogenous GLP-1 metab. and thereby increasing GLP-1 level in the physiol. range.  DPP-4I also increase the half-life of GLP-1 to some extent by inhibiting their quick degrdn. by DPP enzyme ubiquitously present in the body.  Interestingly, even with the effective blockade with currently existing DPP-4I, the half-life of GLP-1 only increases from 1 min to 5 min and therefore its residual time in plasma still remains pretty short.  Intriguingly, this GLP-1 rise is so modest and so short-lived that it may be difficult to believe that this would sufficiently engage and activate the GLP-1 receptor in beta cell to produce significant insulinotropic effect.  However, in clin. trials as well as in real life scenario, the anti-glycemic efficacies seen with DPP-4I are quite satisfactory and sometime very much competitive to GLP-1RA as evident from their head-to-head trials including meta-anal.  This efficacy outcome challenges the "only" GLP-1 dependent mechanism of glucose lowering and provokes an insight that other neuro-endocrine pathway may be playing a second fiddle.  This review will collate those emerging concept and put a perspective as to how DPP-4I might be working though other pathway besides direct GLP-1 mediated receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEPwMXTYmqrVg90H21EOLACvtfcHk0ljbGtQuLTwQfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVensrc%253D&md5=0a38e63a35aa25cdf57910fdc88e697f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4103%2F2230-8210.141319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2230-8210.141319%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%2BK.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%253A%2520Novel%2520mechanism%2520of%2520actions%26jtitle%3DIndian%2520J.%2520Endocrinol.%2520Metab.%26date%3D2014%26volume%3D18%26spage%3D753%26epage%3D759%26doi%3D10.4103%2F2230-8210.141319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulvihill, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladanac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ussher, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggio, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burmeister, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, K. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span> <span> </span><span class="NLM_article-title">Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2016.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.cmet.2016.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=27839908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=152-165&author=E.+E.+Mulvihillauthor=E.+M.+Varinauthor=B.+Gladanacauthor=J.+E.+Campbellauthor=J.+R.+Ussherauthor=L.+L.+Baggioauthor=B.+Yustaauthor=J.+Ayalaauthor=M.+A.+Burmeisterauthor=D.+Matthewsauthor=K.+W.+A.+Bangauthor=J.+E.+Ayalaauthor=D.+J.+Drucker&title=Cellular+sites+and+mechanisms+linking+reduction+of+dipeptidyl+peptidase-4+activity+to+control+of+incretin+hormone+action+and+glucose+homeostasis&doi=10.1016%2Fj.cmet.2016.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis</span></div><div class="casAuthors">Mulvihill, Erin E.; Varin, Elodie M.; Gladanac, Bojana; Campbell, Jonathan E.; Ussher, John R.; Baggio, Laurie L.; Yusta, Bernardo; Ayala, Jennifer; Burmeister, Melissa A.; Matthews, Dianne; Bang, K. W. Annie; Ayala, Julio E.; Drucker, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-165</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pharmacol. inhibition of the dipeptidyl peptidase-4 (DPP4) enzyme potentiates incretin action and is widely used to treat type 2 diabetes.  Nevertheless, the precise cells and tissues crit. for incretin degrdn. and glucose homeostasis remain unknown.  Here, we use mouse genetics and pharmacol. DPP4 inhibition to identify DPP4+ cell types essential for incretin action.  Although enterocyte DPP4 accounted for substantial intestinal DPP4 activity, ablation of enterocyte DPP4 in Dpp4Gut-/- mice did not produce alterations in plasma DPP4 activity, incretin hormone levels, and glucose tolerance.  In contrast, endothelial cell (EC)-derived DPP4 contributed substantially to levels of sol. plasma DPP4 activity, incretin degrdn., and glucose control.  Surprisingly, DPP4+ cells of bone marrow origin mediated the selective degrdn. of fasting GIP, but not GLP-1.  Collectively, these findings identify distinct roles for DPP4 in the EC vs. the bone marrow compartment for selective incretin degrdn. and DPP4i-mediated glucoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEb9Z3NduUzrVg90H21EOLACvtfcHk0ljbGtQuLTwQfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeqsL3E&md5=6863e0483ae2e8629f2b2d4c5c39d29d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2016.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DE.%2BE.%26aulast%3DVarin%26aufirst%3DE.%2BM.%26aulast%3DGladanac%26aufirst%3DB.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DUssher%26aufirst%3DJ.%2BR.%26aulast%3DBaggio%26aufirst%3DL.%2BL.%26aulast%3DYusta%26aufirst%3DB.%26aulast%3DAyala%26aufirst%3DJ.%26aulast%3DBurmeister%26aufirst%3DM.%2BA.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DBang%26aufirst%3DK.%2BW.%2BA.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DCellular%2520sites%2520and%2520mechanisms%2520linking%2520reduction%2520of%2520dipeptidyl%2520peptidase-4%2520activity%2520to%2520control%2520of%2520incretin%2520hormone%2520action%2520and%2520glucose%2520homeostasis%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D25%26spage%3D152%26epage%3D165%26doi%3D10.1016%2Fj.cmet.2016.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, H.</span></span> <span> </span><span class="NLM_article-title">Role of gut microbiota-gut hormone axis in the pathophysiology of functional gastrointestinal disorders</span>. <i>J. Neurogastroenterol. Motil.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.5056/jnm18071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.5056%2Fjnm18071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29969855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FksFWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=367-386&author=H.+Fukuiauthor=X.+Xuauthor=H.+Miwa&title=Role+of+gut+microbiota-gut+hormone+axis+in+the+pathophysiology+of+functional+gastrointestinal+disorders&doi=10.5056%2Fjnm18071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders</span></div><div class="casAuthors">Fukui Hirokazu; Xu Xin; Miwa Hiroto; Xu Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurogastroenterology and motility</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-386</span>
        ISSN:<span class="NLM_cas:issn">2093-0879</span>.
    </div><div class="casAbstract">Gut microbiota exert a pivotal influence on various functions including gastrointestinal (GI) motility, metabolism, nutrition, immunity, and the neuroendocrine system in the host.  These effects are mediated by not only short-chain fatty acids produced by microbiota but also gut hormones and inflammatory signaling by enteroendocrine and immune cells under the influence of the microbiota.  GI motility is orchestrated by the enteric nervous system and hormonal networks, and disturbance of GI motility plays an important role in the pathophysiology of functional gastrointestinal disorders (FGIDs).  In this context, microbiota-associated mediators are considered to act on specific receptors, thus affecting the enteric nervous system and, subsequently, GI motility.  Thus, the pathophysiology of FGIDs is based on alterations of the gut microbiota/gut hormone axis, which have crucial effects on GI motility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRo9EiENZlhS2gRQsDqrjW_fW6udTcc2ebllZrbh0IGg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FksFWrsw%253D%253D&md5=72cb1108ec86deed0e89dd39f4dc512e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.5056%2Fjnm18071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5056%252Fjnm18071%26sid%3Dliteratum%253Aachs%26aulast%3DFukui%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DMiwa%26aufirst%3DH.%26atitle%3DRole%2520of%2520gut%2520microbiota-gut%2520hormone%2520axis%2520in%2520the%2520pathophysiology%2520of%2520functional%2520gastrointestinal%2520disorders%26jtitle%3DJ.%2520Neurogastroenterol.%2520Motil.%26date%3D2018%26volume%3D24%26spage%3D367%26epage%3D386%26doi%3D10.5056%2Fjnm18071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. D.</span></span> <span> </span><span class="NLM_article-title">Gut microbiota: an integral moderator in health and disease</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">151</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.3389%2Ffmicb.2018.00151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29515527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BC1MroslKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=151&author=Q.+Fengauthor=W.+D.+Chenauthor=Y.+D.+Wang&title=Gut+microbiota%3A+an+integral+moderator+in+health+and+disease&doi=10.3389%2Ffmicb.2018.00151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Gut Microbiota: An Integral Moderator in Health and Disease</span></div><div class="casAuthors">Feng Qingqing; Wang Yan-Dong; Chen Wei-Dong; Chen Wei-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">The gut microbiota, as the main member in gut microecology, is an essential mediator in health and disease.  The gut microbiota interacts with various organs and systems in the body, including brain, lung, liver, bone, cardiovascular system, and others.  Microbiota-derived metabolites such as the short chain fatty acid (SCFA) butyrate are primary signals, which link the gut microbiota and physiology.  Recently, the gut microbiota has been identified as the origin of a number of diseases by influencing the related cell signaling pathways such as WNT/beta-catenin pathway in colorectal cancer and T cell receptor signaling in the central nervous system.  Moreover, several microRNAs participate in signaling networks through the intervention of the gut microbiota.  The interaction between the gut microbiota and miRNAs plays a crucial role in vascular dysfunction and hepatocellular carcinoma (HCC).  In this review, we will report and discuss recent findings about the crosstalk between the gut microbiota and physical organs and how the gut microbiota and miRNAs regulate each other while influencing the host via genes, proteins, or metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6VkEBjsea1SEJCPKhJPuqfW6udTcc2ebWOpTwVO4wGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MroslKqtQ%253D%253D&md5=0e4e44b329a8546c6628f71ecf03096a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00151%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DW.%2BD.%26aulast%3DWang%26aufirst%3DY.%2BD.%26atitle%3DGut%2520microbiota%253A%2520an%2520integral%2520moderator%2520in%2520health%2520and%2520disease%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D151%26doi%3D10.3389%2Ffmicb.2018.00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fyfe, M. C.</span></span> <span> </span><span class="NLM_article-title">Non-systemic intestine-targeted drugs</span>. In  <i>Progress in Medicinal Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawton, G.</span>, <span class="NLM_string-name">Witty, D. R.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier UK</span>, <span class="NLM_year">2016</span>,  <span class="NLM_volume">55</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">44</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1-44&author=M.+C.+Fyfeauthor=G.+Lawton&author=D.+R.+Witty&title=Progress+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFyfe%26aufirst%3DM.%2BC.%26atitle%3DNon-systemic%2520intestine-targeted%2520drugs%26btitle%3DProgress%2520in%2520Medicinal%2520Chemistry%26aulast%3DLawton%26aufirst%3DG.%26pub%3DElsevier%2520UK%26date%3D2016%26volume%3D55%26spage%3D1%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroso, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbins, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harston, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5094</span>– <span class="NLM_lpage">5114</span>, <span class="refDoi"> DOI: 10.1021/jm400459m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400459m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5094-5114&author=Y.+Wuauthor=C.+J.+Aquinoauthor=D.+J.+Cowanauthor=D.+L.+Andersonauthor=J.+L.+Ambrosoauthor=M.+J.+Bishopauthor=E.+E.+Borosauthor=L.+Chenauthor=A.+Cunninghamauthor=R.+L.+Dobbinsauthor=P.+L.+Feldmanauthor=L.+T.+Harstonauthor=I.+W.+Kaldorauthor=R.+Kleinauthor=X.+Liangauthor=M.+S.+McIntyreauthor=C.+L.+Merrillauthor=K.+M.+Pattersonauthor=J.+S.+Prescottauthor=J.+S.+Rayauthor=S.+G.+Rollerauthor=X.+Yaoauthor=A.+Youngauthor=J.+Yuenauthor=J.+L.+Collins&title=Discovery+of+a+highly+potent%2C+nonabsorbable+apical+sodium-dependent+bile+acid+transporter+inhibitor+%28GSK2330672%29+for+treatment+of+type+2+diabetes&doi=10.1021%2Fjm400459m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Wu, Yulin; Aquino, Christopher J.; Cowan, David J.; Anderson, Don L.; Ambroso, Jeff L.; Bishop, Michael J.; Boros, Eric E.; Chen, Lihong; Cunningham, Alan; Dobbins, Robert L.; Feldman, Paul L.; Harston, Lindsey T.; Kaldor, Istvan W.; Klein, Ryan; Liang, Xi; McIntyre, Maggie S.; Merrill, Christine L.; Patterson, Kristin M.; Prescott, Judith S.; Ray, John S.; Roller, Shane G.; Yao, Xiaozhou; Young, Andrew; Yuen, Josephine; Collins, Jon L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5094-5114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract to the liver via the portal vein.  Multiple pharmaceutical companies have exploited the physiol. link between ASBT and hepatic cholesterol metab., which led to the clin. investigation of ASBT inhibitors as lipid-lowering agents.  While modest lipid effects were demonstrated, the potential utility of ASBT inhibitors for treatment of type 2 diabetes has been relatively unexplored.  We initiated a lead optimization effort that focused on the identification of a potent, nonabsorbable ASBT inhibitor starting from the first-generation inhibitor 264W94 (1).  Extensive SAR studies culminated in the discovery of GSK2330672 (56) as a highly potent, nonabsorbable ASBT inhibitor which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJcOxeK4rL_LVg90H21EOLACvtfcHk0likh8PAtC_GqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGiur0%253D&md5=4eb5eb2acc34f96469e23987b224ca35</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm400459m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400459m%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DAquino%26aufirst%3DC.%2BJ.%26aulast%3DCowan%26aufirst%3DD.%2BJ.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DAmbroso%26aufirst%3DJ.%2BL.%26aulast%3DBishop%26aufirst%3DM.%2BJ.%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCunningham%26aufirst%3DA.%26aulast%3DDobbins%26aufirst%3DR.%2BL.%26aulast%3DFeldman%26aufirst%3DP.%2BL.%26aulast%3DHarston%26aufirst%3DL.%2BT.%26aulast%3DKaldor%26aufirst%3DI.%2BW.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DMcIntyre%26aufirst%3DM.%2BS.%26aulast%3DMerrill%26aufirst%3DC.%2BL.%26aulast%3DPatterson%26aufirst%3DK.%2BM.%26aulast%3DPrescott%26aufirst%3DJ.%2BS.%26aulast%3DRay%26aufirst%3DJ.%2BS.%26aulast%3DRoller%26aufirst%3DS.%2BG.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DYuen%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520potent%252C%2520nonabsorbable%2520apical%2520sodium-dependent%2520bile%2520acid%2520transporter%2520inhibitor%2520%2528GSK2330672%2529%2520for%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5094%26epage%3D5114%26doi%3D10.1021%2Fjm400459m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span> <span> </span><span class="NLM_article-title">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3982</span>– <span class="NLM_lpage">3999</span>, <span class="refDoi"> DOI: 10.2174/092986712802002491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2174%2F092986712802002491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=22709010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3982-3999&author=Y.+Liuauthor=Y.+Huauthor=T.+Liu&title=Recent+advances+in+non-peptidomimetic+dipeptidyl+peptidase+4+inhibitors%3A+medicinal+chemistry+and+preclinical+aspects&doi=10.2174%2F092986712802002491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span></div><div class="casAuthors">Liu, Y.; Hu, Y.; Liu, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3982-3999</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase 4 (DPP-4), a substrate-specific serine protease, has been validated as a promising drug target for the treatment of type 2 diabetes.  DPP-4 inhibitors significantly lowered blood glucose levels in patients with type 2 diabetes without common body wt. gain, hypoglycemia and gastrointestinal disturbance side effects.  Therefore, DPP-4 inhibitors attracted more and more attention.  In particular, non-peptidomimetic DPP-4 inhibitors have been a focus of research and development and made great progress in recent years, which resulted in the discovery of a wide variety of potent non-peptidomimetic DPP-4 inhibitors.  Some of them, such as sitagliptin, alogliptin and linagliptin have already been used as marketed drugs, while others have been into clin. trials.  Based on the core structural features of non-peptidomimetic DPP-4 inhibitors, seven types were classified in the article.  For each type, we focused on the description of strategies for design and optimization, together with a discussion on concluded structure-activity relationships (SAR).  In addn., the contribution of specific substituents to the inhibition of DPP-4 was summarized.  Selectivity towards the inhibition of DPP-4 over dipeptidyl peptidase 8 (DPP-8) and dipeptidyl peptidase 9 (DPP-9) was also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLqQuB1LrfarVg90H21EOLACvtfcHk0lhCvcRsqlQJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI&md5=3ad3980483dcdcb29868b34a8bf77e6b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F092986712802002491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712802002491%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26atitle%3DRecent%2520advances%2520in%2520non-peptidomimetic%2520dipeptidyl%2520peptidase%25204%2520inhibitors%253A%2520medicinal%2520chemistry%2520and%2520preclinical%2520aspects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3982%26epage%3D3999%26doi%3D10.2174%2F092986712802002491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumagai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, H.</span></span> <span> </span><span class="NLM_article-title">(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl ]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5435</span>– <span class="NLM_lpage">5438</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.09.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.bmcl.2008.09.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=18819797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cqs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5435-5438&author=A.+Nittaauthor=H.+Fujiiauthor=S.+Sakamiauthor=Y.+Nishimuraauthor=T.+Ohyamaauthor=M.+Satohauthor=J.+Nakakiauthor=S.+Satohauthor=C.+Inadaauthor=H.+Kozonoauthor=H.+Kumagaiauthor=M.+Shimamuraauthor=T.+Fukazawaauthor=H.+Kawai&title=%283R%29-3-amino-4-%282%2C4%2C5-trifluorophenyl%29-N-%7B4-%5B6-%282-methoxyethoxy%29benzothiazol-2-yl+%5Dtetrahydropyran-4-yl%7Dbutanamide+as+a+potent+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes&doi=10.1016%2Fj.bmcl.2008.09.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">(3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Nitta, Aiko; Fujii, Hideaki; Sakami, Satoshi; Nishimura, Yutaka; Ohyama, Tomofumi; Satoh, Mikiya; Nakaki, Junko; Satoh, Shiho; Inada, Chifumi; Kozono, Hideki; Kumagai, Hiroki; Shimamura, Masahiro; Fukazawa, Tominaga; Kawai, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5435-5438</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides and 3-amino-N-(4-aryltetrahydropyran-4-yl)butanamides were synthesized and evaluated as dipeptidyl peptidase IV (DPP-IV) inhibitors.  Derivs. incorporating the 6-substituted benzothiazole group showed highly potent DPP-IV inhibitory activity.  Oral administration of (3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide reduced blood glucose excursion in an oral glucose tolerance test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrObdiSLW27ZbVg90H21EOLACvtfcHk0lhCvcRsqlQJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cqs77K&md5=a47b223cce3a0848638cb8b9a479df46</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.09.042%26sid%3Dliteratum%253Aachs%26aulast%3DNitta%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DH.%26aulast%3DSakami%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DOhyama%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DM.%26aulast%3DNakaki%26aufirst%3DJ.%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DInada%26aufirst%3DC.%26aulast%3DKozono%26aufirst%3DH.%26aulast%3DKumagai%26aufirst%3DH.%26aulast%3DShimamura%26aufirst%3DM.%26aulast%3DFukazawa%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DH.%26atitle%3D%25283R%2529-3-amino-4-%25282%252C4%252C5-trifluorophenyl%2529-N-%257B4-%255B6-%25282-methoxyethoxy%2529benzothiazol-2-yl%2520%255Dtetrahydropyran-4-yl%257Dbutanamide%2520as%2520a%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5435%26epage%3D5438%26doi%3D10.1016%2Fj.bmcl.2008.09.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giampietro, O.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2943</span>– <span class="NLM_lpage">2951</span>, <span class="refDoi"> DOI: 10.2174/092986709788803114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2174%2F092986709788803114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=19689275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2943-2951&author=E.+Matteucciauthor=O.+Giampietro&title=Dipeptidyl+peptidase-4+%28CD26%29%3A+knowing+the+function+before+inhibiting+the+enzyme&doi=10.2174%2F092986709788803114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme</span></div><div class="casAuthors">Matteucci, E.; Giampietro, O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2943-2951</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase-4 (DPP4) or adenosine deaminase complexing protein 2 (ADCP 2) or T-cell activation antigen CD26 (EC 3.4.14.5.) is a serine exopeptidase belonging to the S9B protein family that cleaves X-proline dipeptides from the N-terminus of polypeptides, such as chemokines, neuropeptides, and peptide hormones.  The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types, whose physiol. functions are largely unknown.  Protein dimerization should be required for catalytic activity and glycosylation of the enzyme could impact on its physiol. functions.  The dimeric glycoprotein ADCP has been found linked to adenosine deaminase (ADA) whose relation with lymphocyte maturation-differentiation is well-established.  Since implicated in the regulation of the biol. activity of hormones and chemokines, such as glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, DPP4 inhibition offers a new potential therapeutic approach for type 2 diabetes mellitus, as monotherapy and adjunct therapy to other oral agents.  The clin. use of presently available orally active inhibitors of DPP4, however, has been assocd. with side effects that have been in part attributed to the inhibition of related serine proteases, such as DPP8 and DPP9.  Indeed, it is noteworthy that CD26 has a key role in immune regulation as a T cell activation mol. and in immune-mediated disorder.  All-cause infections were increased after sitagliptin treatment.  It is noteworthy that the effects of DPP4 inhibition on the immune system have not been extensively investigated.  So far, only routine lab. safety variables have been measured in published randomized controlled trials.  The review summarizes present knowledge in the field and suggests some potential directions of future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWf-vE1Djk0rVg90H21EOLACvtfcHk0lhCvcRsqlQJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLg%253D&md5=c183b2b0410a92c1b9e35dc3fcb369f7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F092986709788803114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803114%26sid%3Dliteratum%253Aachs%26aulast%3DMatteucci%26aufirst%3DE.%26aulast%3DGiampietro%26aufirst%3DO.%26atitle%3DDipeptidyl%2520peptidase-4%2520%2528CD26%2529%253A%2520knowing%2520the%2520function%2520before%2520inhibiting%2520the%2520enzyme%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2943%26epage%3D2951%26doi%3D10.2174%2F092986709788803114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braunstein, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span> <span> </span><span class="NLM_article-title">Role of incretin axis in inflammatory bowel disease</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1734</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.01734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.3389%2Ffimmu.2017.01734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29270177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOhu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1734&author=L.+Duanauthor=X.+Raoauthor=Z.+Braunsteinauthor=A.+C.+Toomeyauthor=J.+Zhong&title=Role+of+incretin+axis+in+inflammatory+bowel+disease&doi=10.3389%2Ffimmu.2017.01734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Role of incretin axis in inflammatory bowel disease</span></div><div class="casAuthors">Duan, Lihua; Rao, Xiaoquan; Braunstein, Zachary; Toomey, Amelia C.; Zhong, Jixin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1734/1-1734/7</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract and involve a complicated reciprocity of environmental, genetic, and immunol. factors.  Despite substantial advances in the foundational understanding of the immunol. pathogenesis of IBD, the detailed mechanism of the pathol. progression in IBD remains unknown.  In addn. to Th1/Th2 cells, whose role in IBD has been previously well defined, recent evidence indicates that Th17 cells and Tregs also play a crucial role in the development of IBD.  Diets which contain excess sugars, salt, and fat may also be important actors in the pathogenesis of IBD, which may be the cause of high IBD incidence in western developed and industrialized countries.  Up until now, the reason for the variance in prevalence of IBD between developed and developing countries has been unknown.  This is partly due to the increasing popularity of western diets in developing countries, which makes the data harder to interpret.  The enterocrinins glucagon-like peptides (GLPs), including GLP-1 and GLP-2, exhibit notable benefits on lipid metab., atherosclerosis formation, plasma glucose levels, and maintenance of gastric mucosa integrity.  In addn. to the regulation of nutrient metab., the emerging role of GLPs and their degrading enzyme dipeptidyl peptidase-4 (DPP-4) in gastrointestinal diseases has gained increasing attention.  Therefore, here we review the function of the DPP-4/GLP axis in IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6F8S1rH9bC7Vg90H21EOLACvtfcHk0lhkcCDfYnKLIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOhu7bM&md5=62be86da06683351d91ca8907f6b20b3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.01734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.01734%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DRao%26aufirst%3DX.%26aulast%3DBraunstein%26aufirst%3DZ.%26aulast%3DToomey%26aufirst%3DA.%2BC.%26aulast%3DZhong%26aufirst%3DJ.%26atitle%3DRole%2520of%2520incretin%2520axis%2520in%2520inflammatory%2520bowel%2520disease%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D1734%26doi%3D10.3389%2Ffimmu.2017.01734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Detel, D.</span>; <span class="NLM_string-name">Batii, L.</span>; <span class="NLM_string-name">Pernjak, E.</span>; <span class="NLM_string-name">Kui, N.</span>; <span class="NLM_string-name">Buljevi, S.</span>; <span class="NLM_string-name">Mijandrui, B.</span>; <span class="NLM_string-name">Peri, M.</span>; <span class="NLM_string-name">Varlje, J.</span></span> <span> </span><span class="NLM_article-title">Role of dipeptidyl peptidase IV/CD26 in inflammatory bowel disease</span>. In  <i>Inflammatory Bowel Disease—Advances in Pathogenesis and Management</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karoui, S.</span></span>, Eds.; <span class="NLM_publisher-name">IntechOpen</span>: <span class="NLM_publisher-loc">Rijeka, Croatia</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">88</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.5772%2F29285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=59-88&author=D.+Detel&author=L.+Batii&author=E.+Pernjak&author=N.+Kui&author=S.+Buljevi&author=B.+Mijandrui&author=M.+Peri&author=J.+Varljeauthor=S.+Karoui&title=Inflammatory+Bowel+Disease%E2%80%94Advances+in+Pathogenesis+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.5772%2F29285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F29285%26sid%3Dliteratum%253Aachs%26aulast%3DDetel%26aufirst%3DD.%26atitle%3DRole%2520of%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520in%2520inflammatory%2520bowel%2520disease%26btitle%3DInflammatory%2520Bowel%2520Disease%25E2%2580%2594Advances%2520in%2520Pathogenesis%2520and%2520Management%26aulast%3DKaroui%26aufirst%3DS.%26pub%3DIntechOpen%26date%3D2012%26spage%3D59%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abrahami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, O. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renoux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azoulay, L.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study</span>. <i>B. M. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>, <span class="NLM_elocation-id">k872</span> <span class="refDoi"> DOI: 10.1136/bmj.k872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1136%2Fbmj.k872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29563098" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&author=D.+Abrahamiauthor=A.+Dourosauthor=H.+Yinauthor=O.+H.+Y.+Yuauthor=C.+Renouxauthor=A.+Bittonauthor=L.+Azoulay&title=Dipeptidyl+peptidase-4+inhibitors+and+incidence+of+inflammatory+bowel+disease+among+patients+with+type+2+diabetes%3A+population+based+cohort+study&doi=10.1136%2Fbmj.k872"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fbmj.k872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.k872%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahami%26aufirst%3DD.%26aulast%3DDouros%26aufirst%3DA.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DO.%2BH.%2BY.%26aulast%3DRenoux%26aufirst%3DC.%26aulast%3DBitton%26aufirst%3DA.%26aulast%3DAzoulay%26aufirst%3DL.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520and%2520incidence%2520of%2520inflammatory%2520bowel%2520disease%2520among%2520patients%2520with%2520type%25202%2520diabetes%253A%2520population%2520based%2520cohort%2520study%26jtitle%3DB.%2520M.%2520J.%26date%3D2018%26volume%3D360%26doi%3D10.1136%2Fbmj.k872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sueyoshi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods Ignatoski, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitelbaum, D. H.</span></span> <span> </span><span class="NLM_article-title">Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model</span>. <i>Am. J. Physiol. Gastrointest Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">G410</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00363.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1152%2Fajpgi.00363.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=24970775" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2014&pages=G410-419&author=R.+Sueyoshiauthor=K.+M.+Woods+Ignatoskiauthor=M.+Okawadaauthor=B.+Hartmannauthor=J.+Holstauthor=D.+H.+Teitelbaum&title=Stimulation+of+intestinal+growth+and+function+with+DPP4+inhibition+in+a+mouse+short+bowel+syndrome+model&doi=10.1152%2Fajpgi.00363.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00363.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00363.2013%26sid%3Dliteratum%253Aachs%26aulast%3DSueyoshi%26aufirst%3DR.%26aulast%3DWoods%2BIgnatoski%26aufirst%3DK.%2BM.%26aulast%3DOkawada%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DB.%26aulast%3DHolst%26aufirst%3DJ.%26aulast%3DTeitelbaum%26aufirst%3DD.%2BH.%26atitle%3DStimulation%2520of%2520intestinal%2520growth%2520and%2520function%2520with%2520DPP4%2520inhibition%2520in%2520a%2520mouse%2520short%2520bowel%2520syndrome%2520model%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest%2520Liver%2520Physiol.%26date%3D2014%26volume%3D307%26spage%3DG410%26epage%3D419%26doi%3D10.1152%2Fajpgi.00363.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baticic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Detel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buljevic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugel, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varljen, J.</span></span> <span> </span><span class="NLM_article-title">Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">3322</span>– <span class="NLM_lpage">3333</span>, <span class="refDoi"> DOI: 10.1002/jcb.23261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1002%2Fjcb.23261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=21751235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlagur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2011&pages=3322-3333&author=L.+Baticicauthor=D.+Detelauthor=N.+Kucicauthor=S.+Buljevicauthor=E.+P.+Pugelauthor=J.+Varljen&title=Neuroimmunomodulative+properties+of+dipeptidyl+peptidase+IV%2FCD26+in+a+TNBS-induced+model+of+colitis+in+mice&doi=10.1002%2Fjcb.23261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice</span></div><div class="casAuthors">Baticic, Lara; Detel, Dijana; Kucic, Natalia; Buljevic, Suncica; Pugel, Ester Pernjak; Varljen, Jadranka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3322-3333</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Causal connections between dipeptidyl peptidase IV, also known as CD26 mol. (DPP IV/CD26) and inflammatory bowel disease (IBD) have been shown, but mechanisms of these interactions are unclear.  Our hypothesis was that DPP IV/CD26 could affect the neuroimmune response during inflammatory events.  Therefore, we aimed to evaluate its possible role and the relevance of the gut-brain axis in a model of IBD in mice.  Trinitrobenzenesulfonic acid-induced (TNBS) colitis was induced in CD26-deficient (CD26-/-) and wild-type (C57BL/6) mice.  Pathohistol. and histomorphometrical measurements were done.  Concns. and protein expressions of DPP IV/CD26 substrates neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) were detd.  Concns. of IL-6 and IL-10 were evaluated.  Investigations were conducted at systemic and local levels.  Acute inflammation induced increased serum NPY concns. in both mice strains, more enhanced in CD26-/- mice.  Increased NPY concns. were found in colon and brain of C57BL/6 mice, while in CD26-/- animals only in colon.  VIP and IL-6 serum and tissue concns. were increased in both mice strains in acute inflammation, more pronouncedly in CD26-/- mice.  IL-10 concns., after a decrease in serum of both mice strains, increased promptly in CD26-/- mice.  Decreased IL-10 concn. was found in brain of C57BL/6 mice, while it was increased in colon of CD26-/- mice in acute inflammation.  DPP IV/CD26 deficiency affects the neuroimmune response at systemic and local levels during colitis development and resoln. in mice.  Inflammatory changes in the colon reflected on investigated parameters in the brain, suggesting an important role of the gut-brain axis in IBD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAmlJ2ctLOhrVg90H21EOLACvtfcHk0lhkcCDfYnKLIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlagur7J&md5=ebc65552d18a150bc9a55847f7e32aab</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcb.23261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.23261%26sid%3Dliteratum%253Aachs%26aulast%3DBaticic%26aufirst%3DL.%26aulast%3DDetel%26aufirst%3DD.%26aulast%3DKucic%26aufirst%3DN.%26aulast%3DBuljevic%26aufirst%3DS.%26aulast%3DPugel%26aufirst%3DE.%2BP.%26aulast%3DVarljen%26aufirst%3DJ.%26atitle%3DNeuroimmunomodulative%2520properties%2520of%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520in%2520a%2520TNBS-induced%2520model%2520of%2520colitis%2520in%2520mice%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D112%26spage%3D3322%26epage%3D3333%26doi%3D10.1002%2Fjcb.23261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrowiecka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malecka-Panas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamysz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichna, J.</span></span> <span> </span><span class="NLM_article-title">New peptide inhibitor of dipeptidyl peptidase IV, EMDB-1 extends the half-Life of GLP-2 and attenuates colitis in mice after topical administration</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.242586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1124%2Fjpet.117.242586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=28724693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVWgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2017&pages=92-103&author=M.+Salagaauthor=A.+Mokrowieckaauthor=M.+Zielinskaauthor=E.+Malecka-Panasauthor=R.+Kordekauthor=E.+Kamyszauthor=J.+Fichna&title=New+peptide+inhibitor+of+dipeptidyl+peptidase+IV%2C+EMDB-1+extends+the+half-Life+of+GLP-2+and+attenuates+colitis+in+mice+after+topical+administration&doi=10.1124%2Fjpet.117.242586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New peptide inhibitor of dipeptidyl peptidase IV, EMDB-1 extends the half-life of GLP-2 and attenuates colitis in mice after topical administration</span></div><div class="casAuthors">Salaga, Maciej; Mokrowiecka, Anna; Zielinska, Marta; Malecka-Panas, Ewa; Kordek, Radzislaw; Kamysz, Elzbieta; Fichna, Jakub</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-103</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Protease inhibition has become a possible new approach in inflammatory bowel disease (IBD) therapy.  A serine exopeptidase, dipeptidyl peptidase IV (DPP IV), is responsible for the inactivation of incretin hormone, glucagon-like peptide 2 (GLP-2), a potent stimulator of intestinal epithelium regeneration and growth.  Recently, we showed that the novel peptide analog of endomorphin-2, Tyr-Pro-D-ClPhe-Phe-NH2 (EMDB-1) is a potent blocker of DPP IV and has an inhibitory effect on gastrointestinal (GI) smooth muscle contractility.  The aim of this study was to characterize the anti-inflammatory effect and mechanism of action of EMDB-1 in the mouse GI tract.  We used two models of exptl. colitis (induced by TNBS and DSS).  The anti-inflammatory effect of EMDB-1 was assessed by the detn. of macroscopic score, ulcer score, colonic wall thickness, as well as myeloperoxidase activity.  Addnl., we measured the expression of GLP-2, GLP2R, and DPP IV in the colon of control and colitic animals treated with the test compd.  The expression of GLP-2 and GLP2R in the serum and colon of IBD patients and healthy control subjects has been assessed.  We showed that EMDB-1 elevates the half-life of GLP- 2 in vitro and attenuates acute, semichronic, and relapsing TNBS as well as DSS-induced colitis in mice after topical administration.  The anti-inflammatory action of EMDB-1 is assocd. with changes in the level of colonic GLP-2 but not DPP IV expression.  Our results validate DPP IV as a pharmacol. target for the anti-IBD drugs, and its inhibitors based on natural substrates, such as EMDB-1, have the potential to become valuable antiinflammatory therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkAWkaxVrLg7Vg90H21EOLACvtfcHk0ljjlhtoS5vaNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVWgur4%253D&md5=d6bccbaf92a5875bb6c4c6f396f6b0a4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.242586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.242586%26sid%3Dliteratum%253Aachs%26aulast%3DSalaga%26aufirst%3DM.%26aulast%3DMokrowiecka%26aufirst%3DA.%26aulast%3DZielinska%26aufirst%3DM.%26aulast%3DMalecka-Panas%26aufirst%3DE.%26aulast%3DKordek%26aufirst%3DR.%26aulast%3DKamysz%26aufirst%3DE.%26aulast%3DFichna%26aufirst%3DJ.%26atitle%3DNew%2520peptide%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%252C%2520EMDB-1%2520extends%2520the%2520half-Life%2520of%2520GLP-2%2520and%2520attenuates%2520colitis%2520in%2520mice%2520after%2520topical%2520administration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D363%26spage%3D92%26epage%3D103%26doi%3D10.1124%2Fjpet.117.242586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yazbeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geier, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, C. A.</span></span> <span> </span><span class="NLM_article-title">Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">6850</span>– <span class="NLM_lpage">6858</span>, <span class="refDoi"> DOI: 10.2741/3193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.2741%2F3193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=18508699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=6850-6858&author=R.+Yazbeckauthor=G.+S.+Howarthauthor=M.+S.+Geierauthor=H.-U.+Demuthauthor=C.+A.+Abbott&title=Inhibiting+dipeptidyl+peptidase+activity+partially+ameliorates+colitis+in+mice&doi=10.2741%2F3193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice</span></div><div class="casAuthors">Yazbeck, Roger; Howarth, Gordon S.; Geier, Mark S.; Demuth, Hans-Ulrich; Abbott, Catherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6850-6858</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">New treatment strategies are required for the debilitating inflammatory bowel diseases (IBD), Crohn's Disease and Ulcerative Colitis.  DP inhibitors can prolong the bioactivity of the potent intestinotrophic growth factor glucagon-like peptide-2 (GLP-21-33).  We investigated whether novel inhibitors of DP activity could modify the course of disease activity in the dextran sulfate sodium (DSS) model of colitis.  C57BL/6 mice consumed 2% DSS in drinking water for 6 days.  Mice were orally gavaged twice daily with 0.9% saline, 10mg/kg isoleucyl-cyano-pyrrolidine (P59/99) or isoleucyl-thiazolidine (P32/98).  Assessment of disease severity incorporated a disease activity index (DAI), together with histol. assessment of crypt area and depth in the distal colon.  DP activity was significantly inhibited at all time points.  The DAI was significantly lower in the P59/99 and P32/98 treatment groups compared to saline treatment in all three time courses.  Crypt hyperplasia (p<0.05) was obsd. in the saline group compared to P32/98 treatment at day 9.  This preliminary study shows that novel inhibitors of DP activity may provide a new treatment strategy for IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSueeEb4t-0LVg90H21EOLACvtfcHk0ljjlhtoS5vaNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOiur4%253D&md5=15b8b06bfd37689a90c2096d5c18561e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2741%2F3193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3193%26sid%3Dliteratum%253Aachs%26aulast%3DYazbeck%26aufirst%3DR.%26aulast%3DHowarth%26aufirst%3DG.%2BS.%26aulast%3DGeier%26aufirst%3DM.%2BS.%26aulast%3DDemuth%26aufirst%3DH.-U.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26atitle%3DInhibiting%2520dipeptidyl%2520peptidase%2520activity%2520partially%2520ameliorates%2520colitis%2520in%2520mice%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2008%26volume%3D13%26spage%3D6850%26epage%3D6858%26doi%3D10.2741%2F3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morise, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funasaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, H.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis</span>. <i>Scand. J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.3109/00365521.2013.832366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.3109%2F00365521.2013.832366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=24047394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyrurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=1152-1159&author=S.+Mimuraauthor=T.+Andoauthor=K.+Ishiguroauthor=O.+Maedaauthor=O.+Watanabeauthor=M.+Ujiharaauthor=Y.+Hirayamaauthor=K.+Moriseauthor=K.+Maedaauthor=M.+Matsushitaauthor=K.+Funasakaauthor=M.+Nakamuraauthor=R.+Miyaharaauthor=N.+Ozakiauthor=H.+Goto&title=Dipeptidyl+peptidase-4+inhibitor+anagliptin+facilitates+restoration+of+dextran+sulfate+sodium-induced+colitis&doi=10.3109%2F00365521.2013.832366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis</span></div><div class="casAuthors">Mimura, Shunya; Ando, Takafumi; Ishiguro, Kazuhiro; Maeda, Osamu; Watanabe, Osamu; Ujihara, Masaki; Hirayama, Yutaka; Morise, Kazuhiro; Maeda, Keiko; Matsushita, Masanobu; Funasaka, Kohei; Nakamura, Masanao; Miyahara, Ryoji; Ozaki, Nobuaki; Goto, Hidemi</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1152-1159</span>CODEN:
                <span class="NLM_cas:coden">SJGRA4</span>;
        ISSN:<span class="NLM_cas:issn">0036-5521</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Objective: Inflammatory bowel disease (IBD) is a chronic debilitating disease assocd. with severe damage to the intestinal mucosa.  Glucagon-like peptide-2 (GLP-2) is a potent and specific gastrointestinal growth factor.  GLP-2 released from enteroendocrine cells is inactivated by dipeptidyl peptidase-4 (DPP-4).  The aim of this study was to examine whether the DPP-4 inhibitor anagliptin improves exptl. murine colitis.  Material and methods: Male C57BL/6 mice aged 8 wk were exposed to 1.5% dextran sulfate sodium (DSS) in drinking water for 7 days to induce exptl. colitis.  Anagliptin (0.1% in diet) was administrated from 2 days before the beginning of DSS to 7 days after the end of DSS.  Changes in body wt. and disease activity index were evaluated daily.  Histol. colitis severity, cellular proliferation and gene expression were detd. in colonic tissues.  Results: Treatment with anagliptin clearly improved body wt. loss and disease activity index in the recovery phase.  Histol. score in the DSS + anagliptin group at day 14 was significantly lower than that in the DSS alone group.  Treatment with anagliptin increased the Ki67-pos. rate at days 10 and 14, and tended to increase insulin-like growth factor-1 mRNA expression in the DSS + anagliptin group.  Conclusion: In this model of exptl. colitis, the DPP-4 inhibitor anagliptin facilitated the restoration of mucosal damage, thereby resulting in the acceleration of healing.  These findings suggest a new and novel therapeutic approach for the treatment of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPcEVGLp6qnLVg90H21EOLACvtfcHk0ljjlhtoS5vaNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyrurzE&md5=108391c0ec4a80f8b127d92195b78cb9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3109%2F00365521.2013.832366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00365521.2013.832366%26sid%3Dliteratum%253Aachs%26aulast%3DMimura%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DO.%26aulast%3DWatanabe%26aufirst%3DO.%26aulast%3DUjihara%26aufirst%3DM.%26aulast%3DHirayama%26aufirst%3DY.%26aulast%3DMorise%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DFunasaka%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMiyahara%26aufirst%3DR.%26aulast%3DOzaki%26aufirst%3DN.%26aulast%3DGoto%26aufirst%3DH.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitor%2520anagliptin%2520facilitates%2520restoration%2520of%2520dextran%2520sulfate%2520sodium-induced%2520colitis%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D2013%26volume%3D48%26spage%3D1152%26epage%3D1159%26doi%3D10.3109%2F00365521.2013.832366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olivares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyrinck, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potgens, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindels, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delzenne, N. M.</span></span> <span> </span><span class="NLM_article-title">The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1848</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4647-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1007%2Fs00125-018-4647-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29797022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGjtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1838-1848&author=M.+Olivaresauthor=A.+M.+Neyrinckauthor=S.+A.+Potgensauthor=M.+Beaumontauthor=N.+Salazarauthor=P.+D.+Caniauthor=L.+B.+Bindelsauthor=N.+M.+Delzenne&title=The+DPP-4+inhibitor+vildagliptin+impacts+the+gut+microbiota+and+prevents+disruption+of+intestinal+homeostasis+induced+by+a+Western+diet+in+mice&doi=10.1007%2Fs00125-018-4647-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice</span></div><div class="casAuthors">Olivares, Marta; Neyrinck, Audrey M.; Potgens, Sarah A.; Beaumont, Martin; Salazar, Nuria; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1848</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: Dipeptidyl peptidase 4 (DPP-4) inhibitors are agents designed to increase the half-life of incretins.  Although they are administered orally, little is known about their effects on the gut microbiota and functions, despite the fact that some bacteria present in the gut microbiota exhibit DPP-4-like activity.  Our objective was to study the impact of the DPP-4 inhibitor vildagliptin on gut functions and the intestinal ecosystem in a murine model of obesity induced by a Western diet (WD).  Methods: Twenty seven male C57BL/6J mice were randomised to receive a control diet, a WD (45% kJ from fat and 17% kJ from sucrose) or a WD + vildagliptin (0.6 mg/mL in drinking water) for 8 wk.  Results: Vildagliptin significantly reduced DPP-4 activity in the caecal content and faeces.  Vildagliptin impacted on the compn. of the gut microbiota and its metabolic activity.  It mainly decreased Oscillibacter spp. (a direct effect independent of DPP-4 activity was shown on cultured O. valericigenes), increased Lactobacillus spp. and propionate, and reduced the ligands of Toll-like receptors 2 and 4.  Vildagliptin protected against the redns. in crypt depth and ileal expression of antimicrobial peptides induced by the WD.  In the liver, the expression of immune cell populations (Cd3g and Cd11c [also known as Itgax]) and cytokines was decreased in the WD + vildagliptin-fed mice compared with the WD-fed group.  Ex vivo exposure of precision-cut liver slices to vildagliptin showed that this response was not related to a direct effect of the drug on the liver tissue.  Conclusions/interpretation: Our study is the first to consider the DPP-4-like activity of the gut microbiota as a target of DPP-4 inhibition.  We propose that vildagliptin exerts beneficial effects at the intestinal level in assocn. with modulation of gut microbiota, with consequences for hepatic immunity.  If relevant in humans, this could open new therapeutic uses of DPP-4 inhibition to tackle gut dysfunctions in different pathophysiol. contexts.  Data availability: The sequences used for anal. can be found in the MG-RAST database under the project name MYNEWGUT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFyUQGk9n2bbVg90H21EOLACvtfcHk0lj-zKMm30C_LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGjtLnN&md5=9eefa83cf60c502c959e85473b27978c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4647-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4647-6%26sid%3Dliteratum%253Aachs%26aulast%3DOlivares%26aufirst%3DM.%26aulast%3DNeyrinck%26aufirst%3DA.%2BM.%26aulast%3DPotgens%26aufirst%3DS.%2BA.%26aulast%3DBeaumont%26aufirst%3DM.%26aulast%3DSalazar%26aufirst%3DN.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DBindels%26aufirst%3DL.%2BB.%26aulast%3DDelzenne%26aufirst%3DN.%2BM.%26atitle%3DThe%2520DPP-4%2520inhibitor%2520vildagliptin%2520impacts%2520the%2520gut%2520microbiota%2520and%2520prevents%2520disruption%2520of%2520intestinal%2520homeostasis%2520induced%2520by%2520a%2520Western%2520diet%2520in%2520mice%26jtitle%3DDiabetologia%26date%3D2018%26volume%3D61%26spage%3D1838%26epage%3D1848%26doi%3D10.1007%2Fs00125-018-4647-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span> <span> </span><span class="NLM_article-title">Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2019.03.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.ebiom.2019.03.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30922964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3cbpt1Ojsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2019&pages=665-674&author=X.+Liaoauthor=L.+Songauthor=B.+Zengauthor=B.+Liuauthor=Y.+Qiuauthor=H.+Quauthor=Y.+Zhengauthor=M.+Longauthor=H.+Zhouauthor=Y.+Wangauthor=Y.+Duauthor=J.+Xuauthor=R.+Shenauthor=Q.+Tongauthor=L.+Caiauthor=X.+Liauthor=S.+Guoauthor=G.+Yangauthor=Z.+Zhuauthor=X.+Puauthor=H.+Weiauthor=H.+Zheng&title=Alteration+of+gut+microbiota+induced+by+DPP-4i+treatment+improves+glucose+homeostasis&doi=10.1016%2Fj.ebiom.2019.03.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis</span></div><div class="casAuthors">Liao Xiaoyu; Liu Bingyao; Qiu Yuyang; Qu Hua; Zheng Yi; Long Min; Zhou Houdi; Wang Yuan; Du Yingxuan; Xu Jing; Shen Rufei; Tong Qiang; Cai Leiqin; Li Xing; Song Lingyu; Zeng Benhua; Guo Shaodong; Yang Gangyi; Zhu Zhiming; Pu Xiaoyun; Wei Hong; Zheng Hongting</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">665-674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Increasing evidence indicates that the gut microbiota contributes to the occurrence and development of metabolic diseases.  However, little is known about the effects of commonly used antidiabetic agents on the gut microbiota.  In this study, we investigated the roles of dipeptidyl peptidase-4 inhibitors (DPP-4i) and α-glucosidase inhibitor in modulating the gut microbiota.  METHODS:  16S-rDNA sequencing was performed to analyse the effects of DPP-4i and acarbose on the gut microbiota in mice fed a high-fat diet (HFD).  Fecal microbiota transplantation (FMT) from type 2 diabetes patients to germ-free mice was performed to investigate the contribution of the altered microbiome to antidiabetic effects of the drugs.  Fecal metabolomics was also analysed by untargeted and targeted GC-MS systems.  FINDINGS:  Although DPP-4i and α-glucosidase inhibitor both altered the gut microbial composition, only the microbiome modulation of DPP-4i contributed to its hypoglycemic effect.  Specifically, the changes of 68.6% genera induced by HFD were rescued by DPP-4i.  FMT showed that the DPP-4i-altered microbiome improved glucose tolerance in colonized mice, while acarbose did not.  Moreover, DPP-4i increased the abundance of Bacteroidetes, and also promoted a functional shift in the gut microbiome, especially increasing the production of succinate.  INTERPRETATION:  Our findings demonstrate an important effect of DPP-4i on the gut microbiota, revealing a new hypoglycemic mechanism and an additional benefit of it.  Furthermore, modulating the microbial composition, and the functional shift arising from changes in the microbiome, might be a potential strategy for improving glucose homeostasis.  FUND: This work was supported by grants from the National Natural Science Foundation of China (No. 81700757, No. 81471039, No. 81700714 and No. 81770434), the National Key R&D Program of China (No. 2017YFC1309602, No. 2016YFC1101100, No. 2017YFD0500503 and No. 2017YFD0501001), and the Natural Science Foundation of Chongqing (No. cstc2014jcyjjq10006, No. cstc2016jcyjA0093 and No. cstc2016jcyjA0518).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2PvsVJttlHMScOqQTSkOffW6udTcc2ebqB3ht5vucGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbpt1Ojsw%253D%253D&md5=4fcbd9cae5fa47060a712a20f85d51e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2019.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2019.03.057%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPu%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520gut%2520microbiota%2520induced%2520by%2520DPP-4i%2520treatment%2520improves%2520glucose%2520homeostasis%26jtitle%3DEBioMedicine%26date%3D2019%26volume%3D44%26spage%3D665%26epage%3D674%26doi%3D10.1016%2Fj.ebiom.2019.03.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershwin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span> <span> </span><span class="NLM_article-title">Alterations of gut microbiome in autoimmune hepatitis</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">gutjnl-2018-317836</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2018-317836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1136%2Fgutjnl-2018-317836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=gutjnl-2018-317836&author=Y.+Weiauthor=Y.+Liauthor=L.+Yanauthor=C.+Sunauthor=Q.+Miaoauthor=Q.+Wangauthor=X.+Xiaoauthor=M.+Lianauthor=B.+Liauthor=Y.+Chenauthor=J.+Zhangauthor=Y.+Liauthor=B.+Huangauthor=Y.+Liauthor=Q.+Caoauthor=Z.+Fanauthor=X.+Chenauthor=J.+Y.+Fangauthor=M.+E.+Gershwinauthor=R.+Tangauthor=X.+Ma&title=Alterations+of+gut+microbiome+in+autoimmune+hepatitis&doi=10.1136%2Fgutjnl-2018-317836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2018-317836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2018-317836%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DLian%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%2BY.%26aulast%3DGershwin%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DX.%26atitle%3DAlterations%2520of%2520gut%2520microbiome%2520in%2520autoimmune%2520hepatitis%26jtitle%3DGut%26date%3D2019%26spage%3Dgutjnl-2018-317836%26doi%3D10.1136%2Fgutjnl-2018-317836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1038/s41422-019-0190-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1038%2Fs41422-019-0190-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=31201384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3M3mvFOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=516-532&author=Q.+Zhangauthor=Y.+Panauthor=B.+Zengauthor=X.+Zhengauthor=H.+Wangauthor=X.+Shenauthor=H.+Liauthor=Q.+Jiangauthor=J.+Zhaoauthor=Z.+X.+Mengauthor=P.+Liauthor=Z.+Chenauthor=H.+Weiauthor=Z.+Liu&title=Intestinal+lysozyme+liberates+Nod1+ligands+from+microbes+to+direct+insulin+trafficking+in+pancreatic+beta+cells&doi=10.1038%2Fs41422-019-0190-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal lysozyme liberates Nod1 ligands from microbes to direct insulin trafficking in pancreatic beta cells</span></div><div class="casAuthors">Zhang Qin; Pan Ying; Zheng Xiaojiao; Wang Haifang; Shen Xueying; Li Hui; Liu Zhihua; Zeng Benhua; Shen Xueying; Li Hui; Jiang Qian; Li Pingping; Zhao Jiaxu; Chen Zhengjun; Zhao Jiaxu; Chen Zhengjun; Meng Zhuo-Xian; Chen Zhengjun; Wei Hong; Liu Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Cell research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">516-532</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Long-range communication between intestinal symbiotic bacteria and extra-intestinal organs can occur through circulating bacterial signal molecules, through neural circuits, or through cytokines or hormones from host cells.  Here we report that Nod1 ligands derived from intestinal bacteria act as signal molecules and directly modulate insulin trafficking in pancreatic beta cells.  The cytosolic peptidoglycan receptor Nod1 and its downstream adapter Rip2 are required for insulin trafficking in beta cells in a cell-autonomous manner.  Mechanistically, upon recognizing cognate ligands, Nod1 and Rip2 localize to insulin vesicles, recruiting Rab1a to direct insulin trafficking through the cytoplasm.  Importantly, intestinal lysozyme liberates Nod1 ligands into the circulation, thus enabling long-range communication between intestinal microbes and islets.  The intestine-islet crosstalk bridged by Nod1 ligands modulates host glucose tolerance.  Our study defines a new type of inter-organ communication based on circulating bacterial signal molecules, which has broad implications for understanding the mutualistic relationship between microbes and host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE2A638uprk8jl5L8hwNX0fW6udTcc2eZAC_-WWFUoILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3mvFOjug%253D%253D&md5=d25136abde7538f84c4bfa24c599faf1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41422-019-0190-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-019-0190-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMeng%26aufirst%3DZ.%2BX.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DIntestinal%2520lysozyme%2520liberates%2520Nod1%2520ligands%2520from%2520microbes%2520to%2520direct%2520insulin%2520trafficking%2520in%2520pancreatic%2520beta%2520cells%26jtitle%3DCell%2520Res.%26date%3D2019%26volume%3D29%26spage%3D516%26epage%3D532%26doi%3D10.1038%2Fs41422-019-0190-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandal, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bramer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isern, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noecker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweredoski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moradian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borenstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwind, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajmalnik-Brown, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazmanian, S. K.</span></span> <span> </span><span class="NLM_article-title">Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">1600</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2019.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.cell.2019.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=31150625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVygu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2019&pages=1600&author=G.+Sharonauthor=N.+J.+Cruzauthor=D.+W.+Kangauthor=M.+J.+Gandalauthor=B.+Wangauthor=Y.+M.+Kimauthor=E.+M.+Zinkauthor=C.+P.+Caseyauthor=B.+C.+Taylorauthor=C.+J.+Laneauthor=L.+M.+Bramerauthor=N.+G.+Isernauthor=D.+W.+Hoytauthor=C.+Noeckerauthor=M.+J.+Sweredoskiauthor=A.+Moradianauthor=E.+Borensteinauthor=J.+K.+Janssonauthor=R.+Knightauthor=T.+O.+Metzauthor=C.+Loisauthor=D.+H.+Geschwindauthor=R.+Krajmalnik-Brownauthor=S.+K.+Mazmanian&title=Human+gut+microbiota+from+autism+spectrum+disorder+promote+behavioral+symptoms+in+mice&doi=10.1016%2Fj.cell.2019.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice</span></div><div class="casAuthors">Sharon, Gil; Cruz, Nikki Jamie; Kang, Dae-Wook; Gandal, Michael J.; Wang, Bo; Kim, Young-Mo; Zink, Erika M.; Casey, Cameron P.; Taylor, Bryn C.; Lane, Christianne J.; Bramer, Lisa M.; Isern, Nancy G.; Hoyt, David W.; Noecker, Cecilia; Sweredoski, Michael J.; Moradian, Annie; Borenstein, Elhanan; Jansson, Janet K.; Knight, Rob; Metz, Thomas O.; Lois, Carlos; Geschwind, Daniel H.; Krajmalnik-Brown, Rosa; Mazmanian, Sarkis K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1600-1618.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) manifests as alterations in complex human behaviors including social communication and stereotypies.  In addn. to genetic risks, the gut microbiome differs between typically developing (TD) and ASD individuals, though it remains unclear whether the microbiome contributes to symptoms.  We transplanted gut microbiota from human donors with ASD or TD controls into germ-free mice and reveal that colonization with ASD microbiota is sufficient to induce hallmark autistic behaviors.  The brains of mice colonized with ASD microbiota display alternative splicing of ASD-relevant genes.  Microbiome and metabolome profiles of mice harboring human microbiota predict that specific bacterial taxa and their metabolites modulate ASD behaviors.  Indeed, treatment of an ASD mouse model with candidate microbial metabolites improves behavioral abnormalities and modulates neuronal excitability in the brain.  We propose that the gut microbiota regulates behaviors in mice via prodn. of neuroactive metabolites, suggesting that gut-brain connections contribute to the pathophysiol. of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzd73CRYRT7Vg90H21EOLACvtfcHk0lhT4nQBK1qtcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVygu7jM&md5=3b84255db0d5e465e480537a4f8084cc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2019.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2019.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DSharon%26aufirst%3DG.%26aulast%3DCruz%26aufirst%3DN.%2BJ.%26aulast%3DKang%26aufirst%3DD.%2BW.%26aulast%3DGandal%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DZink%26aufirst%3DE.%2BM.%26aulast%3DCasey%26aufirst%3DC.%2BP.%26aulast%3DTaylor%26aufirst%3DB.%2BC.%26aulast%3DLane%26aufirst%3DC.%2BJ.%26aulast%3DBramer%26aufirst%3DL.%2BM.%26aulast%3DIsern%26aufirst%3DN.%2BG.%26aulast%3DHoyt%26aufirst%3DD.%2BW.%26aulast%3DNoecker%26aufirst%3DC.%26aulast%3DSweredoski%26aufirst%3DM.%2BJ.%26aulast%3DMoradian%26aufirst%3DA.%26aulast%3DBorenstein%26aufirst%3DE.%26aulast%3DJansson%26aufirst%3DJ.%2BK.%26aulast%3DKnight%26aufirst%3DR.%26aulast%3DMetz%26aufirst%3DT.%2BO.%26aulast%3DLois%26aufirst%3DC.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DKrajmalnik-Brown%26aufirst%3DR.%26aulast%3DMazmanian%26aufirst%3DS.%2BK.%26atitle%3DHuman%2520gut%2520microbiota%2520from%2520autism%2520spectrum%2520disorder%2520promote%2520behavioral%2520symptoms%2520in%2520mice%26jtitle%3DCell%26date%3D2019%26volume%3D177%26spage%3D1600%26doi%3D10.1016%2Fj.cell.2019.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomaeus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakoub, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoges, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsvetkov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krannich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wundersitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusche-Vihrog, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollasch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhumadilov, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozhakhmetov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushugulova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rump, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forslund, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegbauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilck, N.</span></span> <span> </span><span class="NLM_article-title">Short-chain fatty acid propionate protects from hypertensive cardiovascular damage</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">1407</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.118.036652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1161%2FCIRCULATIONAHA.118.036652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30586752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks1altrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2019&pages=1407-1421&author=H.+Bartolomaeusauthor=A.+Baloghauthor=M.+Yakoubauthor=S.+Homannauthor=L.+Markoauthor=S.+Hogesauthor=D.+Tsvetkovauthor=A.+Krannichauthor=S.+Wundersitzauthor=E.+G.+Averyauthor=N.+Haaseauthor=K.+Krakerauthor=L.+Heringauthor=M.+Maaseauthor=K.+Kusche-Vihrogauthor=M.+Grandochauthor=J.+Fielitzauthor=S.+Kempaauthor=M.+Gollaschauthor=Z.+Zhumadilovauthor=S.+Kozhakhmetovauthor=A.+Kushugulovaauthor=K.+U.+Eckardtauthor=R.+Dechendauthor=L.+C.+Rumpauthor=S.+K.+Forslundauthor=D.+N.+Mullerauthor=J.+Stegbauerauthor=N.+Wilck&title=Short-chain+fatty+acid+propionate+protects+from+hypertensive+cardiovascular+damage&doi=10.1161%2FCIRCULATIONAHA.118.036652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage</span></div><div class="casAuthors">Bartolomaeus, Hendrik; Balogh, Andras; Yakoub, Mina; Homann, Susanne; Marko, Lajos; Hoeges, Sascha; Tsvetkov, Dmitry; Krannich, Alexander; Wundersitz, Sebastian; Avery, Ellen G.; Haase, Nadine; Kraeker, Kristin; Hering, Lydia; Maase, Martina; Kusche-Vihrog, Kristina; Grandoch, Maria; Fielitz, Jens; Kempa, Stefan; Gollasch, Maik; Zhumadilov, Zhaxybay; Kozhakhmetov, Samat; Kushugulova, Almagul; Eckardt, Kai-Uwe; Dechend, Ralf; Rump, Lars Christian; Forslund, Sofia K.; Mueller, Dominik N.; Stegbauer, Johannes; Wilck, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1407-1421</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Arterial hypertension and its organ sequelae show characteristics of T cell-mediated inflammatory diseases.  Exptl. anti-inflammatory therapies have been shown to ameliorate hypertensive end-organ damage.  Recently, the CANTOS study (Canakinumab Antiinflammatory Thrombosis Outcome Study) targeting interleukin-1β demonstrated that anti-inflammatory therapy reduces cardiovascular risk.  The gut microbiome plays a pivotal role in immune homeostasis and cardiovascular health.  Short-chain fatty acids (SCFAs) are produced from dietary fiber by gut bacteria and affect host immune homeostasis.  Here, we investigated effects of the SCFA propionate in 2 different mouse models of hypertensive cardiovascular damage.  Methods: To investigate the effect of SCFAs on hypertensive cardiac damage and atherosclerosis, wild-type NMRI or apolipoprotein E knockout-deficient mice received propionate (200 mmol/L) or control in the drinking water.  To induce hypertension, wild-type NMRI mice were infused with angiotensin II (1.44 mg·kg·d s.c.) for 14 days.  To accelerate the development of atherosclerosis, apolipoprotein E knockout mice were infused with angiotensin II (0.72 mg·kg·d s.c.) for 28 days.  Cardiac damage and atherosclerosis were assessed using histol., echocardiog., in vivo electrophysiol., immunofluorescence, and flow cytometry.  Blood pressure was measured by radiotelemetry.  Regulatory T cell depletion using PC61 antibody was used to examine the mode of action of propionate.  Results: Propionate significantly attenuated cardiac hypertrophy, fibrosis, vascular dysfunction, and hypertension in both models.  Susceptibility to cardiac ventricular arrhythmias was significantly reduced in propionate-treated angiotensin II-infused wild-type NMRI mice.  Aortic atherosclerotic lesion area was significantly decreased in propionate-treated apolipoprotein E knockout-deficient mice.  Systemic inflammation was mitigated by propionate treatment, quantified as a redn. in splenic effector memory T cell frequencies and splenic T helper 17 cells in both models, and a decrease in local cardiac immune cell infiltration in wild-type NMRI mice.  Cardioprotective effects of propionate were abrogated in regulatory T cell-depleted angiotensin II-infused mice, suggesting the effect is regulatory T cell-dependent.  Conclusions: Our data emphasize an immune-modulatory role of SCFAs and their importance for cardiovascular health.  The data suggest that lifestyle modifications leading to augmented SCFA prodn. could be a beneficial nonpharmacol. preventive strategy for patients with hypertensive cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI9q2pZMnlX7Vg90H21EOLACvtfcHk0lhT4nQBK1qtcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks1altrg%253D&md5=55c35a8a7aba56286ce1606c78d17c90</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.118.036652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.118.036652%26sid%3Dliteratum%253Aachs%26aulast%3DBartolomaeus%26aufirst%3DH.%26aulast%3DBalogh%26aufirst%3DA.%26aulast%3DYakoub%26aufirst%3DM.%26aulast%3DHomann%26aufirst%3DS.%26aulast%3DMarko%26aufirst%3DL.%26aulast%3DHoges%26aufirst%3DS.%26aulast%3DTsvetkov%26aufirst%3DD.%26aulast%3DKrannich%26aufirst%3DA.%26aulast%3DWundersitz%26aufirst%3DS.%26aulast%3DAvery%26aufirst%3DE.%2BG.%26aulast%3DHaase%26aufirst%3DN.%26aulast%3DKraker%26aufirst%3DK.%26aulast%3DHering%26aufirst%3DL.%26aulast%3DMaase%26aufirst%3DM.%26aulast%3DKusche-Vihrog%26aufirst%3DK.%26aulast%3DGrandoch%26aufirst%3DM.%26aulast%3DFielitz%26aufirst%3DJ.%26aulast%3DKempa%26aufirst%3DS.%26aulast%3DGollasch%26aufirst%3DM.%26aulast%3DZhumadilov%26aufirst%3DZ.%26aulast%3DKozhakhmetov%26aufirst%3DS.%26aulast%3DKushugulova%26aufirst%3DA.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DRump%26aufirst%3DL.%2BC.%26aulast%3DForslund%26aufirst%3DS.%2BK.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26aulast%3DStegbauer%26aufirst%3DJ.%26aulast%3DWilck%26aufirst%3DN.%26atitle%3DShort-chain%2520fatty%2520acid%2520propionate%2520protects%2520from%2520hypertensive%2520cardiovascular%2520damage%26jtitle%3DCirculation%26date%3D2019%26volume%3D139%26spage%3D1407%26epage%3D1421%26doi%3D10.1161%2FCIRCULATIONAHA.118.036652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghar-Jaffar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shun-Shin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeran, K.</span></span> <span> </span><span class="NLM_article-title">Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and meta-analysis</span>. <i>J. A. M. A</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1580</span>– <span class="NLM_lpage">1591</span>, <span class="refDoi"> DOI: 10.1001/jama.2018.3024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1001%2Fjama.2018.3024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29677303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVCmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2018&pages=1580-1591&author=S.+L.+Zhengauthor=A.+J.+Roddickauthor=R.+Aghar-Jaffarauthor=M.+J.+Shun-Shinauthor=D.+Francisauthor=N.+Oliverauthor=K.+Meeran&title=Association+between+use+of+sodium-glucose+cotransporter+2+inhibitors%2C+glucagon-like+peptide+1+agonists%2C+and+dipeptidyl+peptidase+4+inhibitors+with+all-cause+mortality+in+patients+with+type+2+diabetes%3A+A+systematic+review+and+meta-analysis&doi=10.1001%2Fjama.2018.3024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis</span></div><div class="casAuthors">Zheng, Sean L.; Roddick, Alistair J.; Aghar-Jaffar, Rochan; Shun-Shin, Matthew J.; Francis, Darrel; Oliver, Nick; Meeran, Karim</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1580-1591</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Importance The comparative clin. efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors for treatment of type 2 diabetes is unknown. objective To compare the efficacies of SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors on mortality and cardiovascular end points using network meta-anal. data sources MEDLINE, Embase, Cochrane Library Central Register of Controlled Trials, and published meta-analyses from inception through Oct. 11, 2017. study selection Randomized clin. trials enrolling participants with type 2 diabetes and a follow-up of at least 12 wk were included, for which SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors were compared with either each other or placebo or no treatment. data extn. and synthesis Data were screened by 1 investigator and extd. in duplicate by 2 investigators.  A Bayesian hierarchical network meta-anal. was performed. main outcomes and measures The primary outcome: all-cause mortality; secondary outcomes: cardiovascular (CV) mortality, heart failure (HF) events, myocardial infarction (MI), unstable angina, and stroke; safety end points: adverse events and hypoglycemia. results This network meta-anal. of 236 trials randomizing 176310 participants found SGLT-2 inhibitors (abs. risk difference [RD], -1.0%; hazard ratio [HR], 0.80 [95% credible interval {CrI}, 0.71 to 0.89]) and GLP-1 agonists (abs. RD, -0.6%; HR, 0.88 [95% CrI, 0.81 to 0.94]) were assocd. with significantly lower all-cause mortality than the control groups.  SGLT-2 inhibitors (abs. RD, -0.9%; HR, 0.78 [95% CrI, 0.68 to 0.90]) and GLP-1 agonists (abs. RD, -0.5%; HR, 0.86 [95% CrI, 0.77 to 0.96]) were assocd. with lower mortality than were DPP-4 inhibitors.  DPP-4 inhibitors were not significantly assocd. with lower all-cause mortality (abs. RD, 0.1%; HR, 1.02 [95% CrI, 0.94 to 1.11]) than were the control groups.  SGLT-2 inhibitors (abs. RD, -0.8%; HR, 0.79 [95% CrI, 0.69 to 0.91]) and GLP-1 agonists (abs. RD, -0.5%; HR, 0.85 [95% CrI, 0.77 to 0.94]) were significantly assocd. with lower CV mortality than were the control groups.  SGLT-2 inhibitors were significantly assocd. with lower rates of HF events (abs. RD, -1.1%; HR, 0.62 [95% CrI, 0.54 to 0.72]) and MI (abs. RD, -0.6%; HR, 0.86 [95% CrI, 0.77 to 0.97]) than were the control groups.  GLP-1 agonists were assocd. with a higher risk of adverse events leading to trial withdrawal than were SGLT-2 inhibitors (abs. RD, 5.8%; HR, 1.80 [95% CrI, 1.44 to 2.25]) and DPP-4 inhibitors (abs. RD, 3.1%; HR, 1.93 [95% CrI, 1.59 to 2.35]). conclusions and relevance In this network meta-anal., the use of SGLT-2 inhibitors or GLP-1 agonists was assocd. with lower mortality than DPP-4 inhibitors or placebo or no treatment.  Use of DPP-4 inhibitors was not assocd. with lower mortality than placebo or no treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJe1Scr94JCLVg90H21EOLACvtfcHk0lgs1uvPf0aeUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVCmsLY%253D&md5=b6922dbdcf25ea4580fde2e1498f8b9c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1001%2Fjama.2018.3024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2018.3024%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%2BL.%26aulast%3DRoddick%26aufirst%3DA.%2BJ.%26aulast%3DAghar-Jaffar%26aufirst%3DR.%26aulast%3DShun-Shin%26aufirst%3DM.%2BJ.%26aulast%3DFrancis%26aufirst%3DD.%26aulast%3DOliver%26aufirst%3DN.%26aulast%3DMeeran%26aufirst%3DK.%26atitle%3DAssociation%2520between%2520use%2520of%2520sodium-glucose%2520cotransporter%25202%2520inhibitors%252C%2520glucagon-like%2520peptide%25201%2520agonists%252C%2520and%2520dipeptidyl%2520peptidase%25204%2520inhibitors%2520with%2520all-cause%2520mortality%2520in%2520patients%2520with%2520type%25202%2520diabetes%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJ.%2520A.%2520M.%2520A%26date%3D2018%26volume%3D319%26spage%3D1580%26epage%3D1591%26doi%3D10.1001%2Fjama.2018.3024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomovic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarevic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deljanin-Ilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderluh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smelcerovic, A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1002/med.21513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1002%2Fmed.21513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29806214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVylsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=404-422&author=K.+Tomovicauthor=J.+Lazarevicauthor=G.+Kocicauthor=M.+Deljanin-Ilicauthor=M.+Anderluhauthor=A.+Smelcerovic&title=Mechanisms+and+pathways+of+anti-inflammatory+activity+of+DPP-4+inhibitors+in+cardiovascular+and+renal+protection&doi=10.1002%2Fmed.21513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection</span></div><div class="casAuthors">Tomovic, Katarina; Lazarevic, Jelena; Kocic, Gordana; Deljanin-Ilic, Marina; Anderluh, Marko; Smelcerovic, Andrija</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">404-422</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase-4 (DPP-4) cleaves N-terminal dipeptides, with Pro, Ala or Ser at the penultimate position, and, in that way, modulates biol. activity of certain polypeptides.  Due to its ubiquitous distribution, many pathol. processes are assocd. with altered DPP-4 expression and activity.  Besides the regulation of glucose metab., DPP-4 also exhibits many other systemic effects, and the inhibition of its activity might lead to cardiovascular and renal protection.  Mechanisms underlying these protective effects of DPP-4 inhibition are ascribed to elevated bioavailability of its substrates, to impacts on mediators and signaling pathways that ameliorate cardiovascular and renal function through the suppression of oxidative stress, inflammation, fibrosis and apoptosis, improved endothelial function and tissue reparation.  Inflammation contributes to and promotes progression of cardiovascular and renal disorders.  Herein, we discuss cellular and mol. mechanisms mediating the anti-inflammatory activity of clin. used DPP-4 inhibitors in cardiovascular and renal protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Su3xWAKUWbVg90H21EOLACvtfcHk0lgs1uvPf0aeUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVylsLnP&md5=87a742ddc5cbf260ea34dc2140f411e6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fmed.21513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21513%26sid%3Dliteratum%253Aachs%26aulast%3DTomovic%26aufirst%3DK.%26aulast%3DLazarevic%26aufirst%3DJ.%26aulast%3DKocic%26aufirst%3DG.%26aulast%3DDeljanin-Ilic%26aufirst%3DM.%26aulast%3DAnderluh%26aufirst%3DM.%26aulast%3DSmelcerovic%26aufirst%3DA.%26atitle%3DMechanisms%2520and%2520pathways%2520of%2520anti-inflammatory%2520activity%2520of%2520DPP-4%2520inhibitors%2520in%2520cardiovascular%2520and%2520renal%2520protection%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D404%26epage%3D422%26doi%3D10.1002%2Fmed.21513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, C. F.</span></span> <span> </span><span class="NLM_article-title">A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/dom.13135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1111%2Fdom.13135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=34-46&author=C.+F.+Deacon&title=A+review+of+dipeptidyl+peptidase-4+inhibitors.+Hot+topics+from+randomized+controlled+trials&doi=10.1111%2Fdom.13135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Do we know the true mechanism of action of the DPP-4 inhibitors?</span></div><div class="casAuthors">Andersen, Emilie S.; Deacon, Carolyn F.; Holst, Jens J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-41</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The prevalence of type 2 diabetes is increasing, which is alarming because of its serious complications.  Anti-diabetic treatment aims to control glucose homeostasis as tightly as possible in order to reduce these complications.  Dipeptidyl peptidase-4 (DPP-4) inhibitors are a recent addn. to the anti-diabetic treatment modalities, and have become widely accepted because of their good efficacy, their benign side-effect profile and their low hypoglycemia risk.  The actions of DPP-4 inhibitors are not direct, but rather are mediated indirectly through preservation of the substrates they protect from degrdn.  The two incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, are known substrates, but other incretin-independent mechanisms may also be involved.  It seems likely therefore that the mechanisms of action of DPP-4 inhibitors are more complex than originally thought, and may involve several substrates and encompass local paracrine, systemic endocrine and neural pathways, which are discussed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriEo3tDF-sUbVg90H21EOLACvtfcHk0ljLuupuTcqpaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCktbjL&md5=2d2783806da287d3bb50b932056fb5d2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fdom.13135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13135%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DA%2520review%2520of%2520dipeptidyl%2520peptidase-4%2520inhibitors.%2520Hot%2520topics%2520from%2520randomized%2520controlled%2520trials%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2018%26volume%3D20%26spage%3D34%26epage%3D46%26doi%3D10.1111%2Fdom.13135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Home, P.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular outcome trials of glucose-lowering medications: an update</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4801-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1007%2Fs00125-018-4801-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30607467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyrsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=357-369&author=P.+Home&title=Cardiovascular+outcome+trials+of+glucose-lowering+medications%3A+an+update&doi=10.1007%2Fs00125-018-4801-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular outcome trials of glucose-lowering medications: an update</span></div><div class="casAuthors">Home, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-369</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Three further cardiovascular (CV) outcome studies of glucose-lowering drugs (linagliptin, albiglutide and dapagliflozin) have recently been published, adding to the twelve earlier within-class studies.  The linagliptin study (CARMELINA) recruited people with renal disease as well as prior CV events and confirms the overall CV safety (and other safety) of the dipeptidylpeptidase-4 (DPP4) inhibitors, with no heart failure risk assocd. with this agent.  However, taken together with the findings from two previous studies of DPP4 inhibitors (sitagliptin and saxagliptin), the three DPP4 inhibitor CV outcome trials (CVOTs) have highlighted a safety signal regarding risk of pancreatitis.  Like CARMELINA, the albiglutide study (Harmony Outcome) had a very high CV event rate.  Despite being a short duration study, albiglutide showed strong superiority for redn. in the major adverse CV events (MACE) composite in people with extant cardiovascular disease (CVD), in line with the earlier studies on the GLP-1 receptor agonists (GLP-1RAs) liraglutide and semaglutide.  Pos. effects can be detected for all these medications from before 12 mo and continue for the whole study duration.  No new safety issues for albiglutide are identified and the lack of a pancreatitis or a pancreatic cancer signal for this class is now clear.  For the sodium-glucose cotransporter-2 (SGLT2) inhibitor class, the DECLARE-TIMI 58 study (of dapagliflozin) clearly indicates strong protection for heart failure in those with CVD, and probably in those with no prior CVD.  There is also strong protection against renal decline with dapagliflozin, with similar risk ests. in DECLARE as previously reported for empagliflozin and canagliflozin.  However, findings for MACE outcomes with dapagliflozin are not concordant with the empagliflozin and canagliflozin studies, and are not convincingly superior across class and for the longer term.  Care is required when prescribing the SGLT2 inhibitor class of medications to people with foot vascular issues or prior amputation, and to insulin users in regard of ketoacidosis.  In summary, taking into account the findings from these new studies, it is suggested that a GLP-1RA should be offered to all people with CVD and type 2 diabetes, and SGLT2 inhibitors should be prescribed for those at high risk of heart failure or with progressive decline in eGFR.  DPP4 inhibitors are a safe choice within the glucose-lowering stepped algorithm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPxrbhQh-aCbVg90H21EOLACvtfcHk0ljLuupuTcqpaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyrsLjO&md5=e3685b3b5094e126fd118737e1ed6c60</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4801-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4801-1%26sid%3Dliteratum%253Aachs%26aulast%3DHome%26aufirst%3DP.%26atitle%3DCardiovascular%2520outcome%2520trials%2520of%2520glucose-lowering%2520medications%253A%2520an%2520update%26jtitle%3DDiabetologia%26date%3D2019%26volume%3D62%26spage%3D357%26epage%3D369%26doi%3D10.1007%2Fs00125-018-4801-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheen, A. J.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies</span>. <i>Diabetes Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1016/j.diabet.2018.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.diabet.2018.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30126735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtV2lsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2018&pages=386-392&author=A.+J.+Scheen&title=Cardiovascular+safety+of+DPP-4+inhibitors+compared+with+sulphonylureas%3A+Results+of+randomized+controlled+trials+and+observational+studies&doi=10.1016%2Fj.diabet.2018.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies</span></div><div class="casAuthors">Scheen, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes & Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">DIMEFW</span>;
        ISSN:<span class="NLM_cas:issn">1262-3636</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">After failure of metformin monotherapy, another glucose-lowering agent should be added to improve glucose control.  The clinician has several pharmacol. choices, including the addn. of a sulfonylurea (SU) or a dipeptidyl peptidase-4 inhibitor (DPP-4i).  While the cardiovascular safety of SUs remains a matter of controversy, DPP-4is have proven their non-inferiority vs placebo in recent cardiovascular (CV) outcome trials.  In the absence of a head-to-head CV outcome trial-the CAROLINA, comparing linagliptin with glimepiride, is still ongoing-only indirect information can be found in the literature to compare CV outcomes (major CV events, myocardial infarction, ischemic stroke, CV death and all-cause mortality) in patients with type 2 diabetes mellitus (T2DM) treated with SUs or DPP-4is.  Thus, this comprehensive review summarizes the CV outcomes (excluding heart failure) reported in meta-analyses of randomized controlled trials (RCTs) of SUs vs placebo or other glucose-lowering agents, DPP-4is vs placebo or other glucose-lowering agents and SUs vs DPP-4is in phase-II/III studies.  Also, the results of observational studies reporting CV events in patients treated with either SUs or DPP-4is have been carefully examd.  Overall, the CV safety of SUs appears to be poorer than that of DPP-4is in both RCTs and cohort studies.  However, the results are somewhat disparate, and such heterogeneity may be explained by different patient characteristics across studies, but also perhaps by differences between various mols. in each pharmacol. class.  In particular, some doubt about a class effect affecting SU CV safety has been raised.  The results of CAROLINA are expected to shed more light on SU CV concerns, esp. compared with DPP-4is.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj98Szvgx5PbVg90H21EOLACvtfcHk0ljLuupuTcqpaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtV2lsLbP&md5=700ccc408771016bc561b8e69ba0039d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.diabet.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabet.2018.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DScheen%26aufirst%3DA.%2BJ.%26atitle%3DCardiovascular%2520safety%2520of%2520DPP-4%2520inhibitors%2520compared%2520with%2520sulphonylureas%253A%2520Results%2520of%2520randomized%2520controlled%2520trials%2520and%2520observational%2520studies%26jtitle%3DDiabetes%2520Metab.%26date%3D2018%26volume%3D44%26spage%3D386%26epage%3D392%26doi%3D10.1016%2Fj.diabet.2018.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M.</span></span> <span> </span><span class="NLM_article-title">The alchemist’s nightmare: Might mesenchymal stem cells that are recruited to repair the injured heart be transformed into fibroblasts rather than cardiomyocytes?</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.117.032190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1161%2FCIRCULATIONAHA.117.032190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29735591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVOisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2018&pages=2068-2073&author=M.+Packer&title=The+alchemist%E2%80%99s+nightmare%3A+Might+mesenchymal+stem+cells+that+are+recruited+to+repair+the+injured+heart+be+transformed+into+fibroblasts+rather+than+cardiomyocytes%3F&doi=10.1161%2FCIRCULATIONAHA.117.032190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The Alchemist's Nightmare: Might Mesenchymal Stem Cells That Are Recruited to Repair the Injured Heart Be Transformed Into Fibroblasts Rather Than Cardiomyocytes?</span></div><div class="casAuthors">Packer, Milton</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2068-2073</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The injection of mesenchymal stem cells into the injured myocardium to induce cardiac regeneration has yielded disappointing results, conceivably because cells with cardioreparative potential must be supplied for long periods of time to produce a salutary effect.  Accordingly, investigators have devised ways of directing such cells to the heart on an ongoing basis: by enhancing the action of endogenous peptides that function as cardiac homing signals (eg, stromal cell-derived factor-1).  Stromal cell-derived factor-1 is released during acute cardiac injury and heart failure, but it has a short half-life because of degrdn. by dipeptidyl peptidase-4.  Inhibition of dipeptidyl peptidase-4 potentiates the actions of stromal cell-derived factor-1 and, theor., could enhance cardiac recovery.  However, in large-scale trials in patients with type 2 diabetes mellitus, dipeptidyl peptidase-4 inhibitors have not reduced the risk of atherosclerotic ischemic events, and they have unexpectedly increased the risk of heart failure, most probably heart failure with a preserved ejection fraction.  Such an outcome might be explained if the channeling of mesenchymal stem cells to the heart by the actions of stromal cell-derived factor-1 (esp. from nearby adipose tissue) were followed by the transformation of these cells into fibroblasts rather than cardiomyocytes.  This concern has been supported by exptl. studies; the resulting fibrosis would be expected to exacerbate the pathophysiol. derangements that lead to heart failure with a preserved ejection fraction.  Given the widespread use of dipeptidyl peptidase-4 inhibitors, the possibility that these drugs potentiate the cardiac homing of mesenchymal stem cells that cause myocardial fibrosis (rather than repair) warrants further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq08vqDhxkmobVg90H21EOLACvtfcHk0ljLuupuTcqpaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVOisbw%253D&md5=38b134ebee9403f29dc75f68b99928cf</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.117.032190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.117.032190%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DM.%26atitle%3DThe%2520alchemist%25E2%2580%2599s%2520nightmare%253A%2520Might%2520mesenchymal%2520stem%2520cells%2520that%2520are%2520recruited%2520to%2520repair%2520the%2520injured%2520heart%2520be%2520transformed%2520into%2520fibroblasts%2520rather%2520than%2520cardiomyocytes%253F%26jtitle%3DCirculation%26date%3D2018%26volume%3D137%26spage%3D2068%26epage%3D2073%26doi%3D10.1161%2FCIRCULATIONAHA.117.032190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M.</span></span> <span> </span><span class="NLM_article-title">Do DPP-4 inhibitors cause heart failure events by promoting adrenergically mediated cardiotoxicity? Clues from laboratory models and clinical trials</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.118.312673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1161%2FCIRCRESAHA.118.312673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=29436388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVGnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2018&pages=928-932&author=M.+Packer&title=Do+DPP-4+inhibitors+cause+heart+failure+events+by+promoting+adrenergically+mediated+cardiotoxicity%3F+Clues+from+laboratory+models+and+clinical+trials&doi=10.1161%2FCIRCRESAHA.118.312673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically Mediated Cardiotoxicity?: Clues From Laboratory Models and Clinical Trials</span></div><div class="casAuthors">Packer, Milton</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">928-932</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Rationale: DPP-4 (dipeptidyl peptidase-4) inhibitors have increased the risk of heart failure events in both randomized clin. trials and observational studies, but the mechanisms that underlie their deleterious effect remain to be elucidated.  Previous work has implicated a role of these drugs to promote cardiac fibrosis.  Objective: This article postulates that DPP-4 inhibitors increase the risk of heart failure events by activating the sympathetic nervous system to stimulate cardiomyocyte cell death, and it crystallizes the findings from both exptl. studies and clin. trials that support the hypothesis.  Methods and results: Inhibition of DPP-4 not only potentiates the actions of GLP-1 (glucagon-like peptide-1; which can increase myocardial cAMP) but also potentiates the actions of SDF-1 (stromal cell-derived factor 1), NPY (neuropeptide Y), and substance P to activate the sympathetic nervous system and stimulate β-adrenergic receptors to cause cardiomyocyte apoptosis, presumably through a CaMKII (Ca++/calmodulin-dependent protein kinase II) pathway.  An action of SDF-1 to interfere with cAMP and protein kinase A signaling may account for the absence of a clin. overt pos. chronotropic effect.  This conceptual framework is supported by the apparent ability of β-blocking drugs to attenuate the increased risk of DPP-4 inhibitors in a large-scale clin. trial.  Conclusions: Sympathetic activation may explain the increased risk of heart failure produced by DPP-4 inhibitors.  The proposed mechanism has major implications for clin. care because in the treatment of patients with type 2 diabetes mellitus, DPP-4 inhibitors are widely prescribed, but β-blockers are underutilized because of fears that they might mask hypoglycemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq68cYo2y1Ge7Vg90H21EOLACvtfcHk0lgfHjzAUbxe-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVGnsr0%253D&md5=65cc92af095cc92cc0605f193bac855c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.118.312673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.118.312673%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DM.%26atitle%3DDo%2520DPP-4%2520inhibitors%2520cause%2520heart%2520failure%2520events%2520by%2520promoting%2520adrenergically%2520mediated%2520cardiotoxicity%253F%2520Clues%2520from%2520laboratory%2520models%2520and%2520clinical%2520trials%26jtitle%3DCirc.%2520Res.%26date%3D2018%26volume%3D122%26spage%3D928%26epage%3D932%26doi%3D10.1161%2FCIRCRESAHA.118.312673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sano, M.</span></span> <span> </span><span class="NLM_article-title">Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk</span>. <i>J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.jjcc.2018.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=10.1016%2Fj.jjcc.2018.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=30318179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;key=1%3ACAS%3A280%3ADC%252BB3czptVCmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2019&pages=28-32&author=M.+Sano&title=Mechanism+by+which+dipeptidyl+peptidase-4+inhibitors+increase+the+risk+of+heart+failure+and+possible+differences+in+heart+failure+risk&doi=10.1016%2Fj.jjcc.2018.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk</span></div><div class="casAuthors">Sano Motoaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dipeptidyl peptidase-4 (DPP-4) inhibitors are oral antidiabetic drugs that safely reduce the blood glucose level over the long term.  In Japan, DPP-4 inhibitors have become the oral antidiabetic drugs most frequently prescribed for patients with type 2 diabetes.  However, the results of several cardiovascular outcomes studies have suggested that some DPP-4 inhibitors may increase the risk of hospitalization for heart failure.  In patients with diabetes, heart failure is the most frequent cardiovascular condition, and it has a negative impact on the quality of life as well as being a potentially fatal complication.  Therefore, it is important to determine whether an increased risk of heart failure is associated with certain DPP-4 inhibitors or is a class effect of these drugs.  This review explores the mechanism by which DPP-4 inhibitors may increase the risk of heart failure and possible differences among these drugs.  The available research suggests that DPP-4 inhibitors cause sympathetic activation as a class effect and this may increase the risk of heart failure.  Unlike other DPP-4 inhibitors, sitagliptin and alogliptin are mainly excreted in the urine and suppress renal sodium-hydrogen exchanger 3 activity.  These two drugs did not increase the risk of hospitalization for heart failure in large-scale cardiovascular outcomes studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3yJgEKIPSJkHdcurJClFcfW6udTcc2eYrqDeYU-ycRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czptVCmtA%253D%253D&md5=dbbd6808a97a710648200652384836a7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jjcc.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jjcc.2018.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSano%26aufirst%3DM.%26atitle%3DMechanism%2520by%2520which%2520dipeptidyl%2520peptidase-4%2520inhibitors%2520increase%2520the%2520risk%2520of%2520heart%2520failure%2520and%2520possible%2520differences%2520in%2520heart%2520failure%2520risk%26jtitle%3DJ.%2520Cardiol.%26date%3D2019%26volume%3D73%26spage%3D28%26epage%3D32%26doi%3D10.1016%2Fj.jjcc.2018.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01649">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37118"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01649?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01649</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">DPPIV inhibitory effects of compounds in vitro, the solubility test, Caco-2 permeability assay, the stability test in human and mouse intestinal S9 fraction, in vivo pharmacokinetic study, determina-tion of plasma and intestinal DPPIV activity in vivo, DPP8 and DPP9 inhibitory effect of compounds in vitro, in vitro cytotoxicity test by MTT assay, acute toxicity study of compound <b>7</b> in mice, synthetic chemistry and abbreviations (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_001.pdf">jm9b01649_si_001.pdf (1.04 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01649/suppl_file/jm9b01649_si_002.csv">jm9b01649_si_002.csv (1.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01649&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01649%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-23" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01649" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                980KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679952210e6f3d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
